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DEFINITION OF KEY TERMS 
 
Traditional Medicine: “Diverse health practices, approaches, knowledge and beliefs 
incorporating plant, animal and/ or mineral-based medicines, spiritual therapies, manual 
techniques and exercises, applied singularly or in combination to maintain wellbeing, as well 
as to treat, diagnose or prevent illness” (WHO, 2002d:7).  
 
Herbal Medicine: “Plant-derived material or preparation with therapeutic or other human 
benefits, which contains either raw or processed ingredients from one or more plants” (WHO, 
2005:1).  
 
Over-the-Counter Medicines: Drugs that are produced and dispensed without medical 
prescription and patients buy them by their own initiative (WHO, 2000b)  
 
Packaging: “The container for a product-encompassing the physical appearance of the 
container and including the design, colour, shape, labelling and materials used” (Arens, 1996 
cited in Kuvykaite, Dovaliene, & Navickiene, 2009: 53).  
 
Brand Equity:  “A set of brand assets or liabilities linked to a brand, its name and symbol that 
add to or subtract from the value provided by a product or service to a firm and /or to the firm`s 
customers." (Aaker, 1991:15).   
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ABSTRACT 
  
In a highly competitive drug market, building vibrant brands would ensure that traditional 
herbal medicine companies gain sustainable competitive edge and long term profits. More 
importantly, successful brands need to be recognized as strong and enduring assets that can 
boost the companies` future growth in the industry. Distinctive packaging design is well-
acknowledged to provide less expensive means of creating healthy brands with high 
commercial value. Despite the numerous advantages associated with well-designed packaging 
and brand equity of late, traditional herbal medicine companies are yet to reap the benefits in 
the over-the-counter pharmaceutical market. The purpose of this study was to evaluate the 
influence of packaging and brand equity of herbal drugs in the over-the-counter medicine 
market. The research utilized a quantitative research method to align the research objectives 
with the philosophy underpinning the study. Using a systematic sampling technique, data were 
gathered face-to-face from 348 respondents selected from the herbal medicine market in 
Kumasi metropolis in Ghana. Through structural equation modelling (SEM) technique using 
SPSS Amos 22, the proposed research hypotheses were analysed.  The findings of the research 
indicate that brand loyalty, brand awareness and brand association are the key sources of 
customer perceptions of brand equity in the over-the counter market. Essentially, brand loyalty 
was found to be the most important driver of value for brands in the over-the-counter medicine 
industry. The results also demonstrate that packaging contributes to enhance brand equity 
through the impact of brand loyalty, brand association, perceived quality and brand awareness 
of herbal medicine in the over-the-counter market. The study further found that, among the 
dimensions of brand equity, packaging plays a substantial role in creating brand loyalty in the 
over-the-counter pharmaceutical market. The study recommends that traditional herbal 
medicine companies need to concentrate their efforts on developing brand loyalty given its 
strategic role in the success of a business. Furthermore, traditional herbal medicine companies 
need to consider packaging in their brand-building efforts to strengthen overall brand equity in 
the over-the-counter drug market.     
 
 
 Keywords: Herbal medicine, Over-the-Counter, Brand equity, Packaging, Customers  
 
vi 
 
TABLE OF CONTENTS 
 
DECLARATION ........................................................................................................................ i 
ACKNOWLEGEMENTS ......................................................................................................... ii 
ABBREVIATIONS AND ACRONYMS ................................................................................ iii 
DEFINITION OF KEY TERMS .............................................................................................. iv 
ABSTRACT .............................................................................................................................. v 
LIST OF TABLES ................................................................................................................... xii 
LIST OF FIGURES ............................................................................................................... xiii 
LIST OF APPENDICES ........................................................................................................ xiv 
CHAPTER ONE ........................................................................................................................ 1 
INTRODUCTION AND CONTEXTUALIZATION OF THE STUDY .................................. 1 
1.1 Introduction .......................................................................................................................... 1 
1.2 Background to the Research ................................................................................................ 2 
1.2.1 Health Care System in Ghana ................................................................................... 4 
1.2.2 Health Infrastructure ................................................................................................. 6 
1.2.3 State of Traditional Herbal Medicine in Ghana ........................................................ 8 
1.2.4 Packaging in Ghana ................................................................................................ 10 
1.3 Statement of the Problem ................................................................................................... 12 
1.4 Motivation of the Study ..................................................................................................... 14 
1.5 Purpose of the Research ..................................................................................................... 15 
1.5.1 Specific Objectives ................................................................................................. 15 
1.5.2 Research Questions ................................................................................................. 16 
1.5.3 Study Conceptual Model and Research Hypotheses............................................... 16 
1.6 Significance of the Research .............................................................................................. 17 
1.7 Overview of Research Methodology ................................................................................. 19 
1.8 De-limitation of the Study ................................................................................................. 20 
1.8.1 Product Selection .................................................................................................... 20 
1.8.2 Theoretical and Geographical Boundary ................................................................ 20 
1.9 Structure of the Study ........................................................................................................ 21 
1.10 Chapter Summary ............................................................................................................ 22 
CHAPTER TWO ..................................................................................................................... 24 
LITERATURE REVIEW ........................................................................................................ 24 
vii 
 
2.1 Introduction ........................................................................................................................ 24 
2.2 Traditional Medicine .......................................................................................................... 24 
2.2.1 Traditional Medicine Patronage .............................................................................. 27 
2.2.2 Herbal Medicine ...................................................................................................... 29 
2.2.3 Medicinal Herbal Market ........................................................................................ 32 
2.2.4 Challenges of Herbal Medicine Industry ................................................................ 35 
2.3 Over–the–Counter Medications ......................................................................................... 38 
2.3.1 Over–the–Counter Medications and Health Care Delivery .................................... 39 
2.3.2 Adverse Effects of Over-the-Counter Medications ................................................ 43 
2.4 Overview of Packaging ...................................................................................................... 45 
2.4.1 Pharmaceutical Packaging Industry ........................................................................ 47 
2.4.2 Conceptualization of Packaging ............................................................................. 48 
2.4.3 Elements of Good Packaging Design ..................................................................... 50 
2.5 Packaging and Over-the-Counter Drug Market ................................................................. 51 
2.5.1 Functions of Packaging in Over-the-Counter Drug Market.................................... 52 
2.5.2 Logistic Functions ................................................................................................... 53 
2.5.3 Marketing Functions ............................................................................................... 55 
2.5.4 Environmental Functions ........................................................................................ 59 
2.5.5 Packaging and Marketing Mix ................................................................................ 60 
2.6 Components of Packaging Design ..................................................................................... 62 
2.6.1 Visual Elements ...................................................................................................... 65 
2.6.2 Informational Elements ........................................................................................... 71 
2.7 Brands and Products .......................................................................................................... 73 
2.7.1 Branding in the Drug Industry ................................................................................ 74 
2.7.2 Branding Strategies in the Drug Industry ............................................................... 77 
2.8 Definition of Brand Equity ................................................................................................ 79 
2.8.1 Perspectives of Brand Equity .................................................................................. 80 
2.8.2 Customer – Based Brand Equity ............................................................................. 82 
2.8.3 Financial Perspective of Brand Equity ................................................................... 84 
2.8.4 Hybrid Approach to Brand Equity .......................................................................... 85 
2.8.5 Empirical Measures of Brand Equity ...................................................................... 86 
2.8.5 Brand Resonance Model ......................................................................................... 88 
2.9 Chapter Summary .............................................................................................................. 92 
viii 
 
CHAPTER THREE ................................................................................................................. 93 
THEORETICAL AND CONCEPTUAL FRAMEWORK ...................................................... 93 
3.1 Introduction ........................................................................................................................ 93 
3.2 Keller`s Brand Equity Theory ............................................................................................ 93 
3.3 Aaker`s Brand Equity Theory ............................................................................................ 95 
3.3.1 Adopted Customer-Based Brand Equity Theory .................................................... 98 
3.4 Research Hypotheses ......................................................................................................... 99 
3.4.1 Relationship between Brand Equity and its Dimensions ........................................ 99 
3.4.2 Relationship between Packaging and Brand Equity Dimensions ......................... 106 
3.4.3 Study Conceptual Model ....................................................................................... 110 
3.5 Chapter Summary ............................................................................................................ 111 
CHAPTER FOUR ................................................................................................................. 113 
RESEARCH METHODOLOGY .......................................................................................... 113 
4.1 Introduction ...................................................................................................................... 113 
4.2 Research Problem ............................................................................................................ 113 
4.2.1 Purpose of the Study ............................................................................................. 113 
4.2.2 Specific Objectives ............................................................................................... 113 
4.2.3 Research Questions ............................................................................................... 114 
4.2.4 Research Hypotheses ............................................................................................ 114 
4.3 Research Philosophy ........................................................................................................ 115 
4.3.1 Positivist Paradigm ............................................................................................... 115 
4.4 Research Approaches ....................................................................................................... 118 
4.4.1 Quantitative Research Method .............................................................................. 119 
4.5 Research Design............................................................................................................... 120 
4.5.1 Survey Research Strategy ..................................................................................... 120 
4.6 Kumasi Metropolis in Ghana ........................................................................................... 121 
4.7 Study Population .............................................................................................................. 123 
4.8 Sampling Strategy ............................................................................................................ 123 
4.8.1 Sample Size Determination ................................................................................... 124 
4.8.2 Sampling Techniques ............................................................................................ 127 
4.9 Data Sources .................................................................................................................... 128 
4.9.1 Data Collection Instruments ................................................................................. 129 
4.9.2 Questionnaire Design ............................................................................................ 129 
ix 
 
4.9.3 Questionnaire Pilot–Testing .................................................................................. 132 
4.9.4 Questionnaire Administration ............................................................................... 132 
4.9.5 Data Quality Control ............................................................................................. 133 
4.10 Exploratory Factor Analysis .......................................................................................... 135 
4.10.1 Confirmatory Factor Analysis ............................................................................. 136 
4.11 Data Analysis Plan ......................................................................................................... 137 
4.11.1 Data Analysis Procedure ..................................................................................... 138 
4.11.2 Descriptive Statistics ........................................................................................... 138 
4.11.3 Inferential Statistics............................................................................................. 138 
4.12 Ethical Considerations ................................................................................................... 141 
4.13 Chapter Summary .......................................................................................................... 141 
CHAPTER FIVE ................................................................................................................... 143 
DATA ANALYSIS AND PRESENTATION OF RESULTS .............................................. 143 
5.1.1 Research Objectives .............................................................................................. 143 
5.1.2 Research Questions ............................................................................................... 144 
5.1.3 Study Hypotheses .................................................................................................. 144 
5.2 Response Rate .................................................................................................................. 144 
5.3 Data Quality Controls ...................................................................................................... 145 
5.3.1 Reliability of Test Instruments .............................................................................. 145 
5.3.2 Reliability of Test Instruments of Packaging and Brand Equity .......................... 145 
5.3.4 Construct Validity of Packaging and Brand Equity Constructs ............................ 146 
5.4 Demographic Structure of Respondents .......................................................................... 148 
5.4.1 Gender Characteristics .......................................................................................... 148 
5.4.2 Age Structure of Respondents............................................................................... 148 
5.4.3 Educational Characteristics of Respondents ......................................................... 149 
5.4.4 Occupational Distribution of Respondents ........................................................... 150 
5.4.5 Respondents` Expenditure per Day ...................................................................... 150 
5.5 Herbal Medicines Purchased from the OTC Medicine Market ....................................... 151 
5.5.1 Capsules of Herbal Medicines .............................................................................. 151 
5.5.2 Creams / Ointment of Herbal Medicines .............................................................. 152 
5.5.3 Mixtures/ Liquids of Herbal Medicines ................................................................ 152 
5.6 Herbal Medicines Patronage ............................................................................................ 153 
5.6.1 Relationship between Expenditure per Day and Patronage of Herbal Medicines 154 
x 
 
5.6.2 Chi-Square Test of Income Spent per Day and Patronage of Herbal Medicine ... 155 
5.6.3 Respondents` Education Level and Frequency of Patronage of Herbal Medicines
........................................................................................................................................ 155 
5.6.4 Chi-square Statistic of Level of Education and Patronage of Herbal Medicines.. 156 
5.7 Objective One: To Examine Customers` Perceptions of Packaging of Herbal Medicines 
Sold at the OTC Market in Kumasi ....................................................................................... 157 
5.7.1 Packaging Colour .................................................................................................. 157 
5.7.2 Packaging Photography......................................................................................... 157 
5.7.3 Printed Information ............................................................................................... 158 
5.7.4 Packaging Material ............................................................................................... 159 
5.7.5 Packaging Typography ......................................................................................... 160 
5.7.6 Packaging Shape and Size..................................................................................... 161 
5.7.7 Overall Packaging of Herbal Medicine ................................................................. 162 
5.8 Relationship between Packaging and Brand Equity ........................................................ 163 
5.8.1 Factor Analysis ..................................................................................................... 163 
5.8.2 Structural Equation Modelling .............................................................................. 166 
5.8.3 Path Estimates of Packaging and Overall Brand Equity ....................................... 174 
5.8.4 Structural Model Fit Indices of Packaging and Overall Brand Equity ................. 178 
5.8.5 Structural Model Path Diagram of Packaging and Overall Brand Equity ............ 181 
5.9 Summary Results of Hypotheses Testing ........................................................................ 183 
5.9.1 Objective Two: To Examine the Brand Equity of Herbal Medicines in the OTC Drug 
Market ............................................................................................................................ 183 
5.9.2 Relationship between Packaging and Brand Equity Dimensions ......................... 184 
5.10 Chapter Summary .......................................................................................................... 187 
CHAPTER SIX ...................................................................................................................... 188 
DISCUSSIONS OF THE RESEARCH FINDINGS ............................................................. 188 
6.1 Introduction ...................................................................................................................... 188 
6.2 To Examine Customers` Perceptions of Packaging of Herbal Medicines Sold at the OTC
................................................................................................................................................ 188 
Market in Kumasi .................................................................................................................. 188 
6.3 To Examine the Brand Equity of Herbal Medicines in the OTC Drug Market ............... 189 
6.4 To Examine the Influence of Packaging on Brand Awareness in the OTC Drug Market
................................................................................................................................................ 193 
xi 
 
6.5 To Examine the Influence of Packaging on Brand Association in the OTC Medicine Market
................................................................................................................................................ 194 
6.6 To Examine the Influence of Packaging on Perceived Quality in the OTC Drug Market
................................................................................................................................................ 194 
6.7 To Examine the Influence of Packaging on Brand Loyalty in the OTC Drug Market .... 195 
6.8 Chapter Summary ............................................................................................................ 196 
CHAPTER SEVEN ............................................................................................................... 197 
SUMMARY, CONCLUSIONS AND RECOMMENDATIONS ......................................... 197 
7.1 Introduction ...................................................................................................................... 197 
7.2 Summary of the Research ................................................................................................ 197 
7.3 Recommendations ............................................................................................................ 200 
7.4 Contribution to Body of Knowledge................................................................................ 202 
7.5 Limitations of the Research ............................................................................................. 204 
7.6 Direction for Future Research .......................................................................................... 205 
7.7 Conclusion ....................................................................................................................... 206 
LIST OF REFERENCES ....................................................................................................... 209 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
LIST OF TABLES 
 
Table 2. 1: Commonly Used Therapies and Therapeutic Techniques ..................................... 25 
Table 2. 2: Summary of Packaging Design Elements.............................................................. 64 
Table 2. 3: Empirical Studies on Brand Equity Measures ....................................................... 87 
Table 4. 1: Selected Wholesale Herbal Shops…………………………………………... ….126 
Table 4. 2: Selected Retail Herbal Shops ............................................................................... 126 
Table 4. 3: Summary of Sample Size and Method ................................................................ 128 
Table 4. 4: Test Items Development ...................................................................................... 131 
Table 5. 1: Summary of the Response Rate…………………………………………….. ….145 
Table 5. 2: Results of Reliability Test Items of Packaging and Brand Equity ...................... 146 
Table 5. 3: Results of Construct Validity of Packaging and Brand Equity ........................... 147 
Table 5. 4: Gender Characteristics of Respondents ............................................................... 148 
Table 5. 5: Respondents` Age Distribution............................................................................ 149 
Table 5. 6: Educational Characteristics of Respondents ........................................................ 149 
Table 5. 7: Respondents` Occupational Distribution ............................................................. 150 
Table 5. 8: Income Spent by Respondents per Day ............................................................... 151 
Table 5. 9: Capsules of Herbal Medicines ............................................................................. 152 
Table 5. 10: Creams / Ointment of Herbal Drugs .................................................................. 152 
Table 5. 11: Mixtures / Liquids of Herbal Medicines ............................................................ 153 
Table 5. 12: Do you frequently buy herbal drugs? ................................................................ 153 
Table 5. 13: Cross-tabulation of Income Spend per Day and Patronage of Herbal Medicine
........................................................................................................................................ 154 
Table 5. 14: Results of Chi-square Test of Income Spent per Day and Patronage of Herbal 
Medicine ........................................................................................................................ 155 
Table 5. 15: Cross-tabulation of Respondents` Education and Herbal Drugs Patronage ...... 156 
Table 5. 16: Results of Chi-square Test of Level of Education and Patronage of Herbal 
Medicine ........................................................................................................................ 156 
Table 5. 17: Respondents` Perception of Packaging Colour ................................................. 157 
Table 5. 18: Respondents` Perception on Packaging Photography ....................................... 158 
Table 5. 19:  Respondents` View on Printed information ..................................................... 159 
Table 5. 20: Respondents` Perception of Packaging Material ............................................... 160 
Table 5. 21: Respondents` Perception of Packaging Typography ......................................... 161 
Table 5. 22: Respondents` Perception of Packaging Shape and Size .................................... 162 
xiii 
 
Table 5. 23: Respondents` Perception of Overall Packaging of Herbal Medicines ............... 163 
Table 5. 24: Results of KMO and Bartlett's Test of Sphericity ............................................. 164 
Table 5. 25: Results of the Factor Loadings of Packaging and Brand Equity ....................... 165 
Table 5. 26: Packaging and Brand Equity Constructs and their Indicators ........................... 165 
Table 5. 27: Results of Confirmatory Factor Analysis of Packaging and Brand Equity ....... 169 
Table 5. 28: Packaging and Brand Equity Constructs and their Indicators ........................... 170 
Table 5. 29: Model Fit Summary of Confirmatory Factor Analysis...................................... 173 
Table 5. 30: Criteria Used to Assess the Measurement Model Fit ........................................ 174 
Table 5. 31: Path Estimates of Packaging and Overall Brand Equity ................................... 177 
Table 5. 32: Path Model Fit Summary of Packaging and Overall Brand Equity................... 179 
Table 5. 33: Assessing the Structural Model Fit of Packaging and Brand Equity ................. 180 
Table 5. 34: Significant Relationship between Brand Equity and its Dimensions ................ 184 
Table 5. 35: Significant Relationship between Packaging and Overall Brand Equity .......... 185 
Table 5. 36: Summary of Model Fit Measures of Packaging and Brand Equity ................... 186 
 
 
                               
 
LIST OF FIGURES 
 
Figure 1. 1: Proposed Conceptual Model of the Study ............................................................ 17 
Figure 2. 1: Packaging Functions in the OTC Market………………………………… …..52 
Figure 2. 2: Approaches of Brand Equity Measures ................................................................ 82 
Figure 2. 3: Brand Resonance Pyramid ................................................................................... 90 
Figure 3. 1: Keller`s Customer-Based Brand Equity Model……………………………. …...95 
Figure 3. 2: Aaker`s Brand Equity Model ............................................................................... 97 
Figure 3. 3: Study Conceptual Framework ............................................................................ 111 
Figure 4. 1: Research Approaches………………………………………………………. ….118 
Figure 5. 1: Path Diagram of Measurement Model of Packaging and Brand Equity…… ….171 
Figure 5. 2: Path Diagram of Structural Model of Packaging and Brand Equity .................. 182 
Figure 5. 3: Research Model of Relationship between Packaging and Brand Equity ........... 186 
 
 
 
 
xiv 
 
LIST OF APPENDICES 
 
 Appendix 1A: Herbal Drug Capsules Bought by Participants……………………………..243  
Appendix 1B: Herbal Drug Ointment Bought by Participants……………………………...243  
Appendix 1C: Herbal Drug Mixture Bought by Participants………………………………..244  
Appendix 2: Informed Consent……………………………………………………………...245 
Appendix 3: Questionnaire………………………………………………………………….247  
Appendix 4: Turnitin Originality Report……………………………………………………253  
Appendix 5: Ethical Clearance Certificate…………………………………………………..254  
Appendix 6: Gatekeepers Letters…………………………………………………………....255  
Appendix 7: Editing Confirmation …………………………………………………………261 
 
 
 
 
 
 
1  
  
CHAPTER ONE  
  
INTRODUCTION AND CONTEXTUALIZATION OF THE STUDY 
  
This chapter provides the introductory part of the study, specifically, the background 
information, research problem, rationale, scope, research objectives and questions as well as 
the contributions, ethical considerations and limitations of the research.   
  
1.1 Introduction  
The customer market is growing steadily and the number of closely-related products sold in 
the retail markets keeps on increasing every year. Firms are searching for new ways to gain 
competitive distinctiveness for providing products that will stand out from the clutter to satisfy 
their customers. One of the essential marketing elements in today`s competitive environment 
used to position products differently from that of competitors is packaging design. Packaging 
design is recognized as one of the important brand-building elements that distinguishes the 
brand from that of competitors and attracts and sustains customers’ attention to the brand. It 
also strengthens its position and maintains its share in the market, and overall contributes to 
the sales and profitability of the brand (Garber, Burke, & Morgan, 2000a; Brodersen & 
Manolova, 2008).  
  
Branding has existed for centuries and over the years, successful companies have been building 
strong brands to create value over and above competition to satisfy their customers` needs and 
wants. This is the core objective of marketing strategy: to gain competitive advantage to 
accomplish growth.    
  
Due to changes in customer lifestyle and an increase in self-service in the retail environment, 
packaging design has always been used as a major vehicle for advertising brands at the point 
of-purchase and is a dominant influencer in customer-buying decisions in the store (Brodersen 
& Manolova, 2008). As a result, packaging design has become an essential part of the 
marketing strategies of customer-packaged goods industry. In the over-the-counter (OTC) drug 
market, medicinal products are packaged by combining colours, shapes, images, symbols, 
graphics and messages, and has been key element for identification and differentiation of 
medicinal products` brands which engenders safe use of medicines.  Arguably, the significance 
2  
  
of product packaging as a promotional and brand-building tool has been increasing (Rettie & 
Brewer, 2000), as packaging is considered as one of the invaluable brand attributes for creating 
strong brands with positive equity (Keller, 2013). Building powerful brands has been widely 
acknowledged as the most valuable intangible asset of a company because it adds financial 
value to the company. Indeed, in a highly competitive market, products or services can be 
copied by competitors but it is almost impossible to duplicate a brand as it represents the 
attitudes and beliefs strongly registered in the memory (Keller, 2013; Dickov & Igić, 2013).   
  
1.2 Background to the Research  
The importance of herbal medicines in the primary health care has received worldwide 
attention, despite the widespread use of conventional drugs in the health care delivery in the 
world over. It is estimated that about 70 to 95 percent of the people living in the less developed 
countries depend upon medicinal plant products for basic medical care (WHO, 2011). In 
Ghana, approximately 80 percent of the populace depends on plant medicines for their basic 
health care needs (UNDP, 2007).   
  
Herbal medicines consist of processed plant materials or raw plant materials as well as herbal 
medicinal products with therapeutic or human benefits derived from one or more plants (WHO, 
1998:5). In Ghana, medicinal plant products are produced by small-scale traditional medicine 
firms and these products are usually in the form of mixtures, capsules, pills, tablets, creams and 
ointments. These medicinal herbal products are distributed in pharmaceutical stores, chemist 
shops, hospitals and clinics, herbal shops and by licensed practitioners (WHO, 2011; Essegbey,  
Awuni, Essegbey, Akuffobea, & Mica, 2014; WHO, 2005). Herbal medicines are bought to 
combat minor sickness, maintenance or fitness of health and also for chronic ailments 
(Samojlik, 2013 cited by Naresh & Reddy, 2016), and are often used as OTC drugs (WHO, 
2011; Essegbey et al., 2014; WHO, 2005).   
  
Medicinal product packaging is considered as an essential regulatory requirement (GFDA, 
2013), and it is a key element in the sale of prescription and non-prescription medications. In 
the OTC product market, medicines are usually bought without prescription, and packaging is 
the key element that conveys comprehensive information critical to the effective and safe use 
of the drugs by health care providers as well as patients. The package leaflet, together with the 
label is the only source of instruction that patients receive (WHO, 2002a), in order to identify 
3  
  
and select the appropriate medication. Indeed, the role of innovative packaging design in the 
pharmaceutical market cannot be overlooked because it is estimated that 33 percent of all 
medical errors are caused by poor packaging and labelling, whilst 25 percent is attributed to 
confusion over naming that has the potential to cause treatment failures (Berman, 2004). 
Packaging relates to different materials that surround medicinal product from the period of its 
manufacture till consumption (WHO, 2002a:125).   
  
However, in the recent past, the importance of packaging design was overlooked by many drug 
companies and was only considered at the final stage of the production processes (Markets & 
Markets, 2015). And yet, customer product preference is well-influenced by product 
appearance and more importantly, the design of packaging can contribute to the success of the 
product in the market (Kauppinen-Raisanen, 2010). Besides, effective packaging design does 
not only reduce a drug’s adverse events resulting from medication errors (European Medicines 
Agency, 2011), but can also create brand equity (Keller, 2013).   
 
Underwood and Ozanne (1998) are of the view that, due to growing rivalry in business setting, 
the opportunities for packaging to communicate, attract and influence product choice has been 
increasing at the point-of-purchase compared to the traditional promotional tools. Kauppinen-
Raisanen (2010) also argued that, these developments in the customer goods market have 
propelled the growing interest for packaging and design issues among marketers and 
researchers.   
  
Despite the growing importance of packaging design, many firms have not moved beyond their 
industry’s regulatory requirements (Underwood & Ozanne, 1998) to design customer-driven 
packages to build brand equity. Farquhar (1989) defined brand equity as the additional value a 
market offering gains from the branding.  It is, however, emphasized that the pharmaceutical 
industry as a whole has been slow to embrace branding strategies and practices compared to 
their counterparts in the customer-packaged goods industry (Ladha, 2007).   
  
Over the years, the traditional medicine companies, whether small or large have been sustaining 
their sales through innovations ranging from manufacturing processes to products (Essegbey 
et al., 2014). The critical success factors for most traditional medicine practice (TPM) in Ghana 
have been a strong sales force and innovations (Shuiling & Moss, 2004; Essegbey et al., 2014). 
Arguably, there has been lack of brand focus in the industry, and therefore the key assets and 
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competitive strength as well as the source of differentiation were solely dependent on the 
superiority of functional attributes of products rather than brands. It has also been stated that 
companies do not get money by selling products, but through brands (Kapferer, 2008).   
  
Although, there has been steady growth in the sale of herbal medicines in Ghana, the sector is 
now facing challenges and problems in the pharmaceutical market (Kumah, Agyapong, & 
Acheampong, 2015). This is as a result of the increase in cost of research and development, 
keen competition within the industry as well as the influx of conventional medicines and 
complementary and or alternative medicines (CAM) imported from India, China and Korea 
(Essegbey et al., 2014). It has therefore become necessary for herbal medicine manufacturers 
to find new ways to sustain themselves in the market because they cannot rely solely on 
innovations and a powerful sales force to achieve a sustainable edge over competition to 
succeed in the industry.   
  
According to Chaudhary (2011) building a successful brand is one of the powerful competitive 
weapons to break through the competition. It has also been suggested that improvement in 
packaging design has the potential to create strong brands (Keller, 2013). Building strong 
brands represents a new competitive tool (Shuiling & Moss, 2004) which can insulate against 
competitive attacks and entry into the market, and maintain market share (Farquhar, 1989; 
Keller, 2013). This perhaps has been neglected by herbal medicine companies in Ghana in their 
efforts to sustain and increase their market share.   
  
In spite of, the importance of packaging design and branding in the distribution of herbal 
medicines at the OTC drug market, there is little or no comprehensive theory available to 
confirm their significance in the OTC medicines in Ghana. It is in this vein that, there is a need 
to understand the potential influence of packaging design and branding in the distribution of 
medicinal plant products in the OTC pharmaceutical market in the country.  
 
1.2.1 Health Care System in Ghana  
Since independence, Ghana has made remarkable gains in health care delivery through 
improvements in science, technology and medicine. Nations exist to promote the collective 
well-being and the socio-economic development of their citizens. Among the socio-economic 
development priorities of most countries is the health of the populace (Salisu & Prinz, 2009). 
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One of the strategic directions of Ghana`s developmental efforts is to improve human capital 
by making health care the pivot around which productivity and economic growth revolve 
(MOH, 2007). Moreover, the 1992 Constitution of Ghana contains the Directive Principles of 
State Policy which enjoins the state to guarantee the basic human rights of the citizenry which 
include, among other things, the right to good health care for all in the country.   
  
Health has been one of the topical issues in the Millennium Development Goals (MDGs) which 
Ghana has acceded to and has shaped the dynamics of the national health policy. Resources 
were mobilized, and huge investments were made to scale up activities to achieve this and other 
goals by the end of 2015 (MOH, 2007). The primary objective of the national health care 
system is to enhance equity and access to essential and basic health care services (UNDP, 
2007).    
  
Health care in Ghana has been a plural medical system where allopathic health care operates 
side-by-side with traditional medical care. Orthodox health care is the official medical model 
which has well-developed structures as well as quality human resource base (Asante & 
Avornyo, 2013). The emphasis of conventional health care is on curative treatment, preventive 
activities (e.g. antenatal care, family planning) and rehabilitation services. In contrast, the 
traditional health care system focuses on holistic approach to health which ensures a healthy 
balance between mental, physical and social factors, and emphasises the entire patient`s health 
rather than the sickness (UNDP, 2007).   
  
Traditional health care has been dominated by private entrepreneurs and practitioners dotted 
across the country (Asante & Avornyo, 2013). The main components of traditional medical 
care in Ghana are traditional medicine and CAM. In the Ghanaian context, alternative 
medicines are practices and therapies which are not part of the allopathic and traditional health 
care system. These practices are magico-religious and most often the combination of the natural 
defensive mechanisms of the body are used as a means of treatment. Alternative medicine is 
new to the health care system in Ghana and includes homeopathy, chiropractic, hydrotherapy, 
acupuncture, naturopathy, radionics and reflexology which are mostly practiced in cities like 
Kumasi, Accra, Tema and Takoradi ( Bodeker, Ong,  Grundy, Burford, & Shein, 2005; UNDP, 
2007).  
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Traditional medical practitioners are categorized into three, namely: traditional birth attendants 
(TBA`s), psychic and traditional healing operators, and herbalists; while a few others specialize 
in circumcision and bone setting. The number of registered traditional medicine providers and 
alternative medical practitioners in the country was estimated to be around 50 000 providing 
different kinds of curative and preventive treatments to ailments such as malaria, infertility, 
hernia, abdominal pains, and asthma. About 70 percent of this number was found in the rural 
communities in the country (UNDP, 2007). It has also been reported that roughly 70% of the 
population use traditional health services while 30 percent depend on orthodox medical care 
(ibid).   
    
1.2.2 Health Infrastructure   
Health infrastructure relates to the facilities and equipment used for the delivery of health 
services, including those that exist in both public and private sectors. The public health services 
are delivered through a network of hospitals, clinics, health and maternity homes. Most of the 
health care services are offered by the state and are managed by Ghana Health Services (GHS) 
and the Ministry of Health (MOH). The health care system encompasses five levels of 
providers in order of increasing scope. The first level is the health posts which offer primary 
health care services to rural communities, followed by health centres and clinics, district, 
regional and tertiary hospitals. These are organized in three different levels: primary, secondary 
and tertiary. Administratively, the national health care system is categorized into community, 
sub-district, and district, regional and national levels. The community and sub-district levels 
provide basic medical care, whiles secondary health care is offered at the district and regional 
levels. The tertiary health care services are delivered in four teaching hospitals in the country. 
Two of them are found in Accra and the others are located in Kumasi and Tamale (UNDP, 
2007). Some of the clinics and hospitals are owned and run by faith-based organizations. It is 
reported that the country has approximately 200 hospitals, while not-for-profit private clinics 
also operate side by side with them providing about two percent of the health care services in 
the country (Adrinkra, 2016).   
  
It has been highlighted that accessibility and availability of health care services impact 
positively on the socio-economic factors that define a country`s economic and socio-political 
growth (Baidoo, 2009). And yet, it is estimated that about 30% of the global population do not 
have daily access to essential modern pharmaceuticals and in some remote parts of Asia, Latin 
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America and Africa as much as 50 percent of the population face acute shortages of them 
(Bodeker et al., 2005; WHO, 2003). Ampofo, Ando, Tetteh, and Bello (2012) are of the view 
that modern medicine is more successful in the advanced countries than in the developing 
regions like Africa. The authors further argue that the high cost of pharmaceutical medicines 
coupled with poor accessibility and congestion in hospitals, clinics and medical facilities 
account for this. Similarly, access to health care facilities in Ghana is not evenly distributed, 
with remote and rural communities experiencing shortages of basic health care facilities 
(clinics, hospitals, etc.) and personnel (medical doctors, nurses, etc.)  (Van de Boom et al., 
2004 cited by Salisu & Prinz, 2009).  It is estimated that only about 35 percent of the population 
have access to allopathic health services, whilst the remaining 65 percent use traditional 
medicine (MOH, 2007).   
  
Despite more Ghanaians relying on traditional medical services, the focus has been on 
allopathic services rather than the development of traditional medicine (ibid). While the 
orthodox health care gets financial assistance from the government because of the soaring 
prices of medical services, the traditional health system receives little or no support from the 
state (Asante & Avornyo, 2013).  Meanwhile, a large proportion of the population are unable 
to access basic health care services largely due to shortage of the health care personnel and the 
high price of health services.   
  
It has also been reported that the ratio of orthodox medical doctor to the population in Ghana 
was around 1: 20 000 in 2000 (Bodeker et al., 2005). Clearly, the low proportion of orthodox 
medical doctors to the population has effect on access to health care which ultimately affects 
the quality, efficiency and the speed of the health care delivery to the people in the country. In 
contrast, the proportion of traditional medical practitioner to the population is 1:400 (Essegbey 
et al., 2014). It has also been reported that there are roughly 224 people for every traditional 
herbal practitioner in Kwahu District compared to about 21 000 people per medical doctor 
(Okanlawon, Akowuai, Siakwa, & Druye, 2011; Rukangira, 2001). In addition, it has been 
confirmed that there is a traditional health care practitioner who is able to provide health care 
in almost every community in the country (Essegbey et al., 2014).   
  
Furthermore, geographical access to health care services in the country has been hindered by 
inadequate financing, sub-optimal spatial distribution of health facilities, hard-to-reach 
communities and broad socio-cultural barriers such as gender. This has forced many rural 
8  
  
residents to walk long distances to access health care (ibid). Past research indicates that most 
people in Ghana live further than 16 kilometres away from a health care facility, whiles about 
half of the population cannot consult a doctor within five kilometres which corresponds to an 
hour walk distance. Moreover, nearly one-quarter of the population reside more than 15 
kilometres from the facility where the doctor can be consulted (van de Boom et al., 2004 cited 
by Salisu & Prinz, 2009). Coupled with this, the provision of excellent health care has been 
hindered by poor ethical standards, inadequate health care facilities, shortage of and uneven 
distribution of health care personnel, and organizational and managerial bottlenecks (MOH, 
2007).  
  
The mode of payment for health care services, known as the “cash and carry” where payment 
was made on the spot by patients also widened the gap in the access of health care services 
between the rural poor and the rich. Even though exemptions were made to this policy, it had 
a limited success in mitigating the financial burden of the vulnerable and the poor to access 
health care. Consequently, the Government established the National Health Insurance Scheme 
(NHIS) in 2005 as a social protection policy for enhancing financial access to secure excellent 
basic health services by the residents. The scheme had total active subscribers of 11.3 million 
as at the end of 2016 (NHIA, 2016). This indicates that the number of people covered by the 
scheme is relatively low to eliminate the problem of affordability which the poor and 
vulnerable were exposed to under the “cash and carry” system.          
  
1.2.3 State of Traditional Herbal Medicine in Ghana  
Medicines are essential to the health care delivery in any country, and an inadequate supply of 
drugs can make the health care system less effective and attractive. Pharmaceuticals are critical 
to the management and prevention of diseases, and to the overall quality of human health. It is 
estimated that medicines constitute nearly 60 to 80 percent of the cost of health care in Ghana 
(MOH, 2004). According to Harper and Gyansa-Lutterodt (2007) approximately 70 percent of 
conventional drugs consumed in Ghana are imported whilst 30 percent are produced by the 
local manufacturers.   
  
However, more than half of the population in Ghana turn to medicinal plant preparations to 
address their basic medical care (UNDP, 2007). Plant medicine is not only near-at-hand and 
relatively cheaper but also many Ghanaians have confidence in it. Coupled with this, the nation 
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has a rich biodiversity and a culture of plant medicine in different forms, as well as wide variety 
of medicinal plants (Ampofo et al., 2012).   
Identifying the potential impact of plant medicines on the health care delivery, successive 
governments have embarked on programmes to consolidate it into a national health care 
system. In 1961, the Ghana Psychic and Traditional Healers Association (GPTHA) was 
established to uphold, promote and protect the traditional health care in the country (Asare, 
2005). This was followed by the setting up in 1975 of a national research institute, known as, 
the Centre for Scientific Research into Plant Medicine (CSRPM), which is currently the Centre 
for Plant Medicine Research (CPMR), to carry out and promote research into herbal medicine 
used by traditional health care providers.   
  
Furthermore, the Traditional and Alternative Medicine Directorate was established in 1991 as 
one of the seven directorates in the Ministry of Health, followed by Food and Drugs Authority 
(FDA) in 1992. The regulation of herbal medicine began when Food and Drugs Law, 1992, 
(P.N.D.C.L, 305B), which also regulates modern medicines was promulgated in 1992. The 
Directorate was set up to bring all traditional medicine practitioners together as a single 
national entity. Moreover, the Ghana Federation of Traditional Medicine Practitioners 
(GHAFTRAM) was established in 1999, which comprises all the various traditional health care 
associations. This is to facilitate the capacity building and sharing of information among 
traditional medical practitioners.   
  
In the year 2000, the government passed the Traditional Medicine Practice Act, 2000 (Act, 
575) for the setting up of the Traditional Medicine Practice Council (TMPC). The Council was 
established in 2010, and is tasked to promote, control and regulate the practice of traditional 
health care. These are carried out through registration, training and licensing as well as 
determining and enforcing the appropriate code of ethics and standard of practice of traditional 
medicines. These functions are performed together with the recognized body of traditional 
health care providers and the Ministry of Health (MOH, 2005).   
  
The Traditional Medicine Practice Council (TMPC) collaborates with the Food and Drugs 
Authority (FDA) to regulate the manufacturing, packaging and/or labelling, advertisement, 
preparation, sale and registration of all scientifically approved medicinal herbal products for 
commercial purposes. However, the Ministry of Health (MOH), through the Traditional and 
Alternative Medicine Directorate has the responsibility to develop policy guidelines to 
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facilitate growth and development within the traditional herbal medicine industry. The 
enactment of these laws suggests that traditional herbal medicines have been integrated into 
the national policy and legislation.  
  
Other allied research institutions, such as, the College of Health Sciences at the University of 
Ghana and the Noguchi Memorial Institute for Medical Research have been offering assistance 
in clinical trials of plant medicinal products. To further enhance the study and practice of plant 
medicine in Ghana, the School of Pharmaceutical Sciences in the Kwame Nkrumah University 
of Science and Technology (KNUST) in Kumasi has mounted a programme in traditional 
medicine practice. Furthermore, the School of Pharmaceutical Sciences in the KNUST, Kumasi 
and the College of Health Sciences in the University of Ghana have undertaken numerous 
studies to promote the effectiveness, safety and quality of herbal medicines to modernize the 
industry (Asante & Avornyo, 2013).   
  
In 2012, herbal clinics were introduced into the national health care system nationwide by the 
Ministry of Health and some government hospitals have herbal medicine units across the entire 
country (Asare, 2015). More importantly, some herbal medicines have been added to the 
Essential Drug List by the Ministry of Health, which is an important move to use state 
procurement as a means to expand the market size for plant medicine (Essegbey et al., 2014; 
Kraemer & Wunsch-Vincent, 2016).  
  
1.2.4 Packaging in Ghana  
The Ghanaian economy has seen massive development of late. This is mainly due to the 
liberalization of the economy over the past decades by successive governments. This has led 
to intense competition in the domestic market, specifically, goods imported from India, China 
and Malaysia. As a result, customers are now demanding quality packaged customer goods due 
to their exposure to well-packaged imported products. This development has led to a high 
demand for packaging materials (Obeese, 2010).    
  
However, packaging firms sprang up during the late 1950s after the country had gained 
independence and started massive industrialization programme to produce import substitution 
products. The packaging firms built during this period consisted of large corrugated box factory 
and several micro paper and plastic bag firms. Hence, the bulk of packaging materials were 
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imported, and this negatively affected the country`s industrialization drive (Quashiega, 2009 
cited by Obeese, 2010).  
  
The advent of the trade liberalization and economic reform programme in 1990s also resulted 
in setting up of many small and medium paper and plastic firms in Ghana. More local 
converters operating as small-scale firms relied on imported raw materials, rudimentary 
technologies and machinery for production. Most of the small-scale enterprises in Ghana 
depended on the domestic converters to meet their packaging needs. However, local converters 
were not able to meet the high demand for quality packages needed by several small-scale firms 
in the country. Consequently, when local supplies were inadequate, post-customer packages, 
such as, corrugated boxes, sacks, plastic bags, jars and glass bottles were used as packaging 
products. In addition, leaves, wicker baskets, newsprints, wooden crates and jute bags were 
often used as packaging materials in Ghana (ibid). For example, most of the traditional 
cornmeal consumed in the southern Ghana is still wrapped with leaves.   
  
However, large scale manufacturing firms and exporters usually relied on imported packaging 
materials to make their product appearance look attractive and comparable to international 
standards (Obeese, 2010). The author further stated that, apart from wood and to some extent 
cotton fabrics, all raw materials for packaging consumables were imported. It has also been 
affirmed that designing the appearance of a product substantially increases the expenditure of 
firms which may ultimately affect their profit margins. Consequently, a large number of 
domestic firms employ low-priced and low-quality packaging materials. Though, customers 
were ever-demanding quality packages that were relatively cheap, the packaging industry were 
not well-developed to satisfy these demands (Essuman, 1990).  
 
However, there was remarkable improvement in the packaging industry when the Institute of 
Packaging Ghana (IPG) and the Advertisers Association of Ghana (AAG) was set up. 
Nevertheless, majority of Made-in Ghana products in the market were not packaged at all and 
even the few packaged ones had not achieved the desired impact on the market (Obeese, 2010). 
In many cases, the package did not adequately safeguard the contents and the product 
information was either inadequate or faded.  Almost, all food products packaged by domestic 
venders and processors were not properly labelled. For example, there was no indication of the 
composition of the product, instructions to use and appropriate storage conditions (Essuman, 
1990), while most traditional herbal medicines were not an exception.   
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In addition, the Director of CPMR, Professor Dominic Edoh stated that, “most local herbal 
medicines fail to meet international standards because of poor packaging and lack of scientific 
data”. The Director further added that, “although most of the orthodox medicines are of quality 
standards, lack of effective packaging continues to affect local companies. “We must repackage 
our products if the country is really in serious development” (Daily Graphic, March 8, 2014).  
Furthermore, a past study indicates that doses of crushed, squeezed and pounded herbal 
medicines were measured in cups, spoons, glasses, pinches and lids depending upon the age of 
the patient, physical status, severity of the disease and the experience of the individual healer 
in the Bongo District in Ghana (Aniah, 2015). This might have made most Made-in-Ghana 
products less competitive in both domestic and international markets.   
  
Despite these unfavourable developments, most traditional medicine practitioners have 
improved their practices by adopting innovations ranging from products, packaging, 
production processes and health care delivery. A wide variety of herbal drugs have been 
produced including capsules, tablets, creams in tubes, pills and liquids packaged in bottles to 
prolong the useful life of the product using quality packaging materials and labelling (Kraemer 
& Wunsch-Vincent,  2016). The authors argued that it is not uncommon to find stocks of herbal 
medicines on the shelves of orthodox pharmacies which an allopathic pharmacist may 
recommend for use. Such products are manufactured in conformity with the quality standards 
of allopathic drugs and drug regulations with complete labels. While, these indicate positive 
development in the plant medicine industry in Ghana, there are quite a number of practitioners 
who are not ready to embrace these innovations to enhance their practices.    
  
1.3 Statement of the Problem  
In recent decades, there has been an increasing demand for herbal drugs to satisfy the health 
care needs in both the developing and developed worlds. It has become important for medicinal 
herbal products to be distinctively packaged and branded to achieve an edge over competition 
to gain access to both domestic and foreign markets (Chaudhary, 2011). In Ghana, many 
locally-manufactured medicinal herbal products sold in the local markets are poorly packaged 
and branded (Business & Finance, 2011; Kumah et al., 2015; Edoh, 2014). It has been 
suggested that, unattractive packaging and ineffective branding is one of the major reasons for 
poor performance of products in the market (Kumah et al., 2015; Business & Finance, 2011).  
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It appears that herbal medicines produced in most advanced countries have been more 
attractively packaged and branded than their counterparts in the less developed economies. It 
has also been reported that about 70 percent of well-packaged products on the shelves of  
Ghanaian shops were imported (Business & Finance, 2011). Lack of effective packaging and 
branding has therefore affected the competitiveness of a large proportion of Made-in-Ghana 
herbal medicinal products in both local and international markets (ibid).  
  
As a marketing tool, innovative packaging design is regarded as an important brand-building 
tool for creating strong brands (Keller, 1993; 2013). It has been highlighted that powerful 
brands have greater name awareness, perceptions of high quality, a positive image, greater   
loyalty and strong channel relationships (Kotler, Armstrong, Saunders, & Wong, 2002), which 
overall contribute to higher profits (Keller, 2013). Furthermore, it has been established that 
customers do not buy products, but brands, (Dickov, 2012); therefore, building strong brands 
provides an effective means to market and sell products (Ladha, 2007).    
  
Although, serious efforts have been made to increase and sustain sales of most Made-in-Ghana 
herbal medicines in the local market, the patronage is low. Ultimately, low demand and lack 
of equity of many herbal medicinal brands can be attributed to poor packaging design. In 
essence, many herbal medicine practitioners, perhaps, have not integrated packaging design in 
their brand-building strategies to create strong brands which is one of the sure ways to secure 
sustainable competitive strength to enhance and maintain market share. It is based upon the 
considerations of the influence of packaging and brand equity on the distribution of herbal 
medicines in the OTC market that the problem statement in this research is developed. The 
problem in this study is as follows:  
 
The introduction of packaging in the strategic brand practices may result in improved 
performance of brands of herbal medicines sold at over-the counter drug market in Kumasi.   
 
Kumasi Metropolis is the second largest commercial city and consequently, the second largest 
commercial centre for plant medicines in the Ghana. It also consists of people with different 
levels of education, income and cultural background (KMA, 2014).     
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1.4 Motivation of the Study  
In the last few years, there has been renewed interest in the demand for herbal medicines to 
meet health care needs in both the developing and developed world. This has engaged the 
attention of researchers and practitioners in the plant medicine industry. In view of this, several 
studies have been undertaken to investigate the significance, efficacy, quality and safety of 
plant medicines on health care delivery (Eisenberg, Kessler, Foster, Norlock, Calkins, & 
Delbanco, 1993; WHO, 1998; Calixto, 2000; Kamboj, 2000; WHO, 2002b; 2003; 2011), but 
there is a limited volume of research on strategies for marketing herbal medicines.  In addition, 
the importance of packaging on customer behaviour in the fast-moving customer goods 
(FMCGs) market is well-documented in marketing theory (Deliya & Parmar, 2012; Silayoi & 
Speece, 2004; 2007; Rundh, 2005; Rettie & Brewer, 2000). However, there is a relative scarcity 
of empirical studies on pharmaceutical packaging and its growing importance, particularly in 
the OTC drug market (Roulette & Droulers, 2005; Kauppinen-Raisanen, 2010; Kauppinen 
Raisanen, Owusu, & Bamfo, 2012).  
Also, a review of marketing literature reveals that many researchers have investigated the 
significance of brand equity in the FMCG market in the past few years (Yoo, Donthu, & Lee, 
2000; Pappu, Quester, & Cooksey, 2005; Gil, Andres, & Martinez, 2007; Buil, Martinez, & de 
Chernatony, 2013; Asif, Abbas, Kashif, Hussain, & Hussain, 2015), but little research have 
been done on the traditional medicine market.   
  
Meanwhile, the limited studies on the significance of brand equity of pharmaceuticals were 
undertaken in the orthodox drug market (e.g. Schuiling & Moss, 2004; Panchal, Khan, & 
Ramesh, 2012; Sanyal & Datta, 2011). Though numerous studies have examined the 
importance of packaging on buyer-purchasing behaviour (Deliya & Parmar, 2012; Silayoi & 
Speece, 2004; 2007; Rundh, 2005; Rettie & Brewer, 2000), very little attention has been 
devoted to the significance of packaging, specifically to investigate their potential impact on 
brand equity (Pieterse, 2013; Keller & Lehmann, 2004). A few studies examining the 
contributions of packaging to brand equity were also undertaken in the traditional customer 
goods industry (Pieterse, 2013; Brodersen & Manolova, 2008). There are, however, little or no 
similar studies in the customer health market, particularly in the plant medicine market.  
 
Marketing has been identified as a critical factor to the success or failure of plant medicine 
industry (De Silva, 1997). Effective packaging design and branding have also been recognized 
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as important marketing elements that can generate sustainable competitive advantage (Keller, 
2013; Aaker, 1992) to ensure growth and survival of a firm. The purpose of this study is to 
examine the influence of packaging and brand equity on herbal medicines sold at over-the-
counter in Kumasi Metropolis. Consequently, this study will contribute to bridge the existing 
gap on the key sources of brand equity, significance of packaging and brand equity in the OTC 
pharmaceutical marketing literature. The study will also provide information to traditional 
medicine practitioners on the key sources of brand equity for building and managing brand 
equity and the strategic importance of packaging to brand equity in the OTC market. This will 
contribute to enrich the strategic packaging and branding decisions of traditional medicine 
practitioners in the industry.  
   
1.5 Purpose of the Research 
The purpose of the study is to examine the influence of packaging and brand equity of herbal 
medicine sold at the OTC in Kumasi Metropolis, Ghana.    
 
1.5.1 Specific Objectives 
The following specific objectives are formulated to address the purpose of the study:  
 To examine customers` perceptions of the packaging of herbal medicine in the OTC 
market in Kumasi   
 To examine the brand equity of herbal medicines in the OTC drug market in Kumasi.    
 To examine the influence of packaging on brand awareness in the OTC drug market in 
Kumasi.  
 To examine the influence of packaging on brand associations in the OTC drug market 
in Kumasi.  
 To examine the influence of packaging on perceived quality in the OTC drug market in 
Kumasi.  
 To examine the influence of packaging on brand loyalty in the OTC drug market in 
Kumasi. 
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1.5.2 Research Questions  
Based on the research objectives, the research questions that guided the study were:  
 What is the customers’ perceptions of packaging of herbal drugs in the OTC market in 
Kumasi?   
 What influence does a brand of herbal medicine have on overall brand equity in the 
OTC drug market in Kumasi?   
 To what extent does packaging influence brand awareness in the OTC pharmaceutical 
market in Kumasi?  
 How does packaging influence brand associations in the OTC medicine market in 
Kumasi?  
 To what extent does packaging influence perceived quality in the OTC drug market in 
Kumasi?  
 How does packaging influence brand loyalty in the OTC pharmaceutical market in 
Kumasi?  
 
1.5.3 Study Conceptual Model and Research Hypotheses 
In accordance with the existing literature, the following conceptual framework was put forward 
to assist in formulating the research hypotheses and their testing to better explain the 
relationship between the constructs in the research as illustrated in Figure 1.1.  
Based on the conceptual framework exhibited in Figure I.1 below, the hypotheses that guided 
the study were as follows;  
 
 H1a: Packaging positively and significantly influence brand awareness 
 H2a: Packaging positively and significantly influence brand association  
 H3a: Packaging positively and significantly influence perceived quality  
 H4a: Packaging positively and significantly influence brand loyalty  
H1b:  Brand awareness positively and significantly influence overall brand equity  
 H2b:  Brand association positively and significantly influence overall brand equity  
 H3b:  Perceived quality positively and significantly influence overall brand equity  
 H4b:  Brand loyalty positively and significantly influence overall brand equity  
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Figure 1. 1: Proposed Conceptual Model of the Study 
 Source:  Developed from Extant Literature  
 
Full details of the proposed conceptual model and the hypotheses are discussed in Chapter 
Three of this research. 
 
1.6 Significance of the Research   
The current research is of immense importance to academia, the manufacturers of herbal 
medicines and the policy-makers in the drug industry as a whole.  
Given the relative scarcity of studies on the importance of packaging in the OTC drug market 
(Kauppinen-Raisanen, 2010; Kauppinen-Raisanen et al., 2012; Roulette & Droulers, 2005), the 
results of the current research did not only exhibit the attributes of packaging but also the 
customer perceptions of packaging of medicinal herbal products. This would guide traditional 
herbal medicine practitioners in their strategic packaging decisions in the OTC health market. 
The study also highlighted the role of packaging in the OTC pharmaceutical market which has 
advanced the current frontiers of knowledge on the significance of packaging in the OTC 
pharmaceutical market in Ghana.     
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Moreover, Keller and Lehmann (2006) emphasized that, apart from the brand name (as one of 
the brand elements) which has been well-studied, little is known about the importance of the 
other cues in the brand theory. The findings of the current study brought to light the key role 
of packaging in supporting the overall value of a brand of medicinal plant products in the OTC 
health market. Consequently, this research could guide practitioners in the traditional health 
industry in their packaging decisions to design quality and distinctive packaging to enhance 
the value of brands in the OTC drug market. This would enhance their competitiveness in the 
OTC pharmaceutical industry.   
  
Coupled with this, this study has added to the previous studies and extant stock of literature on 
branding and packaging as the study brought to the fore the strategic importance of packaging 
to brand loyalty, brand awareness, perceived quality and brand associations, and ultimately, 
the overall value of non-prescription herbal medicines.  
  
Blackett and Robins (2001a) emphasized that the concept of branding in the drug industry is in 
its formative years compared with the extent to which the pharmaceutical marketing as whole 
has developed. Schuiling and Moss (2004) also supported the position of Blackett and Robins 
(2001a) and pointed out that the concept of branding and its practices are not well-documented 
in the pharmaceutical market compared to FMCGs market. The authors further noted that 
“branding within the industry is up to ten years behind that of fast-moving customer goods 
(FMCGs) industry.”  This study has also demonstrated that brand awareness, brand loyalty and 
brand association are brand assets that drive value in the OTC health care market. Furthermore, 
the research has established that brand loyalty is the most important value-creating asset in the 
OTC pharmaceutical market. In this regard, the current research has essentially contributed to 
the expansion of the current frontier of earlier studies and brand marketing literature by 
highlighting the major sources of brand equity of herbal medicines. The results of the study are 
also of immense importance to herbal medicine practitioners as the study could equip them 
with practical knowledge on and insight into the dimensions of brand equity that are critical 
for developing and managing the value of  brands in the OTC health care market.  
  
This study has highlighted the attributes of effective packaging design as well as customer 
perceptions of the packaging of herbal medicines in the OTC market. Consequently, the 
research is of strategic importance to the FDA, Ghana Standards Board, Ministry of Health, 
and other policy makers in the policy formulation of the packaging and /labelling design of 
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herbal medicine, which may not only promote safety and efficacy but also improve the 
commercial value of herbal drugs in Ghana and beyond.   
  
Additionally, the current research is one of the few studies that has examined the empirical 
significance of packaging and brand equity, particularly in the OTC pharmaceutical market. 
As a result, the overall model that emerged from this research would provide useful information 
to academia for future research, especially researchers who are interested in related or similar 
studies on packaging and branding in the customer health industry.   
      
1.7 Overview of Research Methodology  
Here, the focus is to present the summary of the research methodology employed to achieve 
the objectives of the research. A quantitative research method was employed to test the 
statistical significance of the proposed hypotheses in the research. For this purpose, a cross 
sectional survey research design was employed.  
  
Furthermore, through a systematic sampling strategy, a sample of 348 customers who buy 
herbal medicines from the OTC drug market in Kumasi Metropolis participated in the study. 
A stratified sampling was employed to pick a sample of 71 herbal shops to gather data from 
the respondents in Kumasi metropolis.   
   
Survey questionnaires were employed to collect data in the current research due to the limited 
time available to the respondents who were shopping, and the information was obtained by 
face-to-face distributing the questionnaires to the participants at the 71 herbal shops in the 
metropolis.  
The first part of the questionnaire captured the demographic variables of the research 
participants. The second section of the questionnaire was related to the views of the respondents 
on how elements of brand equity influence overall value of the brand. The second part of the 
questionnaire dealt with the perceptions of the respondents on the packaging of medicinal 
herbal products, while the last section covered the impact of packaging on overall brand equity 
of herbal medicines in the OTC medicine market.   
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In order to ensure that the test responses achieved their intended purposes in a consistent 
manner, Cronbach alpha, composite reliability, and exploratory and confirmatory factor 
analyses were undertaken to determine data validity and reliability.   
  
Descriptive statistics were used to capture the demographics of the respondents as well as the 
participants` perceptions of the packaging of herbal medicines. Moreover, a structural equation 
model was employed to determine the significant relationship that existed between packaging 
and customer perceptions of brand equity. Likewise, a structural equation model was employed 
to evaluate the significant relationships that existed between CBBE and its dimensions. All the 
hypotheses formulated in the study were tested by using standardized coefficient and critical 
ratio. Data entry and analysis were done by using IBM SPSS Amos 22.   
  
1.8 De-limitation of the Study   
This section presents the scope of the thesis, which covers product selection, and the 
geographical and theoretical boundaries of the research.  
  
1.8.1 Product Selection  
The research was fundamentally focused on the material part of herbal medicines rather than 
the spiritual aspects. In addition, the study was concerned with medicinal herbal products which 
had undergone scientific testing and had been approved by the FDA and sold in registered 
herbal shops by the TMPC in Kumasi. The aspects of herbal medicine that dealt with fetish 
practices were not part of this research. Furthermore, the study did not cover raw or processed 
medicinal plant materials but rather medicinal herbal products which were fully packaged and 
sold at OTC pharmaceutical markets. The research was also limited to only plant medicines 
produced locally by manufacturers in Ghana and therefore medicinal herbal products foreign 
to the Ghanaian culture such as Alternative Medicines (AM) and/or Complementary and 
Alternative Medicines (CAM) were not included in this research.   
 
1.8.2 Theoretical and Geographical Boundary  
Geographically, the study was limited to Kumasi Metropolis.  Among the pharmaceutical retail 
outlets in Kumasi, only the herbal shops registered by the TMPC were attended to in the study.  
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Moreover, Made-in-Ghana herbal medicines are retailed at both online and retail stores in 
Ghana but this study was limited to only in-store retailing in Kumasi Metropolis in Ghana.   
 
Theoretically, the research dealt only with the concept of packaging, components, and the role 
of packaging in the OTC market as well as its importance to building strong brands with 
positive equity. In contrast, issues relating to packaging material sciences where chemical 
and/or biological properties of each packaging materials were tested with sampled products 
and specifying their optimum barrier properties with regard to their shelf-life were not included 
in the study. Research relating to packaging technology and machinery was also outside the 
ambit of this research.   
 
With respect to the levels of packaging, tertiary package was not given much attention because 
the primary focus of the research was on primary and secondary packaging of herbal medicines. 
The concept of brand equity was critically examined under customer perspectives since the 
study sought to identify customer perceptions of brand equity of herbal medicines in the OTC 
market. In this case, financial and other hybrid approaches to the study of brand equity were 
beyond the limit of the research.  
  
1.9 Structure of the Study   
The research is organized in seven chapters as presented below.   
Chapter One provides the general introduction to the research. This chapter sets out the 
introductory part of the research which entails the background information, the problem under 
investigation, research questions and objectives, delimitations and limitations.  
  
Chapter Two focuses on the literature review part of the study. This relates to the review of 
relevant literature, and explains the concepts of branding, brand equity and its perspectives, 
and packaging and its components as well as its functions in the OTC drug market. It also 
presents relevant literature on OTC medications, herbal medicines and the challenges facing 
the herbal medicine industry. An in-depth literature review provided a better understanding and 
insight into the relevant existing body of knowledge and the emerged trends in the literature. 
This offered a firm theoretical basis on which the research was built, whilst assisting in 
developing and refining the research questions and the objectives.   
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Chapter Three covers the conceptual framework. The chapter presents the concepts and 
constructs to be studied and their theoretical relationships. Here, the relationship between 
packaging and brand equity constructs are discussed to offer a model that illustrates the impact 
of packaging on the overall value of the brand. The chapter also draws on the reviewed 
literature presented in the second chapter in order to obtain a conceptual model to provide focus 
to the study. The conceptual model also assisted in formulating research hypotheses for the 
realization of the research objectives.  
   
Chapter Four presents the research methodology for conducting the research which entails 
procedures and techniques of gathering and analysing the data. Moreover, the research 
philosophy, design and approach is discussed, followed by sampling and sampling techniques, 
the study site and the data source.  
  
Chapter Five provides the findings of the research. This is done by analyzing the data gathered 
from the respondents through various statistical measures and presented in the form of tables 
and figures. The purpose is to extract the data that are linked to the research questions and the 
objectives for a meaningful interpretation.  
  
Chapter Six discusses the findings, which entails comparing the empirical results with other 
pertinent previous studies and literature in relation to the research objectives to provide 
meaningful explanation of the results.  
  
Chapter Seven deals with the summary, conclusion as well as recommendations of the 
research. The chapter brings to the fore the summary of the research, draws conclusions on the 
results, and make recommendations for academic and practical applicability and the possibility 
for future research.   
 
1.10 Chapter Summary  
The present chapter opens with discussions on the background to the current state of the general 
market landscape of herbal medicines in Ghana which gives rise to the statement of the 
problem. Following the research problem, objectives and the accompanying research questions 
were developed. The chapter also presents the overview of the research methodology 
employed, and indicates the scope within which the research was successfully carried out. The 
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next chapter focuses on the examination of the relevant literature to provide a theoretical 
background to the study.     
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CHAPTER TWO 
  
LITERATURE REVIEW  
2.1 Introduction  
The preceding chapter highlighted the introductory part of the research, focusing on 
background to the research, statement of the problem, research objectives and questions, 
conceptual model and hypotheses, de-limitations and limitations of the research. The present 
chapter discusses the relevant literature on packaging and its functions, and brand equity as 
well as OTC medications and herbal medicines in order to bring clarity and focus to the 
research problem.   
  
While justifying the existence of the research gap in the literature which this study attempts to 
address, the review of literature also provides justification for the purpose of the study and the 
hypotheses. Moreover, the review of the literature on the research problem serves as a yardstick 
for comparing the results of the study with those of others, as well as to integrating the research 
findings into the ongoing dialogue in the literature.   
  
2.2 Traditional Medicine   
Across the world, the significance of traditional medicine (TM) for health care has gained much 
attention. Traditional medicine is practiced in almost every part of the world, and in some 
communities, it is the mainstay of the health care delivery. Traditional medicine has 
significantly contributed to the reduction of high mortality and morbidity rates as well as 
disability arising out of diseases like mental disorder, malaria, anaemia, HIV/AIDS, sickle-cell 
and diabetes (Elujoba, Odeleye, & Ogunyemi, 2005). The authors further noted that TM has 
enhanced standard of living by creating employment opportunities and has also developed a 
health care system which covers a wider number of people in the society. It is obvious that an 
improvement in the quality, efficacy and safety of TM can extend health care to more people 
than it has up to now.   
  
Traditional medicine is “the sum total of knowledge, skills and practices based on theories, 
beliefs and experiences indigenous to different cultures, whether explicable or not, used in 
maintenance of health as well as in prevention, diagnosis, improvement or treatment of physical 
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and mental illness”. In certain cultures, animal origin or inorganic materials are added (WHO, 
1978; WHO, 2005:1).    
Alternatively, WHO (2002d:7) defined traditional medicine as “diverse health practices, 
approaches, knowledge and beliefs incorporating plant, animal and/or mineral-based 
medicines, spiritual therapies, manual techniques and exercises, applied singularly or in 
combination to maintain well-being, as well as to treat, diagnose or prevent illness”. Thus, 
traditional health services include a wide range of practices and therapies which differ greatly 
from one country to another, and in most cases, they are affected by personal attitudes, history, 
philosophy and culture (WHO, 2000a).  
  
Among the commonly-used traditional therapies are Chinese medicines, ayurveda, unani, 
naturopathy, homeopathy, osteopathy and chiropractic. Essentially, the dominant therapeutic 
techniques employed by the TM practitioners include plant medicine, acupuncture/ 
acupressure, manual therapies, exercises and spiritual therapies (WHO, 2002d), as shown in 
Table 2.1 below.   
  
 Table 2. 1: Commonly Used Therapies and Therapeutic Techniques 
 Chinese   
Medicine                            
Ayurveda Unani Naturopathy Osteopathy 
 
Homeopathy Chiropractic 
 
Herbal 
medicines 
       
Acupuncture/ 
acupressure 
       
Manual 
therapies 
       
 Spiritual 
therapies 
       
 Exercises        
 
  Commonly incorporates this therapy or therapeutic technique 
 Sometimes incorporates this therapy/ therapeutic technique 
 Incorporates therapeutic touch  
  
 Source: WHO (2000d: 1) 
26  
  
 
 
Among these techniques, acupuncture and herbal medicines are widely-used therapies of 
traditional medicine (TM) and complementary and/ alternative medicine (CAM) (WHO, 
2002b). Generally, the method of treatment adopted by TM practitioners are categorized into: 
medication therapies (plants, mineral-based medicines and/or animal parts), non-medication 
treatment (mental, manual, spiritual and physical treatment) and a combination of medication 
and non-medication therapies (UNESCO, 2013). All these practices impact on the general 
condition of health of a person and may account for broad use of TM.   
  
Broadly, adaptations of these traditional therapies in the developed world are referred to as 
CAM.  
Traditional medicine is also known as “natural medicine,” “non-conventional” or “holistic 
medicine”. The significant differences among the various practices of traditional medicine arise 
from the different cultures of the people who practise them. It has been suggested that 
traditional medicine was an integral part of human culture with greater confidence in it and 
provided a valuable means of managing culturally-linked diseases and other health problems 
(WHO, 1978).   
  
While allopathic practitioners concentrate on a scientific approach to orthodox medicine, 
traditional health care evolved differently. It is much more affected by the historical conditions 
and culture within which it originally developed (WHO, 2002d). To a large extent, the long 
period of experience and accumulated wisdom acquired through a prolonged period of practice 
constitute the substantial skills and knowledge used in traditional medicine.   
  
Some of the traditional therapies have been practised for two thousand years and are still 
effective for the treatment, diagnosis and prevention of physical, mental and social ailments 
(Elujoba et al., 2005). For instance, Artemisia annua, a Chinese herbal medicine, has been used 
for nearly two thousand years and is still effective for fighting against resistant malaria (WHO, 
2003). However, most of these methods and techniques used for treatment are kept in secrecy.    
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2.2.1 Traditional Medicine Patronage  
In recent years, the popularity of traditional medicine across the globe has been increasing 
rapidly. It is reported that in many developing countries, 70 to 95 percent of the populace use 
traditional health services to satisfy their basic health care needs (WHO, 2011). However, it 
has been highlighted that traditional therapy does not only address the basic health needs of the 
people in less-developed nations but also provides alternative health care for combating 
infectious and chronic diseases. For example, World Health Organization (2003) pointed out 
that close to 80 percent of population in Africa rely on non-conventional medicine, primarily 
herbal medicine, for basic health care. Moreover, Mander, Ntuli, Diederichs, and Mavundla 
(2007) highlighted that, approximately 72 percent of the black people in South Africa depend 
on traditional medical services which represent approximately 26.6 million people living in the 
country. The authors further stated that traditional remedies in South Africa are however not 
recognized as inferior to modern medicine but are rather comparable to allopathic medicines 
and essential for managing different ailments where orthodox health care has failed.   
  
According to Thillaivana and Samraj (2014) the high demand for traditional health care in the 
developing nations can be attributed to cultural compatibility, affordability, accessibility and 
availability. For example, World Health Organization (2002b) pointed out that the proportion 
of the traditional health care practitioner to the population in Uganda was between 1:200 and 
1:400. On the other hand, the proportion of the conventional medical health practitioner to the 
people living in the country was around 1:20 000 or even lower. Furthermore, the distribution 
of health care personnel was not even, with the large majority located in the urban centres 
relative to those in rural communities (ibid).   
  
Given the relative scarcity of health care institutions and orthodox health care practitioners in 
Africa, the inclusion of non-conventional health care in the public health services would help 
to achieve the agenda of health care for all in the continent. World Health Organization (2003) 
suggested that the provision of safe and effective traditional medicine can increase accessibility 
to health care around the world. Although, some countries like Republic of Korea, China, 
Democratic People`s Republic of Korea and Vietnam had combined traditional health services 
with the national health care system, by 2003 many countries were still in the process of 
integrating this type of medical services into their national health care system (ibid).  
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For instance, World Health Organization (2002b) reported that non-conventional therapies 
accounted for approximately 40 percent of the national medical services in China. Similarly, 
in India, traditional medicine provided medical services for approximately 65 percent of the 
population (ibid). The indigenous health care practices (such as Ayurveda, Unani, Siddha and 
Tibetan) were officially approved by the government and run parallel to the modern medicine. 
Srivastava, Lambert, and Vietmeyer (1996) noted that the traditional medical care was run 
comparably to the modern heath care in terms of degree of organization and research. The 
authors further stated that in 1996 the traditional health care comprised 55 000 licensed 
pharmacies, 13 770 dispensaries, 7 000 licensed manufacturing firms, 16 990 hospitals, 98 
Ayurveda colleges, and 400 000 registered practitioners, in contrast, with 332 000 registered 
physicians.  
  
It has been argued that, traditional health care practices in Africa are embedded in the culture 
of the belief system and as a result, it is used by all people with different socio-demographic 
characteristics (Bodeker et al., 2005).  For instance, in South Africa, the profile of end-users 
of traditional medicine have cut across various age, education, religion and occupational 
distribution in the country (Mander et al., 2007).   
  
Traditional or alternative medicine does not only satisfy the basic health needs of the people in 
less-developed world but also in developed countries where allopathic medicines dominate the 
national health care system (WHO, 2000a). An empirical study shows that about 70 to 80 
percent of people in advanced countries have used some form of alternative or complementary 
medicine to satisfy their basic health care needs (WHO, 2008).   
  
It has been reported that the percentage of people who have used alternative or complementary 
medicine at one point in their lifetime were 38%, 48%, 42%, 75% and 70% in Belgium, 
Australia, USA, France and Canada respectively (WHO, 2002b). A study conducted by 
Eisenberg et al. (1993) revealed that one in every three adult persons at the age of 18 years or 
older in 1990 in United States had used one form of non-conventional medicine. Furthermore, 
the outcome of the research shows that the estimated number of attendances to practitioners of 
alternative medical care far exceeded the total visits to modern health service providers 
nationwide at the same period. Moreover, the study reported that approximately one in every 
four persons in United States had used alternative medical services in addition to orthodox 
health care for the same health problem. In addition to this, an empirical research indicates that 
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roughly 75 percent of the population suffering from HIV/AIDS in San Francisco, South Africa 
and London had used TM/ CAM (WHO, 2003).    
  
According to WHO (2002b), the widespread and increasing use of TM/CAM in industrialized 
countries was fuelled by greater anxiety about the side effects of conventional medicines, by a 
preference for personalised medical services and by the accessibility to health information. 
Furthermore, prolonging life expectancy is usually accompanied by chronic or debilitating 
diseases like heart disease, cancer, diabetes and mental disorder.  Not only this, complementary 
or alternative therapies appeared to offer more gentle way of managing such diseases than 
modern medicines (ibid).   
  
The global market for traditional medicine is also growing faster annually. It is estimated that 
the value of traditional medicine amounted to US$ 83 billion per annum in 2008, and has been 
expected to grow exponentially (WHO, 2011). In Malaysia, the estimated market for traditional 
medicine was around one billion ringgits annually in 1995 (WHO, 1998).   
  
In addition, expenditure on traditional medicine is rising across the globe. It has been estimated 
that annual expenditures on CAM in Australia, Canada and United Kingdom are US$80 
million, US$240 million and US$230 million respectively. Likewise, in Malaysia, a total of 
US$500 million was expended on yearly basis on CAM relative to US$300 million on 
conventional health services (WHO, 2002b). Not only this, the total plant medicinal products 
trade was estimated at the value of R26.6 billion per year, whilst raw plant materials accounted 
for nearly R520 million annually in 2006 market prices in South Africa (Mander et al., 2007). 
It is also estimated that annual expenditures on traditional therapies in Republic of Korea 
amounted to US$4.4 billion in 2004 and rose to US$7.4 billion in 2009 (WHO, 2012).   
  
2.2.2 Herbal Medicine  
Herbal medicine, also known as phyto-therapeutic agents or phyto-medicines, are standardised 
herbal preparations which are made up of plants for combating health problems (Calixto, 2000:  
180). World Health Organization (2005:1) defined herbal medicine as “plant-derived material 
or preparation with therapeutic or other human benefits, which contains either raw or processed 
ingredients from one or more plants”. In most cases, it is also made up of inorganic materials 
as well as animal origin. According to WHO (2002b), herbal medicine encompasses finished 
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herbal products, herbs, herbal preparations and herbal materials which contain active 
ingredients of plants. The World Health Organization (1998) also categorized herbal medicines 
into three groups which include:  
 
 Processed plant materials: These are plant materials treated according to traditional 
procedures to improve safety and efficacy, and to facilitate their clinical use, or to make 
medicinal preparations. 
 
 Medicinal herbal products: These are finished labelled pharmaceutical products in 
dosage form that contain one or more powdered plant materials, extracts, and purified 
extracts or partially purified active substances isolated from plant materials.   
 
 Raw plant materials: These are also fresh or dry plant materials which are marketed 
whole or simply cut into pieces.  
 
Medicines considered to be combinations of plant materials and chemically active ingredients, 
including chemically defined or isolated constituents of plants, are not recognized as herbal 
medicines (ibid).   
  
Long before orthodox medicines came to widespread use across the world, herbal medicines 
played a vital role in human health care.  Herbal medicines have been and continue to be used 
alongside allopathic drugs around the world in some capacity. Plant medicine is usually used 
to offer the first-line of treatment and primary health care for people both residing in remote 
and poorer communities where it is the only available and affordable health service (WHO, 
2003). World Health Organization (1998) suggested that the interest in herbal remedies as well 
as their utilization have been increasing even in areas where modern medicine is available.  
  
The use of plants for health and medicinal purposes dates back to the beginning of human 
history and much of modern medicines were originated from plant sources (Pal & Shukla, 
2003). The World Health Organization (1998) also highlighted that medicinal plants are 
important ingredients for manufacturing of pharmaceutical medicines. It has been reported that 
not less than one quarter of conventional drugs are obtained from medicinal plants (WHO, 
2011; Sharma, Kumar, Mishra, & Gupta, 2010). Furthermore, it is estimated that between 35 
31  
  
000 and 70 000 plant species have, at least, at one point in time, been utilized in some capacity 
for medical reasons (WHO, 1998).   
  
Calixto (2000) is of the view that herbal medicines have a wide range of therapeutic use but 
may not have strong pharmacological action to offer emergency treatment. The author further 
suggested that herbal medicine exhibits some characteristics which distinguish it from modern 
medicine. These include: active substances are rarely known; setting up of quality measures; 
stability and standardization are possible but difficult, problem of getting quality raw materials; 
suitability for chronic treatments and wide range of therapeutic uses; practical use in folk 
medicine; and less expensive and a well-controlled double-blind clinical and toxicological 
studies to prove their efficacy and safety are rare. Zhang (1998) noted that herbal medicines 
differ from conventional drugs in that herbal medicines are derived from raw plant materials 
in which a part of the plant may contain several natural constituents and are often used over a 
longer period of time.    
  
Herbal medicine is one of the traditional medical practices that primarily use medicinal plant 
preparations for therapy. Many herbal medicines used in traditional health care today have long 
historical record of usage for thousands of years and are embedded in the belief systems of a 
particular ethnic group, before the spread of modern medicines. It has been established that 
prolonged clinical experiences built over several years provide a strong evidence of safety and 
the effectiveness of herbal medicines (WHO, 1998).   
  
However, the renewed interest and increase in consumption of herbal medicines have raised 
concerns about the quality, efficacy and safety of these medicinal products. Although, herbal 
medicines are perceived as natural, they are not always safe. The consumption of some plant 
medicines has caused adverse drug events (WHO, 2005), while others contain chemicals like 
carcinogenicity and hyper-toxicity that have long-term negative side effects (WHO, 1998). 
This phenomenon can be attributed to the wrong choice of plant species; over-dosage; 
contamination by poisonous substances, and adulteration of herbal products with other, 
undisclosed medicines by patients; and the misapplication of herbal medicines by either health 
practitioners or patients, or with other medicines (WHO, 2005).   
  
It has been recommended that, though, herbal medicines have been tested for safety and 
efficacy by way of continued uneventful historical procedures, scientific studies could offer 
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extra proof to meet regulatory requirements (WHO, 1998). Calixto (2000) also suggested that 
plant medicines that are used for treatment, prevention, diagnosis and mitigation of diseases 
must be registered and regulated as pharmaceutical product with proven safety and efficacy.   
  
Herbal medicine has been widely acknowledged as a critical resource that can be harnessed to 
become either another source of health care or complement the national health care system set 
up at all levels of health care delivery. As a result of the strategic importance of herbal 
medicines in health care delivery worldwide, WHO has been supporting member countries by 
designing strategies and policies to be followed to bridge the gap created by modern medicine.  
 
2.2.3 Medicinal Herbal Market   
Nowadays, public interest in plant therapies is growing tremendously in the less-developed 
world as well as in advanced nations. It is estimated that herbal medicines have been the key 
source of basic health care for approximately 75% to 80% of the population in the world, 
particularly the least developed countries (Kamboj, 2000). For much of the developing world, 
herbal medicines are accessible, inexpensive, in sync with culture and more convenient relative 
to conventional drugs (WHO, 1998).   
  
Herbal medicinal products are sold and used in different ways in various regions in the world. 
Some traditional herbal medicines are frequently distributed as prescription and/or non-
prescription drugs, and may be used for self-medication or self-care, home remedies, dietary 
supplement, health or functional foods, and phyto-protectants (WHO, 2011). In Ghana, plant 
medicines are sold as non-prescription medicine and as a separate drug segment (WHO, 2005). 
However, in the United States, plant medicines are sold as dietary supplements in supermarkets 
and grocery stores (Calixto, 2000).  
The author also pointed out that the worldwide increase in demand for herbal medicines is due 
to:   
 preference for natural treatment,  
 fear of possible adverse effect of conventional drugs and the perception that herbal 
therapies are safe, since all over the world millions of people have used herbal treatment 
for many decades,  
 preference for preventive medicine,  
 greater interest in alternative medicine due to ageing population,  
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 tendency towards self- medication,  
 high cost of modern medicine,  
 improvement in quality, safety and efficacy of herbal medicine, and  
 perception that herbal therapies are more effective where orthodox health care has 
failed.     
 
Herbal medicine is more often than not the only cheaper source of treatment, especially, for the 
poorest section of the society. In Ghana and Kenya, the cost of treatment of malaria for a course 
of allopathic anti-malaria drugs amounted to an average out-of-pocket spending of about US$6 
per annum. In contrast, the cost of malaria treatment with herbal medicines was more 
affordable relative to other forms of health care and could even be paid in kind or with a 
physical asset (WHO, 2002b). It has also been pointed out that the expenditure on treating 
malaria at the clinic in Ghana was around US$1.60 whilst the cost of self-treatment with plant 
medicine was only US$0.10 (Ahorlu, 1997 cited by WHO, 2002b). A study also suggests that 
as much as 58 percent of adults in America who consumed traditional herbal therapies 
perceived that they were less costly relative to conventional drugs (Johnston, 1997).   
  
Moreover, research conducted by Adjei (2013) in Wassa Amenfi West District in Ghana 
indicates that herbal medicine is potent for treating conditions like infertility, malaria, sexually 
transmitted infections (STIs), sexual weakness, piles, waist pains, epilepsy, menstrual pains, 
chronic skin diseases, hernia, bone fracture, arthritis and boils. Likewise, two in every five 
Americans (42%) were of the opinion that plant medicines can effectively cure diseases like 
cancer (Johnston, 1997).   
  
In addition, in Mali, Ghana, Zambia and Nigeria plant medicines were used as primary therapy 
for more than 60 percent of children suffering from high fever (WHO, 2003). It is estimated 
that between 30% and 50% of the total consumption of medicine in China was produced from 
traditional herbal preparations (ibid). Indeed, phyto-medicine had been the source of medical 
care of about 40 percent of the urban population and over 90 percent of rural dwellers in China 
(Srivastava et al., 1996).   
  
It has also been suggested that 35 percent of outpatients and 22 percent of inpatients of rural 
people living in China were treated with traditional herbal medicine (WHO, 1998). Similarly, 
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in South Asia, out of the total population of one billion, 800 million depended on plant 
medicines for medical care (ibid). The demand for plant medicines in industrialised nations to 
address primary health care needs increased steadily due to their efficacy, safety and largely 
due to lesser side effects (Kamboj, 2000). The author is also of the view that herbal medicines 
are also suitable for managing age-related diseases, such as, memory loss, osteoporosis which 
are more prevalent in most advanced economies.   
  
These factors have accounted for the rise in the price of plant medicines in the global market 
and have attracted a considerable number of multi-national pharmaceutical companies to 
commercialise herbal medicines (Calixto, 2000). WHO (2003) pointed out that about 90 
percent of people in Germany had used herbal therapies at one time in their lifetime, while 70 
percent of the population in Canada had also consumed herbal remedies at least once.   
The world market for herbal market was higher than US$60 billion (WHO, 2003) and was 
increasing exponentially. It is also estimated that the market for herbal remedies in Europe was 
about US$7 billion in 1997 (Calixto, 2000), and between the period of 2003 and 2004 a total 
value of US$5 billion was mobilised from the sale of medicinal herbal products in Western 
Europe (WHO, 2008). Johnston (1997) noted that nearly 60 million Americans over the age of 
18 years had used herbs to fight against insomnia, burns, colds, allergies, headaches, depression 
and rashes. The author further stated that the resultant boom in demand for herbal remedies 
had about US$3.24 billion market for traditional health services.   
  
In China, the sale of medicinal plant products amounted to US$14 billion in 2005, while in 
Brazil, the total sales revenue was US$160 million in 2007 (WHO, 2008). Andel, Myen, and 
Onselen (2012) pointed out that a total amount of US$7.8 million was realised from the sale of 
951 tons of crude medicinal plant products in 2010 in the Ghanaian market. Medicinal plant 
products have also contributed significantly to China`s pharmaceutical market. For instance, 
medicinal plant products contributed 33.1 percent share in the pharmaceutical market in 1995 
(WHO, 1998).   
  
In Germany and France, the sale of herbal medicines in the European market was estimated at 
around $6 billion in 1991, while in United States the turnover was approximately $4 billion 
(Kamboj, 2000). In Hong Kong, it was estimated that over US$ 260 million worth of herbal 
medicines were imported yearly, and more than 900 processed and raw medicinal plant 
products were distributed in the herbal stores (WHO, 1998). It is also reported that the sale of 
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herbal medicine known as “Kampo medicine” rose from US$1.42 billion in 2007 to US$1.47 
billion in 2008 (WHO, 2012).  Furthermore, a total of US$1.12 billion was realized from the 
sale of CAM in 2008 in Australia (ibid).  
  
According to Calixto (2000) herbal medicines were widely used in Germany for circulatory 
disorders (15%), fatigue and exhaustion (12%), common influenza (38%), headache (25%), 
stomach ulcer (34%), cold (66%), intestinal and /or digestive disease (25%), nervousness 
(21%), bronchitis (15%) and skin disease (15%).    
  
Likewise, the plant medicine market in India was about US$1billion, while the export revenue 
from plant-based crude medicine was around US$80 billion (Kamboj, 2000). Moreover, it is 
recognized that India has a well-documented rich culture and notable practical knowledge in 
traditional herbal medicine. However, it has been emphasized that the role of less-developed 
nations in the international trade of medicinal plant products is insignificant due to poor quality 
and the inability to meet global standards (Sharma et al., 2010).   
  
2.2.4 Challenges of Herbal Medicine Industry  
A major challenge facing the plant medicine industry is apparently the limited scientific 
approach as compared to modern medicine (Essegbey et al., 2014). World Health Organization 
(2010) suggested some criteria for assessing traditional herbal medicines which comprise 
scientific proof of quality, efficacy and safety similar to conventional drugs. Pal and Sukla 
(2003) are of the view that medicinal herbal products are heterogeneous in nature and pose a 
number of challenges to quality controls and assurance as well as regulatory process. 
Consequently, this might have led to an absence of acceptable international benchmarks and a 
suitable scientific approach for measuring the quality, efficacy and safety of plant medicines 
(Ampofo et al., 2010; Sharma et al., 2010).   
  
It has also been highlighted that some traditional health practitioners recognize historical 
empirical evidence as the sufficient criterion for a herbal medicine`s efficacy (Ampofo et al., 
2010).  Essegbey et al. (2014) stated that, though it is often argued that traditional medicinal 
products are not conventional medicine and they must not undergo the stringent and rigorous 
processes and systems of conventional medicines, the aspect of efficacy and quality of medical 
product is of paramount importance.  
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However, it has been emphasized that with the view to undertaking scientific research to 
evaluate traditional medicines, experiences and knowledge gained through prolonged period 
of established practices should be considered (WHO, 2000a).  For example, in Ghana, the 
CPMR was set up to facilitate research, the standardization of herbal medicine preparation and 
safety. And yet, many herbal medicines in circulation in the market had no scientific evidence 
of efficacy, safety and quality (Pal & Sukla, 2003; WHO, 2010; MOH, 2005). This can be 
attributed to the relatively high cost of clinical trials, the poor financial status of practitioners 
and a general lack of human capital and logistics in the research centres (MOH, 2005). An 
empirical study conducted by Raynor, Dickinson, Knapp, Long, and Nicolson (2015) revealed 
that about 93% of the plant medicinal products sampled were not licensed for proof of safety, 
quality and efficacy. Furthermore, the production of most herbal medicine did not meet the 
Good Manufacturing Practices (GMPs), and also lacked standardization.   
De Silva (1997) is also of the view that, developing countries have well-trained personnel in 
science disciplines like pharmacy, chemistry, agricultural, but the absence of resources in the 
fields of technology and chemical engineering has impeded the development of a large-scale 
herbal medicine industry. Although, there is a large market for traditional medicinal products 
in both domestic and international markets, commercialization of medicinal plant products in 
Ghana has been impeded by many factors. These include: poor packaging and /or labelling, 
lack of funding, absence of standardization, poor resource base like personnel, materials, 
technology, and the absence of industries to support the idea of commercialization (MOH, 
2005).   
  
De Silva (1997) suggested that most developing countries were ignorant about the potential 
social and economic benefits of the industrial utilization of medicinal plant products. Except 
for use to meet local health care needs, the real potentials of these medicinal plants had not 
been realized by the government and entrepreneurs. In Ghana, most of the herbal medicine 
manufacturers operate as micro-and small-scale entrepreneurs producing mainly for domestic 
consumption (Essegbey et al., 2014).   
  
In addition, De Silva (1997) noted that many countries in the developing world did not have 
procedures for registration of traditional medicine practitioners and if any, were not stringent 
requiring the same standards as allopathic medicines. In Ghana, however, all forms of 
regulations exist to bring sanity to the practice, but it is still marked by many quack 
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practitioners (hawkers and peddlers). It is often difficult to distinguish between genuine 
practitioners and the quacks which have caused serious damage to the image of the practice 
(UNESCO, 2013; MOH, 2005).  Previous research revealed that in Ghana, out of 107 sampled 
traditional medicine practitioners, 33 percent have not been approved by the TMPC or any of 
the other institutions (Essegbey et al., 2014).   
  
Moreover, the escalating demand of plant-based medicines in both developing and developed 
countries has been met by the wanton harvesting of wild plants from the forest. Because of this, 
many plant species have been endangered and some have become extinct (De Silva, 1997). For 
example, in China, it was estimated that more than 80 percent of 700 000 tons of plant material 
harvested annually is derived from wild sources. The destruction of forest by wild fire, 
overgrazing, and rapid urbanization, expansion of industries as well as excessive gathering of 
wild plants imply that the natural sources of medicinal plant products are being destroyed 
(Srivastava et al., 1996).   
  
The lack of marketing was also regarded as major factor that inhibited the growth of plant 
medicine industry and it was a key element for determining the success or collapse of these 
firms (De Silva, 1997). In Ghana, some of the medicinal plant products are sold in the market, 
lorry stations, wheel-barrows and tables (Essegbey et al., 2014) which suggest that there is lack 
of marketing strategies to enhance the sale of the product. Rukangira (2001) recommended that 
new marketing opportunities need to be researched into as demand grows, and efforts should 
be made to add value to medicinal plant products through processing, efficient packaging and 
storage.   
  
Finally, De Silva, (1997) pointed out that simple and old technologies were used by traditional 
medical practitioners to produce medicines for local use, such as, hot-or-cold water extraction, 
pounding of dried materials, extraction of juice after crushing. These traditional methods were 
dependent on the state of technology that existed at that time. In the author`s view, these 
methods need to be modified and improved by using modern technologies to make them more 
efficient, stable and reproducible, controlled and in dosage form that is portable. The author 
further enumerated some factors that negatively affected the competitiveness of herbal 
medicines in the world market. These include: poor agricultural practices, poor quality control 
procedures, absence of studies on the development of high-yielding varieties, lack of research 
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and development on the product and process development, poor propagation techniques, high 
energy losses during processing, and poor harvesting and post-harvesting treatment practices.   
  
2.3 Over–the–Counter Medications  
Medications often form the major cost component of health care expenditure and other health 
care services. The quantity and quality of drugs that a patient receives during a period of 
treatment is crucial in the health care delivery system. Obviously, access to relatively cheaper 
and quality drugs is one of the critical factors that determine the superiority of the health care 
services. Indeed, a patient`s delight in the medication offered to him is a key factor for the 
utilization of particular medical services and the repeated patronage of the facility (Attridge & 
Preker, 2005).   
In health care delivery, access to medicines is via prescription and/or OTC drug market. 
Prescription-only medicines relate to drugs that are strictly sold to patients by a licensed 
pharmacist through the approval of a registered prescriber (MOH, 2004). These drugs are 
usually sold in pharmacies under the close supervision of a pharmacist.   
  
A distinctive feature of prescription medicines is that customers rarely choose a particular drug 
for their ailments (Kim & King, 2009). Instead, the physician is the ultimate decision-maker 
for the selection of prescription medicines. Quraeshi, Lugmani, and Malhotra (1983) 
emphasized that   promotional strategies are usually aimed at inducing the medical practitioner 
to prescribe the brand name product.    
  
Over-the-counter medicines, also known as non-prescription are medications that are widely 
recognized as safe by following the instructions for use and are bought without a prescription 
(MOH, 2004). Alternatively, WHO (2000b) defines OTC medicines as drugs that are produced 
and dispensed without medical prescription and patients buy them by their own initiative. Non-
prescription drugs are usually bought to treat self-recognized symptoms, transitory conditions 
and chronic diseases or symptoms that require continuous use of medication dispensed by 
health care practitioner (WHO, 2000c). Slatter (1977) referenced by El-Meniawy (1991) 
pointed out that an OTC medicine has been characterized by heavy promotion and multiple 
distribution channels, and the drug scarcely has patent protection. These unique features 
distinguish non-prescription drugs from prescription medications.   
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It is also argued that the major reasons for customer choice of non-prescription treatment 
include: the patient’s familiarity with how to treat a particular condition due to previous 
experience, the view that the ailment is not serious enough to warrant consulting a physician, 
and the desire to save time and money (Pharmacy Today, 2010; NCPIE, 2002). Customers only 
turn to health care professionals for medical assistance if the condition fails to respond, persists, 
or becomes more serious (WHO, 2000c). Consequently, OTC medications have been used for 
first-line of treatment at the onset of illness, especially where access to health care facilities 
and cash to pay for health services were limited (Seiter & Gyansa-Lutherodt, 2009).   
  
It has been suggested that effective and safe use of OTC medication requires the customer to 
assume the responsibility of a physician in treating a patient with prescription drugs. The 
patient therefore needs access to reliable comprehensive information on the label material, 
patient information text, past personal experience, advertisement and advice given by the health 
care practitioner to guarantee safe and effective use of the product (WHO, 2000c). Raynor et 
al. (2011) noted that the key safety information to allow for safe and appropriate use of 
traditional herbal medicine sold at OTC includes precaution and warnings for use by people 
with pre-existing ailments, its possible interactions with other products, and adverse effects. 
This must be supported by how to use the medicine, how the side effects can be monitored, 
duration of use, and when to seek professional advice (WHO, 1998).  
  
In Ghana, herbal remedies are sold as non-prescriptions in the retail pharmacies, licensed 
chemist shops, herbal shops and licensed herbal clinics (WHO, 2005). The licensed chemist 
and herbal medicine sellers are limited by law to dispense only OTC medicine (Pharmacy Act, 
1994, Act 489; TMP Act, 2000, Act, 575). The sale of the herbal medicines in OTC 
pharmaceutical market is not only common in Ghana but also across the world. For example, 
in Europe, Australia and North America, herbal medicinal products can be obtained at the OTC 
drug market (Raynor et al., 2011). An empirical research also indicates that out of the 142 
member countries of WHO, 97 of them dispensed herbal medicines as OTC medicines, while 
the rest (50) were selling herbal medicines as prescription medicines (WHO, 2005).   
  
2.3.1 Over–the–Counter Medications and Health Care Delivery  
Commercialization of pharmaceuticals outside the public health care system is found in most 
parts of the world. Over the past few years, OTC drugs have contributed immensely to the 
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health care delivery system the world over. The sale of non-prescription medications is 
recognised as the most preferred means of treating majority of common ailments as they are 
accessible and offer multiple health care options (DeLorme, Hu, Reid, & Ann, 2010). The 
importance of OTC medications to the overall health care is reflected by the presence of many 
laws and treatment guidelines, (GFDA, 2013; WHO, 2000c), the high frequency at which the 
medicine is recommended by health care practitioners, and the increasing use of the products 
by patients (Pharmacy Today, 2010).  
  
It is widely acknowledged that, in Africa and most developing countries access to medications 
is hindered by inadequate pharmacists and medical doctors to attend to every patient on the 
appropriate use of prescription medicines. This is further aggravated by poverty, mass illiteracy 
and a shortage of health facilities. Consequently, OTC medicines have become a potential 
option for treatment for most people in the developing world (Afolabi, 2012). Past research 
reveals that out of 72 percent of care-givers who sought diarrhoea treatment outside home, 59 
percent of them relied on OTC medicine sellers for health care (SHOPS Project, 2015). 
Essentially, OTC drug sellers are recognised as the major health providers of child health care 
services, especially in rural communities in Ghana.   
While, there were only about 1 600 retail pharmacies in Ghana, the number of licensed OTC 
medicine sellers, excluding herbal medicine sellers, was hovering around 10 000 (Seiter & 
Gyansa-Lutterodt, 2009) across the entire country. Similarly, there were approximately 54 000 
pharmacies in the United States, but the estimated OTC medicine retail outlets exceeded 750 
000 (CHPA, 2012).   
  
In Ghana, the estimated retail value of pharmaceutical market was around US$ 300 million in 
2008. However, the total share of OTC drug market was around 30% of overall value of the 
pharmaceutical market (Seiter & Gyansa-Lutterodt, 2009). The steady growth of the OTC 
pharmaceutical sector in Ghana was attributed mainly to poor access to prescription drugs, the 
introduction of the National Health Insurance Scheme in 2005 which covered non-prescription 
medications, the focus of the domestic industry on the production of OTC products at the 
expense of essential medicines, as well as heavy advertisement (Harper & Gyansa-Lutterodt, 
2007).   
  
Although, industrialized countries have enough health care facilities and personnel, many still 
rely on OTC medications for the treatment of minor health problems. It has been highlighted 
41  
  
that an increasing number of the population in the United States use OTC medicines for the 
treatment and prevention of many ailments. Mostly, OTC remedies were used for allergy or 
sinus problems (45%), cough, cold, influenza or sore throat (52%), pain (78%), skin problems 
(10%), other stomach problems (35%), minor infections (12%), and heartburn, indigestion 
constipation, diarrhoea and gas (21%) (NCPIE, 2002).   
  
According to Customer Healthcare Products Association (2012), about 81 percent of adults in 
United States used OTC medicines as the first-line of treatment for common ailments, whilst 
nearly seven in every ten parents have offered OTC medicines to their children in the night to 
treat sudden medical symptoms. In addition, the availability of OTC medicine provided 
symptomatic relief for an estimated population of 60 million who otherwise would not have 
sought treatment. An empirical evidence also indicates that OTC medicines were the most 
popular first-line treatment for children and adults with fever and acute illness in three districts 
in Kenya (Abuya, Mutemi, Karisa, Ochola, Fegan, & Marsh, 2007).   
  
From the perspective of the customer, OTC remedies provide a wide variety of treatment 
options, greater availability of drugs, direct and rapid access to drugs, convenience as well as 
a lower cost of treatment in terms of reduction in the cost of medical consultations, while at the 
community level, OTC drug treatment can save the limited medical resources from being spent 
on minor ailments and lower community-funded health programmes (WHO, 2000c). This has 
considerably reduced the expenditure on national health care (Dajani, Dajani, & Shahwan, 
2004). Furthermore, OTC medications can reduce absenteeism from work (WHO, 2000c) and 
ultimately increase productivity.   
  
According to CHPA (2012), OTC medicines provide affordable treatment options for patients 
in United States and have also reduced the national budget on health care facilities. Moreover, 
it is estimated that OTC medications saved the United States about US$102 billion annually 
relative to other alternatives, whiles US$17 billion and US$25 billion were saved on the cost 
of clinical trials and drugs respectively (ibid).   
  
The volume of OTC medicines was once estimated to be relatively small, but now they account 
for the majority of all medications in United States. It is estimated that there are over 100 000 
OTC health care products dispensed in the United States, comprising almost 1000 significant 
active ingredients (NCPIE, 2002). It has been highlighted that roughly eighty therapeutic types 
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of non-prescription medications were retailed in United States of America in 2010 (Delorme 
et al., 2010).   
  
It has been suggested that the drug market is among the most flourishing markets globally with 
an estimated world sales revenue of about US$534.8 billion in 2005 (Kim & King, 2009). 
Meanwhile, the global OTC drug market was valued at 86 billion Euros in 2013, with growth 
rate of 4.8% in 2014, exceeding the ethical pharmaceutical sub-sector (AESGP, 2015).   
  
Interestingly, the global market for OTC drugs has been expanding rapidly and several factors 
account for this. First, public interest in self-treatment is increasing (DeLorme et al., 2010) and 
non-prescription medicines have become the backbone of much of the self-medications of 
many diseases and their prevention (Brieger, Unwin, Greer, & Meek, 2005). It is also well- 
acknowledged that OTC medications are more accessible and less expensive means of 
combating common health problems (DeLorme et al., 2010) which ultimately, supports ever- 
increasing desire for self-medication.    
  
Secondly, the worldwide transfer of prescription drugs to OTC status is escalating, leading to 
a rise in the quantity of medicines sold in the OTC market (DeLorme et al., 2010). For example, 
in Ghana, ACT, the anti-malaria drug has been removed from Prescription-Only Medicine 
(POM) list and de-classified to OTC to allow for easy access to the medicines and also to 
promote self-treatment (Harper & Gyansa-Lutterodt, 2007).  In the same vein, in the United 
States of America, products comprising more than eighty active ingredients of different 
therapeutic groups had been transferred from Prescription-Only status to OTC from period of 
1976 to 2000 (WHO, 2000b). Also, the use of OTC medications has been promoted by health 
care professionals as more affordable health care compared to prescription medications 
(DeLorme et al., 2010).   
  
Intensive competitive advertisement coupled with the cross-border sale of pharmaceuticals 
through the internet has created additional demand for self-prescription drugs. For example, it 
is estimated that the number of medicinal products sold via Yahoo and WebCrawler search 
engines as of May 7, 2000 amounted to 16 966 and 244 546 respectively (WHO, 2000b).  
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2.3.2 Adverse Effects of Over-the-Counter Medications  
The potential role of OTC medications on health care has attracted the attention of policy 
makers and health care professionals in recent years.   
It has been argued that the benefits of OTC medications can only be achieved if patients use 
them safely and effectively (Pharmacy Today, 2010). Research indicates that, roughly 82 
percent of Americans have not experienced any form of adverse effects from taking non-
prescription drugs, whilst only 17 percent reported to have negative reactions (NCPIE, 2002). 
Generally, customers perceive OTC remedies to be effective and safe compared to prescription 
drugs. For example, a survey conducted by Ajuoga, Sansgiry, Ngo, and Yeh (2008) suggested 
that 71.6 percent regarded OTC medications as safe, while 73.3 percent perceived them as 
effective for managing HIV/Aids. Moreover, research revealed that about 53 percent of 
American adults who consumed OTC herbal remedies thought that they were effective, whilst 
65 percent perceived them to be safe (Johnston, 1997).   
  
Though, OTC drugs are well-recognised to have a positive safety profile, the public anxiety 
relating to the potential risks remains a matter of concern because of the unrestricted use of 
these medicines (Calamusa, Marzio, Cristofani, Arrighetti, Santaniello, Alfani, & Carducci, 
2012). It is also argued that the increasing availability of OTC medicines in the pharmaceutical 
retail outlets in some countries might have led to abuse, delays in diagnosis and a waste of 
resources (WHO, 1988). People who resort to OTC medications sometimes refuse to seek for 
professional advice for conditions which are critical and desist from self-medication for 
alternative therapies (Shaw, 1998; Mathialagan & Kaur, 2012).   
  
It has however been argued that intentional or unintentional failure to follow the usage 
instructions of medicines is applicable to all categories of medicines whether prescription or 
non-prescription drugs (Pharmacy Today, 2010). Additionally, it has been estimated that, 
globally, over 50 percent of all drugs have been sold, dispensed or prescribed wrongly, while 
50 percent of patients failed to take them correctly (WHO, 2002c).   
  
However, many developing countries are faced with an acute shortage of pharmacists and 
qualified dispensing staff to run chemist stores, coupled with poor regulatory mechanisms at 
the grass-root level as well as inefficient storage facilities. The potential effect of this situation 
is poor dispensing and irrational use of medicines in the community that can ultimately result 
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in increased drug resistance (Harper & Gyansa-Lutterodt, 2007). Previous research indicates 
that, out of a sampled population of 215, 37.2% (80) of the respondents had misused OTC 
medications in one way or the other while, out of a total of 380 medicines consumed, 31.9% 
had been misused (Ajuoba et al., 2008).   
  
Moreover, there is misconception among customers that if a medicinal herbal product is 
described as a “natural” and increasing the dosage can boost its effectiveness. This can rather 
cause persistent overdose of the product. For example, a past customer survey indicates that 
about 33 percent of Americans took more than the recommended dosage of OTC medication 
for the simple reason that they thought that the efficacy of the products would increase (NCPIE, 
2002). In addition, overdose could also arise when two or more OTC drugs are taken which are 
used for the same treatment of an ailment (Shaw, 1998). An empirical research revealed that 
almost 36 percent of Americans were more likely to use multiple OTC medicines when they 
have more than one symptoms, such as, headache and sore throat (NCPIE, 2002).  
   
Furthermore, non-prescription medications usually interact with many prescription-only 
pharmaceuticals and other products, such as, food and alcohol. Unfortunately, before a 
prescription is made, the physician may not investigate whether the patient is using any OTC 
drugs (WHO, 2000b). Similarly, several patients fail to inform doctors about non-prescription 
drugs they are using for fear of unfavourable reaction by the health care practitioner. In extreme 
cases, it is only until adverse drug event occurs that the use of these medicines is disclosed 
(Shaw, 1998).   
  
However, a survey in 2002 indicated that nearly 75 percent of medical professionals in America 
frequently inquire directly from the patients about the use of OTC drugs (NCPIE, 2002). It has 
also been highlighted that self-treatment with OTC medicines depends on the patient`s 
judgement, in addition to, the label information to permit correct diagnosis of the condition. 
This requires the patient`s ability to read and interpret the information on the package or the 
leaflet (Brass, 2011).   
  
World Health Organization (2000c), however, pointed out that the ordinary end-user of OTC 
medications usually does not understand the principles of pharmacology or therapy and/or 
particular features of the medicinal product used. Brieger et al. (2005) also stated that most 
patients, specifically, in Africa have low literacy rates and may find it difficult to interpret a 
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picture on the packet insert of a pharmaceutical product. Past research also indicates that only 
38.1 percent completely understand the contents, due to significant differences in educational 
levels (Calamusa et al., 2012). As a result, a wrong diagnosis can result in treatment failures 
of the actual cause of the present condition (Brass, 2011).  
  
Additionally, promotional messages via the media and internet about non-prescription 
medications seem to portray the absence of the risks of the products. This often creates the 
impression that OTC drugs are just like another customer health product which can be taken 
excessively and this can result in the non-medical use of the product (WHO, 2000b).  
  
2.4 Overview of Packaging  
In a highly competitive business environment partly due to global trade liberalization, many 
industries face keen product and / or price competition that succeeds in lowering profits to 
unhealthy levels (Kotler & Rath, 1983). One of the few strategic initiatives that companies can 
adopt to be competitive and to protect and improve market position is to design superior 
packaging for their target market (Rettie & Brewer, 2000). Packaging has accompanied 
mankind from many years ago when primitive humans lived as nomadic hunters and gatherers. 
Wraps of leaves, shells of nuts, animal skins and hollow wood pieces were used in those days 
(WPO, 2008). Since those times, packaging has evolved to the modern-day packaging.   
  
Even though, packaging is perceived to be a negative and unnecessary cost to society, without 
packaging, materials handling and modern customer marketing would be costly, inefficient and 
virtually impracticable (Simms & Trott, 2010; Lockamy III, 1995; Robertson, 2013). 
Packaging has created a platform for customers to have a wide range of products to choose 
from, eliminated seasonality of some products and provided a service in the context of busy 
lifestyles (Stewart, 2007). The distribution of goods is a backbone in modern society due to 
changes in customer lifestyle and self-service. Customers have been demanding smaller 
quantities of products and, coupled with increasing distances between the point of 
manufacturing and consumption, have made packaging more important in the distribution 
chain (Jahre & Hattland, 2004).   
  
In response to new trends in customer lifestyle and business environment, many retail firms as 
well as food services companies, have been established. The growth of these firms has largely 
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depended on a combination of a highly competitive superior logistics which are sustained by 
packaging innovations and marketing (Coles, 2003). Thus, package innovation has 
revolutionized the modern distribution systems for meeting new customer demands and driven 
market growth in the customer goods market. For example, Tetra Pak has invented an “aseptic” 
package to enable dairy products to be distributed over long distances and also to enable them 
to be kept in the store shelves without refrigerator trucks and facilities (WPO, 2008).  
  
It has been asserted that packaging has played an essential role in customers` lifestyle and the 
manner in which businesses are organised (Bundh, 2005; 2009). A lot of packaging has been 
designed for containerization or to fit pallet sizes to facilitate export trade (Bundh, 2009). 
Through packaging, the production of large volumes of commodities on a daily basis can be 
managed, while non-durable goods can be transported over long distances the world over.   
  
Globally, packaging has become a vital tool to facilitate trade and economic growth, especially, 
in the emerging markets (WPO, 2008). It is argued that innovative packaging provides cost- 
effective ways of preserving and sustaining world resources by maximizing the products` shelf 
life, and thus safeguarding the products before final consumption (Coles, 2003). The author 
further noted that a significant proportion of food production is wasted in many developing 
countries ranging from 30% to 50%, whilst in developed economies the percentage is relatively 
insignificant ranging between 2% and 3% due to efficient processing, packaging and 
distribution systems. The product package (that is, to contain, preserve, protect and inform) has 
improved safety and health, and the overall quality of the life of people (Coles, 2003; WPO, 
2011).   
However, the use of many forms of packaging across different parts of the globe depends upon 
the extent of development, and hence the per capita consumption in industrialized countries is 
considerably higher than in less developed economies (Bundh, 2005). The World Packaging 
Organization (2009) suggested that packaging is an important component of trade in some of 
the developed world, whilst it satisfies logistical needs of the distribution chain in most of the 
developing countries.   
  
The global turnover of the packaging industry was estimated around US$500 billion in 2008, 
with the sales of packaging container contributing a larger proportion and packaging machinery 
accounting for about US$25 billion (WPO, 2008). In the United Kingdom, the packaging 
industry` total revenue was GB£11 billion per year and employed about 85 000 people 
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representing 3% of the total labour force in the manufacturing sector. It was also among the 
top ten manufacturing industries and contributed about GB£12 billion annually to the United 
Kingdom`s economy (Packaging Federation, 2015).  
 
Furthermore, the packaging industry contributed a sum of R43 billion to the economy of South 
Africa which accounted for nearly 1.5% of total Gross Domestic Product (GDP) of R2.86 
trillion in 2012. Nor is this all, the contributions of almost all the other industries to GDP largely 
depended on the packaging innovations (WPO, 2014).   
The growth in the packaging industry was attributed to increased global trade, smaller family 
size, new trends in lifestyle and search for convenience (Bundh, 2005). Indeed, packaging is 
an important driver of growth in customer and industrial markets, and its usage is increasing 
consistently with the global economy.   
  
2.4.1 Pharmaceutical Packaging Industry   
It has been emphasized that packaging has contributed significantly to the development of drug 
industry as it has become an integral component of the drug delivery system. Packaging used 
to be considered an afterthought by many pharmaceutical companies. Packaging has been 
widely acknowledged as an essential part of medicinal product whose shelf-life can only be 
guaranteed in its packed state (El-Meniawy, 1991).   
  
The global pharmaceutical industry has increased with annual growth rate of about 5% per year 
from 2010 to 2017 (Kunal, Akhilesh, & Kumar, 2012). The authors further stated that the rate 
of growth has been more visible in emerging countries like China and India due to the rapid 
expansion of outsourcing activities and generics in these economies. In 2010, the world drug 
packaging market was valued at US$47.8 billion and was predicted to increase at a compound 
annual growth rate (CAGR) of 7.3% from 2010 to 2017 to an amount of US$78 billion by 
2017. The packaging market in advanced countries like Japan, United States and Western 
Europe accounts for more than 70 percent of this value, though China presents rapid growth 
opportunities. It is also estimated that the global market for medicinal product packaging was 
predicted to increase at 5.5 percent yearly from 2010 to 2015. While the world packaging 
industry was valued at US$424 billion in 2010, the global pharmaceutical packaging industry 
accounted for approximately 5% of this amount (ibid).   
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In their view, the main drivers of growth of pharmaceutical packaging industry were 
integration, advances in manufacturing processes and technological development. The authors 
further stated that the pharmaceutical packaging industry has been growing as the patent of 
drugs worth about US$142 billion expired in 2017 which could lead to increase in generic 
market and the pharmaceutical industry as whole. Moreover, constant innovations in 
pharmaceutical products have had a direct impact on pharmaceutical packaging.   
  
Munzel (2007) is also of the view that legal changes, the introduction of new medicines and 
technological development have resulted in constant changing in packaging requirements in 
the pharmaceutical industry. Traditionally, close to 51 percent of medicines made up of 
capsules or tablets were taken orally and they were either packed in blister packaging or fed 
into plastic pharmaceutical bottles. Liquids, pastilles and powders also form part of the drugs 
which were taken orally. However, many oral tablets have come with different shapes and 
sizes. Coupled with this, other methods for taking medicines have been increasingly gaining 
popularity. These include transdermal (3%), inhalation (17%) and parenteral (29%). These 
developments in the pharmaceutical industry have contributed tremendously to promote the 
pharmaceutical packaging industry (Kunal et al., 2012).  
  
2.4.2 Conceptualization of Packaging   
Packaging has been defined in several ways by many authors in different academic disciplines. 
According to Jadhav, Zalte, and Saudagar (2014:194), packaging is a “science, art and 
technology of enclosing or protecting products for distribution, storage, sale and use”. The 
author further stated that packaging is the process of designing, evaluation and fabrication of 
packages. A product`s package is also related to the container, closure, carton, and box 
components. 
 
 Kunal et al. (2012: 1) also defined packaging as “an economical means of providing 
presentation, protection, identification, information, containment, convenience and compliance 
for a product during storage, carriage and display until the product is consumed.”   
 
Natarajan, Govindrajan, and Kumar (2015: 15) described packaging as the “art, science and 
technology of preparing and encapsulating goods for the market”. The authors further stated 
that packaging is a “co-ordinated system of preparing goods for transport, distribution, storage, 
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retailing and end-use”. Thus, packaging ensures the safe delivery of goods to the end-user at a 
minimum cost while maximising sales.  
 
Packaging is also described as designing and producing the container or wrapper for a product 
(Kotler et al., 2002), whilst the label relates to the simple tag fixed to the product or an 
elaborately design graphic on the package that conveys the brand name and the printed 
information to the end-user (Kotler, 2003). Kotler et al. (2002) noted that, labelling is an aspect 
of packaging.  
 
Alternatively, Agariya, Johari, Sharma, Chandraul, and Singh (2012) noted that packaging is 
the wrapping material that surrounds a product to contain, identify, describe, protect, display, 
promote, and for the purpose of making the product clean and marketable.   
  
Brassington and Pettit (2003) also suggested that, packaging is a container or wrapping in 
which the product is offered for sale. Arens (1996) cited by Kuvykaite et al. (2009: 53), also 
defines packaging as “the container for a product-encompassing the physical appearance of the 
container and including the design, colour, shape, labelling and materials used”.  
 
Hassan, Leng, & Peng (2012) highlighted that packaging is a container which holds, protects, 
preserves and facilitates the handling and commercialization of products.   
  
Clearly, many authors have conceptualized packaging in terms of its functions, whilst others 
have related packaging to a container for the product as well as its appearance. However, Kotler 
(2003) is one of the few authors who has described packaging as an activity. In this study, 
packaging is seen as the container of the product including its appearance and hence, the 
definition proposed by Arens 1996 cited in Kuvykaite et al. (2009) will be adopted in this 
thesis.  
  
A package for a product may consist of a primary container which is in immediate contact with 
the product. The role of the first phase of product package is to hold and protect the product 
against any substances that can make it unwholesome. The second phase of package contains 
the primary container and is usually discarded during the consumption of the product. The 
primary purpose of secondary packaging is to aid identification and provide additional 
protection needed to ensure safe-keeping of the product at the warehouse and for reuse of the 
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product container. Finally, the third category of product container is the shipping or tertiary 
package which unitizes the primary and secondary packages and serves to identify and protect 
them throughout the distribution chain of the products (Kotler et al., 2002).   
  
Packaging is recognized as an essential aspect of the core product and the brand (Ampuero &  
Vila, 2006; Underwood, 2003; Chirag, Tyagi, Jaimin, Pinkesh, & Parasher, 2012). Simms and 
Trott (2010) suggested that, products in the customer goods market appear to be highly 
characterized by packaging to such an extent that it cannot be detached from the core product. 
Gonzalez, Thornsburg, and Twede (2007) also pointed out that, in most cases, the primary 
packaging forms part of the actual product and the brand, and they are intertwined.   
  
However, Keller (1993) is of the view that packaging aids the buying and consumption of a 
product but it is not an ingredient of the product itself. Additionally, most authors in the 
contemporary marketing consider packaging as a component of product strategy which is an 
essential element of the marketing mix (Kotler, 2003; Kotler & Keller, 2009; Brassington & 
Petitt, 2007; El-Meniawy, 1991). However, Kotler (2003) pointed out that some authors also 
recognize packaging as a fifth “P” in addition to place, price, product and promotion in the 
marketing mix model.  
  
2.4.3 Elements of Good Packaging Design  
Griffin et al. (1995) referenced by Agariya et al. (2012) suggested that elements of good 
packaging design include; attraction of customers’ attention, transmitting information, creating 
desire and selling the product.  
  
 Attraction-of-Attention  
Packaging must create visible impact on the shelf by differentiating itself from other competing 
products. The package must draw and grab potential buyers` attention and assists existing 
customers to identify the brand. This can be achieved by effectively combining the colours, 
shape, logo and other characteristics of packaging design (ibid).  
  
 Communication–Information  
According to the authors package designed must clearly signal to the buyer the contents of the 
product, its use and instructions as well as the outcome after usage. All other relevant 
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information must be directly or indirectly conveyed to the prospective purchaser through the 
design. Directly, the packaging must describe the product, its features and benefits, and the 
method of application. More importantly, the packaging characteristics, such as the shape, 
colour, design forms, and graphics can be implicitly used to transfer the intrinsic attributes of 
the product to the customer. Printed information on the label relating to the contents, 
instructions for use and that required by law must be legible, simple and understandable to 
assist the customer in product choice (ibid). 
  
 Create desire for the package  
A well-designed package must point out to customers that the product could satisfy their needs 
or give them inner satisfaction. According to Robertson (1993), a distinctive package must 
show the contents of the product and powerfully communicate to the customer the satisfaction 
the product offers. Innovation in packaging technology has added several convenient features 
to a package to meet the ever-changing demands of customers for convenient purchases.   
  
 Selling the product   
Effective packaging design does not only stimulate demand for the product but also supports 
loyalty of the brand. Thus, an appealing packaging must transfer extra benefits to customers 
such as easy dispensing devices, special give-always and re-usable benefits to facilitate repeat 
purchases (Griffin et al. 1995 cited by Agariya et al., 2012).   
  
2.5 Packaging and Over-the-Counter Drug Market  
Nowadays, customers have assumed more responsibility for their health care because of 
convenience and desire to save time and cost. Hence, OTC medicines have gained popularity 
in recent years due to their role in self-care and self-medication practices.  
Packaging has been well-acknowledged as the key influencer in customer choice decisions and 
the use of OTC drugs (Sansgiry & Pawasker, 2005; Wright, 1997; Kim & King, 2009). Past 
research also reveals that packaging was more important to consumers when purchasing non-
prescription medications than prescription drugs (Kim & King, 2009). The authors further 
pointed out that, for most ethical drugs, the customer might pay less attention to packaging due 
to the recommendation from the physician before final purchases are made (Kim & King, 
2009). Furthermore, empirical research indicates that customers considered packaging as an 
important attribute when buying herbal medicines in Ghana (Kumah et al., 2015).  
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Kim and King (2009) suggested that OTC products are by nature similar to FMCGs because 
they are bought by the customer`s own initiative. Dickov (2012) also highlighted that all the 
roles with regard to customer buying, the decision-making process and the consumption of 
non-prescription products are performed by the end-user. Kim and King (2009) therefore 
concluded that the functions of packaging in the OTC product market are analogous to the 
customer-packaged goods market.  
  
2.5.1 Functions of Packaging in Over-the-Counter Drug Market   
According to Prendergast and Pitt (1996) packaging performs logistic and marketing functions 
but are inseparable. It has also been suggested that changing customer needs requires packaging 
to perform environmental function in addition to the logistic and marketing roles (Rundh, 
2013). Consequently, the author is of the view that packaging performs logistic, marketing and 
environmental functions as shown in the Figure 2.1 below.  
 
 
                                                        
 
 
 
 
 
 
            Figure 2. 1: Packaging Functions in the OTC Market  
 
               Source: Rundh, (2013:1548)  
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2.5.2 Logistic Functions  
The logistic role relates to the functional aspects of packaging which include to ease the 
movement of products from the manufacturer to the end-user and the physical needs that are 
satisfied by packaging within the supply chain (Rundh, 2013). It is argued that, the basic 
functions that companies have traditionally assigned to packaging are to contain, protect and 
preserve the product during its storage, transportation and handling as well as to facilitate the 
distribution of the market offering from the producer to the end-user (Brassington & Petitt, 
2003; Rundh, 2013). These functions are essential at the times of the manufacturing, 
transportation, storage, selling and consumption of any product (WPO, 2008). Pareek and 
Khunteta (2014) stated that pharmaceutical packaging must essentially provide for the drug`s 
safety, identity, containment, and convenience of handling and delivery. It has been highlighted 
that the crucial role of packaging is to maintain the product integrity by safeguarding the 
product against any event of damage from climatic conditions, bacteria or any hazards the 
product may be exposed to at the time of its manufacture until consumption (Stewart, 1997).   
  
It has also been emphasized that the primary logistic functions of packaging relate to 
containment, protection, apportionment, unitization, convenience and communication 
(Lockamy III, 1997; Robertson, 2013; Prendergast & Pitt, 1996). A package`s apportionment 
and unitization features determine the relative flexibility of the product to warehousing, 
transportation, and handling as well as usage, storage and the quantity purchased. The 
convenience function of the packaging simplifies the usage of the product to the end-user. 
Dickov (2012) also defined convenience in terms of the ease of the therapy and the route of 
administration, in that customers generally look for less painful or complicated treatments. 
Lockamy III (1997) noted that these functions do not only impact on product design, 
transportation, manufacturing, distribution, warehousing and marketing functions but also 
contribute more significantly to the firm`s competitive advantage.  
   
Vernuccio, Cozzolino, and Michelini (2010) also highlighted that the principal logistic roles 
required by a packaging system to achieve the maximum efficiency and high performance 
include handling and transport, conservation and protection, storage and manipulation, and 
information. Dobson and Yadav (2012), however, decomposed these functions into three 
groups, namely handling, transport, manipulation and storage, protection and conservation, and 
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information. An empirical study also reveals that manipulation and storage as well as protection 
and conservation, handling and transport support the principles of innovations in logistics.   
  
In contrast, the informational function seems to have no significant relationship with the 
logistic role of packaging (Vernuccio et al., 2010). Protection and conservation relates to the 
role of the product container in safeguarding the chemical, thermal and physical integrity of 
the market offering through the primary package. Thus, the primary package must not interact 
with the active pharmaceutical ingredients in order to preserve the core product and lengthen 
its life-span (WHO, 2002a). Handling, transportation, manipulation and storage describe the 
collective roles of primary, secondary and shipping packaging in the different activities that 
take place in the course of handling, transporting, manipulation and storage in all aspects of 
the product mixes and across all stages of the manufacturing, distribution and consumption 
processes. Finally, information defines the communicative role of packaging, which relates to 
the messages conveyed by the packaging in order to provide clear instructions for transporting 
the products in the distribution chain.   
  
Nowadays, innovations in packaging technology have promoted the traceability of products 
along the supply chain. For example, tamper-proof packages permit visual inspection of the 
pharmaceuticals before consumption to prevent the product from being tampered with, or to 
detect counterfeiting of certain medicinal products (WHO, 2002a). Additionally, challenges 
such as senior-and user-friendly as well as child resistance keep on growing in importance in 
pharmaceutical industry. The pharmaceutical industry has not only opted for packaging that 
satisfies traditional requirements but also innovative designs (Munzel, 2007) to guarantee user-
friendly and to prevent children from accessing the contents of the formulation (Chirag et al., 
2012).  
  
According to Prendergast and Pitt (1996), the increasing use of material handling, automation 
of warehousing and information technology have contributed to the immense role of packaging 
as an ingredient for logistics. This has had a significant effect on warehouse layout and design 
and ultimately, has contributed to overall productivity of the warehouse.    
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2.5.3 Marketing Functions  
 Today`s highly competitive environment characterized by changing trends in lifestyle, 
increasing self-service ethos and the proliferation of brands in the OTC drug market from 
which customers choose (Kauppinen-Raisanen, 2010; 2011; DeLorme et al., 2010), requires 
traditional herbal medicine firms to make their brands stand out from the clutter in the retail 
shelves.   
  
Furthermore, Underwood and Klein (2002) suggested that as the advertising environment is 
increasingly growing to a point of saturation, firms are re-allocating their advertising funds to 
sales promotion and point-of-purchase communication. DeLorme et al., (2010) also argued that 
the conventional form of advertising has little impact when customers are deciding to buy non-
prescription medicines.   
  
Packaging design is regarded as one of the obvious competitive marketing tools (Kotler & Rath, 
1983) that identifies and differentiates between competing brands and breaks through the over-
crowded marketplace (Underwood & Klein, 2002; Rettie & Brewer, 2000). Quraeshi et al. 
(1983) pointed out that packaging can be used as a tool for visual differentiation to distinguish 
products from other competing generic products. For example, by making the company name 
more visible in the package, stressing the use of colours or bold print, and using symbols or 
other graphic illustrations to distinguish the product from other generic counterparts. More 
importantly, the patient’s safety also depends on rapid and clear identification of drugs during 
emergencies (Drobrucka, 2014).   
  
Packaging design can be used to transmit valuable information, provide customer satisfaction 
and overall gain competitive strength (Kotler & Kath, 1983; Butkeviciene, Stravinskiene, & 
Rutelione, 2008), which can ultimately contribute to business success (Rundh, 2013). Well- 
designed packaging has the potential to build brand and improve sales (Kotler & Keller, 2009). 
As an increasing number of pharmaceutical shops are turning to self-service retail outlets   
(Kauppinen-Raisanen, 2011), packaging may be the primary vehicle of transferring 
information between the product and the end-user at the point-of-purchase (Gonzalez et al., 
2007).   
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It has been reported that, approximately 82 percent of decisions are made in the store, while 62 
percent of all purchases are made on impulse (POPAI, 2014), indicating that potentially the 
role of packaging to communicate and influence product choice at point-of-purchase is 
heightened (Underwood, 1998). Obviously, packaging can be described as a key driver of 
impulse buying behaviour (Butkeviciene at al., 2008), and in some category of purchases, 
unplanned buying is estimated to be about 85 percent of sales (Wallace, 2001). Hence, firms’ 
attention on packaging as an in-store communication and brand-building tool has been 
increasing rapidly (Deliya & Parmar, 2012; Rettie & Brewer, 2000). This has largely replaced 
much of the sales force in the store (Garber et al., 2000a) and also reduced the cost of 
advertisement and branding (Gonzalez et al., 2007).   
  
Essentially, packaging is seen as a promotional tool as it performs a similar role as the other 
marketing communications elements (Silayoi & Speece, 2007). Young (2008) also pointed out 
that packaging design is an important cue that influences product perceptions and brand image, 
improves functionality and post-consumption satisfaction.    
  
Clearly, the contribution of packaging to sales and hence, the overall profit margins of a 
business organization cannot be overlooked as the self-service ethos becomes popular and the 
trend of lifestyle changes. Past research reveals that the customer perception of herbal 
medicines is positively influenced by packaging (Kumah et al., 2015). Indeed, at the point-of-
purchase, packaging obviously provides opportunity to a firm by influencing customer 
perceptions (Kotler et al., 2002). Packaging is also an important product attribute that 
customers infer from in the store when the brand is less familiar or shopping for products in an 
unfamiliar category (Underwood, Klein, & Burke, 2001). Moreover, in the shop, where the 
customer might not have thought deeply about the brand before entering the store, the intention 
to buy a brand may depend upon what is communicated at the selling point (Silayoi & Speece, 
2007).   
  
Lofgren (2005) noted that, packaging must therefore transfer a message to the customer at the 
point-of-sale, while reinforcing the customer`s intention to buy by conveying valuable 
information and user-friendly benefits. The purpose of this message has been to stimulate 
interest in the market offering (Gardner, 1981) and ultimately, sell the offering (Griffin, 
Sacharow, & Brody, 1985). Packaging has been customers` initial point-of-contact with the 
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product in the store shelves, and it affects customers` first and later impressions (Kotler & 
Keller, 2009) about the company and its products.   
  
It has been highlighted that packaging is important at the first moment-of-truth by attracting 
attention and transmitting the product benefits to the customer (Lofgren, 2005). Underwood 
and Ozanne (1998) suggested that with products which are bought in their raw state like food 
stuffs, the buyer often depends on the packaging to form an impression about the final product. 
The product appearance communicates the product`s uniqueness and originality to the 
customer which plays a crucial role in brand preference (Silayoi & Speece, 2007).   
  
Ghoshal, Boatwright, and Cagan (2009) noted that packaging can be considered as special form 
of advertising tool because it can used as a tangible medium of communication to transfer vital 
messages about the actual product. Thus, packaging continues to influence and strengthen 
customer brand preference long after the buying decision is made.  
  
Packaging also appears to be the only advertising tool that communicates to customers at every 
stage of the buying-decision process in the store. A study indicates that packaging influences 
customers’ decision-making before, during and after purchases (Butkeviciene et al., 2008). 
Moore (2012) stated that, the only means of communication between the manufacturer and the 
customer when the product leaves the pharmacy is via packaging. Packaging therefore 
reinforces the instructions given by the OTC medicine seller, and ultimately improves the 
compliance of the drug therapy (Keerthi, Prasanna, Sharuna, & Rao, 2014). For a large majority 
of customer goods, packaging offers a cost and sales-effective medium of communication at 
the selling point (Wallace, 2001). It has also been established that, packaging is the biggest 
vehicle of communication because of its extensive reach to many prospective buyers, its 
presence at the point-of-purchase and at high involvement level when customers actively 
search for package information to make purchase decisions (Peter, 1994 cited by Brassington 
& Petitt, 2003).   
  
It has been emphasised that the traditional form of advertisement usually lasts for a few seconds 
while the average length of OTC commercial is around 21.7 seconds and are mostly transmitted 
in the mid-afternoon (2–4 pm) and early evening (6– 8 pm) in a day (DeLorme et al., 2010).  
Although verifiable data are not available, this situation is not different from the advertisement 
of OTC herbal medicines in Ghana. Indeed, a product package is recognised as a more 
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permanent and pervasive medium of brand communications platform than any other 
promotional tools (Wallace, 2001). In addition, a brand that receives low advertising support 
and loyalty, packaging becomes the only essential tool of communication to the target market 
(Bundh, 2005). Empirical evidence reveals that well over 73 percent of customers rely on 
packaging to support their purchasing decisions at the selling points (Well et al., 2007).   
  
Creusen and Schoormans (1998) also argued that packaging performs six different roles: 
communication of aesthetics, symbolic and functional value, grab attention, categorization and 
ergonomic. In a way, packaging transmits aesthetic and symbolic value, functional features and 
offers quality impressions as well as facilitate ease of use. Enhanced attention can increase 
sales by ensuring that the brand enters the customer`s consideration set (Underwood & Klein, 
2002).   
  
Consequently, packaging performs an invaluable role in the marketing strategy along with 
other marketing variables. From the perspective of the customer, packaging conveys value, 
messages, simplifies choice and entertains (Kotler & Rath, 1983). It has been emphasised that 
customers` perception and consumption of attractively designed product form can enhance 
sensory pleasure and stimulation (Bloch, 1995). A packaging may add value to the product by 
transmitting product features, aesthetic and positive information as well as preserving the 
product quality (Gonzalez et al., 2007).   
  
Packaging also represents the company and its brands which may enhance customers` 
confidence in the company`s image as well as its brands (Kotler & Keller, 2009). A high quality 
packaging design can create an opportunity for companies to charge premium price, and 
increase and sustain market share for their brands. Due to rises in income levels, affluent buyers 
may be willing to pay more for dependability, prestige, convenience and aesthetics offered by 
innovative packaging design (Kotler, 2003).   
  
 Kotler and Rath (1983) suggested that, a well-managed packaging design can re-invigorate 
customer interest for a matured product to increase its share in the market and create a 
personality for a new product to distinguish it from competitors. For example, toothpaste pump 
dispensers increased market share by 12 percent because they offered greater convenience and 
were mess-free (Kotler, 2003). Moreover, warranties and guarantees which are important part 
of the product strategy frequently appear on the packaging (Kotler & Keller, 2009).  
59  
  
2.5.4 Environmental Functions  
The need to protect the environment has become increasingly crucial in many countries of the 
world in the last few years. Rapid deterioration of environment mainly caused by waste 
disposal has attracted greater attention by governments and civil society groups in many parts 
of the world. It has also been established that packaging materials form the largest component 
of solid waste (Min & Galle, 1997).   
  
However, pharmaceutical packaging constitutes a small proportion of the waste, but its disposal 
can negatively affect the environment (WHO, 2002a). Consequently, several laws and 
regulations have been introduced in many countries that prohibit the use of harmful materials, 
while stringent measures have been taken for packaging materials to be reduced, recycled or 
re-used (Mutsikiwa & Marumba, 2013).   
  
Faced with this challenge, companies and pharmacists have introduced new directives and 
policies aimed at reducing, salvaging and recycling packaging as well as eliminating and 
incinerating, especially, contaminated packaging (WHO, 2002a). Mutsikiwa and Marumba 
(2013) noted that, the most influential laws that influence packaging design is associated with 
labelling, which frowns on falsification of information on the label. The authors are also of the 
view that, the purpose of this legislative requirement is to make sure that the product conforms 
to the quality standards and also aids customer decision-making process.   
  
Evidence from marketing literature suggests that many companies have experienced a 
remarkable fall in brand equity due to deceptive packaging practices (Underwood & Ozanne, 
1998). The authors suggested that marketers can enhance brand equity by designing packages 
that convey information which is sincere, truthful, comprehensible and legitimate. Rundh 
(2013) noted that the environmental role of packaging relates to reduction in packaging 
materials, recycling, ecological awareness and re-utilization.   
  
This is done not only to meet legislative requirements but also in recognition of the marketing 
environment and competition. It is also argued that packaging design needs to be compatible 
with the environment by facilitating recycling activities, and reducing waste, harmful materials, 
material used and the risk of environmental damage as well as enhancing energy-saving in the 
production processes (Vernuccio et al., 2010).  
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Bundh (2005) noted that customers and individuals also desire packaging that is eco-friendly 
and packaging materials that can be re-used and recycled. Moreover, issues relating to the 
environment and ethics on buyer purchase decisions are increasing (Rokka & Uusitalo, 2008) 
and as a result, a growing number of firms have developed holistic environmental programs 
and sustainable products in order to build a competitive edge to secure market success (Min & 
Galle, 1997; Magnier & Crie, 2015).   
  
Rundh (2005) emphasized that eco-friendly and ergonomic related issues of packaging are of 
greater importance to ensure competitiveness in the international market. An empirical research 
also shows that environmentally-friendly or ethical product aspects have a positive influence 
on customer product choice (Rokka & Uusitalo, 2008). Magnier and Crie (2015) also noted 
that customers have a favourable perception for brands that incorporate substantial 
environmental and ethical values.   
  
Another important aspect that relates to environmental packaging has been eco-labelling when 
customers are scanning for environmentally-friendly products (Bundh, 2005). Past research 
shows that products with positive environmental information are perceived to be of higher 
quality and value and are more likely to be bought than analogous products that disclose 
negative ecological messages (Borin, Douglas, & Krishnan, 2011). Research conducted by 
Rokka and Uusitalo (2008) confirms that the biggest customer segment considers 
environmentally-labelled packaging as the most essential product cue when choosing among 
functional drink products.     
  
2.5.5 Packaging and Marketing Mix   
Kotler (2003) is of the view that effective packaging design requires harmonizing the elements 
with each other and along with pricing, advertising and other aspects of the marketing mix. 
Jahre and Hattland (2004) highlighted that appealing packaging plays an immeasurable role in 
marketing mix by attracting and retaining existing customers. Effective packaging design 
provides a platform for increasing sales of the product (Brassington & Pettit, 2003).    
  
Moreover, packaging serves a distinctive tool for marketing communications by directly 
transferring the implied meaning of the product and its characteristics, usage and benefits to 
customers at the exact point of purchase (Dobson & Yadav, 2012). The authors also pointed 
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out that packaging provides a complementary and permanent medium of transmitting messages 
to customers.   
  
Packaging also provides a platform for distributing coupons, samples and gifts, advertising 
related commodities, launching and/or developing new products, and presenting on-pack offers 
(Brassington & Pettit, 2003). A product appearance is the face of the product, and may be 
designed to assist identification to enhance the image of the product and also to differentiate it 
from similar products in the market (Marsh & Bugusu, 2007; Dobson & Yadav, 2012).    
  
An appealing packaging has wider coverage than the traditional advertising, and has the 
potential to distinctively position a product in the market and in the customers` memory 
(Agariya et al., 2012). For brands that receive less or no support from media advertising, 
packaging provides the last opportunity to convey the brand message to the target market 
(Rundh, 2005; Underwood et al., 2001).   
  
Packaging of different sizes is an important factor for price variations (Yan, Sengupta, & Wyer, 
2014), end-user segmentation (Brassington & Pettit, 2003), and can extend a product into a 
new target market (Agariya et al., 2012). Past study also established that price perceptions 
affects customers` quality judgement, and that a smaller product package is indicative of higher 
price and hence, of higher quality compared to an analogous product in a bigger container 
despite the latter commanding a higher overall price (Yan et al., 2014).  
  
Convenient packaging features such as ease of use, handling and disposal, product visibility, 
being re-sealable, and traceability, add value and competitive advantage to products (Marsh & 
Bugusu, 2007). Bundh (2005) concluded that, packaging has a major influence on the 
controllable marketing elements by improving customer value or reducing marketing cost as a 
whole. This may arise from ensuring product safety, improving convenience, reducing cost of 
transportation and handling, and the possibility of price differentiation, aiding marketing 
communications activities, contributing to product innovations and strengthening the packed 
product concepts.  
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2.6 Components of Packaging Design  
Many researchers have attempted to identify and classify packaging elements in different ways. 
Kotler (2003: 436) identified six elements for effective package design comprising text, shape, 
size, colour, brand mark and material. Kotler and Keller (2009) noted that the packaging 
characteristics could be classified into functional and aesthetic. The aesthetic elements include 
the package`s shape, size, colour, material, graphics and text, whilst the functional attributes 
entail the structural designs, like package innovations which facilitate convenience, and 
tamper-proof and re-sealable products.   
  
Moreover, Rundh (2013) is of the view that packaging design elements that can be combined 
to become a visible sales device to a customer when purchasing and consuming a market 
offering include package shape, materials, colours, structure, text and images. Consistent with 
Kotler and Keller (2009), the author further classified the design attributes of packaging into 
functional and aesthetic.   
  
In addition, Obeesi (2010) identified topography, colour, size, shape, photography, texture and 
layout as components of packaging when investigating the role of packaging in promoting 
Made-in-Ghana products in Ghana. 
Smith and Taylor (2002) also identified six variables for designing packaging of a product: 
shape, size, colour, graphics, materials and smell. Underwood (2003) also suggested that the 
attributes of packaging design are brand logo, colour, font, packaging material, pictorial, shape, 
and product information. The author further classified these elements into structural (shape, 
size, material) and visual (logo, colour, font, pictorial, product information). It has also been 
established that the elements for effective packaging design of non-prescription medicines 
include: package material, shape, graphics, colour, font size, text, photography, flavour, 
statutory information, and packaging technology (European Medicines Agency, 2011). 
Likewise, Kauppinen-Raisanen (2010) also proposed packaging colour, shape and material, 
and letter font as the components of packaging design of OTC medicines.  
Kumah et al. (2015) also proposed packaging colour, innovations, wrapper and material as 
elements of effective packaging design that influence consumer buying behaviour of herbal 
medicines in the store in Ghana.  
Ampuero and Vila (2006) also classified the packaging characteristics into graphics and 
structural elements. The graphic features include: typography, package colour, graphical 
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images and shapes used, whilst structural design elements consist of size and the form of the 
container.   
  
Deliya and Parmar (2012) pointed out that the design of wrapper, colour, font size, background 
image, material, printed information and innovation as the elements of packaging design. 
Kuvykaite et al. (2009) also identified and distinguished packaging elements into visual and 
verbal elements. This position concurs with similar research conducted by Rettie and Brewer 
(2000).   
Butkeviciene et al. (2008) also suggested the following components of packaging: smell, form, 
colour, images, size, graphics, materials, producer country, product information, name of 
product, brand, instruction for usage and special offers. These elements are dichotomized into 
non-verbal (form, colour, materials, imageries, smell, size and graphics), and verbal 
components (brand, name, producer/country, special offers, instructions of usage and product 
information). It has also been proposed that the visual attributes of packaging design include 
colour, graphics, size, material and form, whilst the verbal elements consist of country-of-
origin, producer`s name, product information and brand (Kuvykaite et al., 2009).   
  
Agariya et al. (2012) also noted that graphics, size, form, and material are visual elements, 
whilst verbal component relates to the producer, country-of-origin, product information and 
brand. This is in contrast with the viewpoint of Keller (2013) who concluded that packaging is 
an element of a brand in addition to personality, brand name, graphic, symbol, slogan and logo.   
  
Silayoi and Speece (2004; 2007) grouped packaging attributes into visual (size, shape, colour 
and graphics), and informational (technology innovations and product information). In 
addition, Kuvykaite et al. (2009) suggested that the type of information that is communicated 
to customers depends upon the nature of the packaging elements. It has been pointed out that, 
while visual attributes convey messages that affect the customers` emotions, verbal elements 
transmit information that influence customers` cognitive orientations (Silayoi & Speece, 2004). 
In their view, the various components of packaging effectively communicate to customers at 
different buying situations. Visual elements (graphics, size, shapes) are suggested to 
significantly influence customers` purchase decision-making process in a low involvement 
retail environment whereas informational attributes play a crucial role in high involvement. 
Moreover, time pressure also determines how a customer evaluates products at the selling 
points, partly, by reducing the attention to informational elements.   
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Table 2.2 below presents the attributes of packaging design proposed by authors in the 
marketing literature.  
  
Table 2. 2: Summary of Packaging Design Elements 
Author (s) and Year   Research Context  Packaging Design Elements  
Kotler (2003)   General   Size, Shape, Material, Colour, Text, Brand 
mark  
Smith and Taylor (2002) General  Shape, Size, Colour, Graphics, Materials, 
Smell  
Underwood (2003)  Groceries   Brand logo, Colour, Font, Packaging Material, 
Pictorial, Shape, Product information  
European Medicines Agency 
(2011)  
Pharmaceutical 
products 
Package material, Shape, Graphics, Colour, 
Font size, Text, Photography, Flavour, 
Statutory information, Packaging technology  
Ampuero and Vila (2006)  General   Typography, Colour, Graphical images, Shapes  
  
Deliya and Parmar (2012)  
Milk, Washing 
powder   
Design of wrapper, Colour, Font size, Material, 
Background image, Printed information, 
Innovation,  
Kotler and Keller (2009)   General   Package`s shape, Size, Colour, Material, 
Graphics, Text, Packaging innovations  
Keller (2013)  General  Graphic, Logo, Brand name,  Personality, 
Symbol, Slogan  
Silayoi and Speece (2004: 
2007)  
Packaged food 
products   
Size, Shape, Graphics, Colour, Product 
information, Technology innovations  
Agariya et al. (2012)  Customer goods  Graphic, Size, Form, Material, Producer, 
Country-of-origin, Brand, Product information  
Kuvykaite et al. (2009)  Milk, Washing 
powder packages  
Colour, Graphics, Size, Material, Form, 
Country-of-origin, Name of producer, Brand, 
Product information  
Kumah et al. (2015) Herbal medicines   Colour, Innovations, Wrapper, Material 
Rundh (2013)  Food and beverage 
industry    
Colours, Material, Text, Image, Structures, 
Shape  
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Butkeviciene et al. (2008)  Milk, Shampoo,  
Chewing gum  
Size, Form, Colour, Graphics, Images,  
Materials, Name of product, Smell,  
Brand, Product information, Country, Special 
offers, Instruction for usage,   
Kauppinen-Raisanen (2010)  Non-prescription 
drugs  (Pain-killers)  
Colour, Shape, Material, Letter font  
Obeesi (2010) Made-in- Ghana 
Products  
Topography, Colour, Size, Shape, 
Photography, Texture, Layout 
       Source: Compiled by the Researcher  
 
 
2.6.1 Visual Elements   
The visual attributes of packaging discussed in this study include; colour, shape or size, 
photography and typography. These elements can create a positive or negative image about the 
brand (Silayoi & Speece, 2004).   
  
2.6.1.1 Packaging Colour   
Colour is an important factor when customers are shopping for products. A package`s colour 
is recognised to stimulate moods and emotions which impact on customers` perceptions and 
behaviour and consequently assist firms to position or differentiate themselves from 
competition (Aslam, 2006).  
  
Colour is regarded as a key attribute of a product`s package because it is vivid, memorable and 
emotionally-loaded. It is also recognized as a dominant visual cue that attracts attention and 
communicates positive brand image (Garber et al., 2000a). Research conducted by Kauppinen- 
Raisanen and Luomala (2010) demonstrates that the colour on the product`s package draws 
attention, communicates and conveys an aesthetic experience about a product or a brand. The 
authors further suggested that customers deliberately use colours for brand search, recognition 
and recall. Indeed, a product`s package colours enhance brand recognition and visual 
distinctiveness, and also build associations and emotions that improve symbolism and/or a 
brand`s benefits (Underwood, 2003).   
  
It has been emphasized that pharmaceutical packaging colour influences customers` 
perceptions and evokes expectations about some drugs. For example, previous research affirms 
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that red, brown and grey packages are perceived to represent serious ailments compared to 
green or yellow packaging. Moreover, brown, red and orange packages indicate a high degree 
of precaution of use as opposed to blue, green and yellow (Roullet & Droulers, 2005). In the 
OTC drug market, effective use of colours on packaging assists in identification of medicines 
in similar containers which can cause medication errors. It also allows for appropriate selection 
and safe use of drugs, especially, in situations where there is no pharmacist intervention 
(European Medicine Agency, 2011).  
  
Colour is also considered as a search attribute which aids customers to determine the product`s 
quality prior to making the purchase decision (Dimara & Skuras, 2005; Kauppinen-Raisanen 
& Luomala, 2010). Kerfoot, Davies, and Ward (2003) pointed out that colour influences a 
customer`s perceptions of price and quality as well as the image of a brand. A past study shows 
that packaging colour is recognized as an extrinsic attribute that signals quality (Goncalves, 
2008).   
   
A package`s colour is therefore a vital marketing tool that potentially influences customer 
product choice decisions because it can stimulate desire and subsequently enhance the buying 
power of the product (Funk & Ndubisi, 2006). A study conducted by Akcay (2013) shows that 
German customers think that colour is an essential attribute that influences their product buying 
decisions. Overall, 68 percent of the customers are of the view that colour is a major influencer 
when deciding to purchase a product.   
  
Akcay, Sable, and Dalgin (2012) also stated that colour is a powerful weapon that can be used 
to build brand image, influence buying decision process and ultimately, change customers` 
moods. The authors concluded that colour is more essential for young adults than the aged, and 
more importantly, to young girls than boys with regard to colour preference. In addition, for 
young adult customers colour choice seems to be critical for value-expressive products as 
opposed to utilitarian products.  
  
Furthermore, Grossman and Wisenblit (1999) argued that buyers study colour associations 
which impacts on their preference for certain colours of products in some product categories. 
Past research suggests that customers` colour preference, attitudes towards colour, 
attractiveness of the colour and normative colour positively influence product choice. The 
results of the research further indicate that customers desire to buy products designed with the 
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colour of their preference, consider attractive and acceptable to those who have influence on 
their behaviour, and ultimately develop a positive attitude towards them (Funk & Ndubisi, 
2006). It has also been emphasized that using colour as a cue on the package can reinforce 
favourable association when it is uniquely linked to a particular brand (Grossman & Wisenblit, 
1999).   
  
In addition, it has been highlighted that colour influences customer`s perceptions of food taste 
(Koch & Koch, 2003) and flavour (Garber, Hyatt, & Starr, 2000b).  Colours can also create a 
positive image and transmit information about the product which can produce a unique selling 
preposition (Mutsikiwa & Marumbwa, 2013).   
  
Grossman and Wisenblit (1999) also stated that people in different cultures associate different 
meanings to colours and form colour preference pertaining to the culture which they belong to.  
However, Madden, Hewett, and Roth (2000) are of the view that across the world, customers 
demonstrate some degree of similarities in colour preference and associations. For example, 
colours such as blue, green and white have a similar meaning and are preferred in many cultures 
in several countries in the world.    
   
2.6.1.2 Packaging Photography   
Visual imagery is another vital element of packaging as it alters customers` attitudes towards 
the product (Underwood & Klein, 2002). It has been noted that a picture on the package plays 
a strategic role in product differentiation and has impact on customers` consciousness (Silayoi 
& Speece, 2007). This is because it is a more vivid than words and can induce instant recall 
and recognition (Underwood & Klein, 2002). The author further stated that a product`s picture 
on the package performs informational functions and also reflects the intrinsic quality of the 
product and ultimately, influence customer`s beliefs about the product. Past research also 
demonstrates that packaging illustration showing a product picture was positioned as upper 
class and safe and guaranteed products. On the other hand, packaging showing a photograph 
of people was used to indicate accessible products for customers who were more price sensitive 
(Ampuero & Villa, 2006).   
  
Underwood et al. (2001) also pointed out that a picture on a package transmits useful message 
to customers in certain buying situations. First, this may occur in product categories where a 
customer`s knowledge in terms of similarities in price and brand quality is low. In this case, 
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the picture on the package may be used as an informational element that can help customers to 
compare and distinguish among similar brands. Secondly, for those products whose perceived 
benefits or attributes can be positively transmitted by a picture, a well-executed product picture 
can evoke recall and favourable associations with the brand. It has been suggested that 
customers can better recall pictorial elements found on the left part of the product container 
(Rettie & Brewer, 2000).   
  
Underwood and Klein (2002) are also of the view that a picture on the package can grab 
attention and convey product benefits and expose the customer to an enjoyable aesthetic 
experience and ultimately create a positive image of the product.   
It has been highlighted that customers can instantly identify the taste, smell and sound of a 
product while looking at the picture on the packaging (Underwood et al., 2001). Previous 
research reports that a package`s picture significantly influences customers` beliefs about the 
taste of the product. Thus, customers perceive that the product will taste better when a package 
contains a picture of the product than when the package has no pictorial elements. The results 
of the study further reveal that packages designed with pictures were perceived to be of high 
quality and well-preferred (Underwood & Klein, 2002).   
  
A research conducted by Wells, Fairley, and Armstrong (2007) also shows that 43 percent of 
customers claimed to use package photography to judge the quality of the product. The results 
further indicate that customers who made unplanned purchases relied heavily on the extrinsic 
elements of packaging, particularly the package photograph, to aid their purchases.  
Furthermore, a picture on the medicinal product`s package depicting a part of a body that the 
medicine can cure or how the drug can be administered conveys vital information to customers 
on what the medicine stands for and where it works (European Medicine Agency, 2011). Thus, 
the visual packaging image can provide information to customers about the content of the core 
product (Silayoi & Speece, 2007). Empirical evidence suggests that product image on the 
package can create instant recognition of new brands and also transfer experiential value to 
customers. This indicates that such brands can be considered in the consideration set 
(Underwood et al., 2001).   
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2.6.1.3 Packaging Shape and Size   
Size and shape also emerges as another dimension of packaging. Though product labels usually 
convey volume information to customers (Folkes & Matta, 2004), it appears that customers use 
shape and size of the package as a simplifying visual heuristic to make volume decisions 
(Raghubir & Krishna, 1999).    
  
Packages are made up of different sizes and shapes and these complicate the ability of end-
users to determine the actual quantity of the product in the package (Folkes & Matta, 2004). 
Nevertheless, customers consider long containers to be bigger, even when they are exposed to 
and familiar with these containers (Silayoi & Speece, 2007). Past research indicates that 
container shape has a positive influence on volume judgements, actual consumption and brand 
choice (Raghubir & Krishna, 1999). Thus, customers prefer elongated packages because they 
are perceived to be larger and actual consumption is likely to be greater than shorter containers.  
In similar research, the results indicate that container shapes have an influence on the volume 
judgement over and above height, and that tall bodies contribute more to overall volume 
appearance than shorter packages (Garber, Hyatt, & Boya, 2009). However, a study conducted 
by Folkes and Matta (2004) shows that shoppers perceived shorter packages to contain greater 
volume suggesting that wider containers are perceived to be larger. Furthermore, the study 
revealed that product packages with shapes that are perceived to grab more attention are also 
considered to contain larger amount of a product compared to same-sized containers that grab 
less attention.  
  
Garber et al. (2009) suggested that package shape can be utilized for marketing mix purposes 
to gain attention, transfer a unique identity and communicate positive brand-specific meaning. 
Ambrose and Harris (2011) pointed out that developing a unique package shape offers a 
platform for distinguishing the product from similar products, aiding brand recall and 
ultimately increasing sales.   
  
 Warlop, Ratneshwar, and Osselaer (2005) also confirmed that distinctive packaging shapes 
and size serves as a cue which customers can accurately base their quality decisions and also 
retrieve past quality experiences from their memory. This is particularly true when a customer 
lacks adequate product knowledge, or when a person`s product experience is ambiguous. The 
authors further emphasized that, packaging size and shape assists customers to learn and recall 
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differences in the quality of similar brands, which provides a platform for creating the brand 
equity of superior brands.   
  
Natarajan et al. (2015) pointed out that unique shapes enhance memorability and recall of 
packages. The authors are also of the view that psychologists have made several discoveries 
about shapes and forms which have an effect on package design. For example, the desire for 
geometric forms is higher than irregular shapes which have the tendency to strain the eye. A 
rectangular shape is more attractive relative to square which tends to be rather solid and lacks 
dynamism. A study also shows that geometrically simple shapes seem to be larger than 
geometrically complex shapes (Garber et al., 2009). Underwood (2003) emphasized that 
cosmetic products like perfumes and cologne with unique container shapes transmit 
experiential and/or symbolic benefit to customers. Some enduring brands like Coca-Cola are 
described as iconic brands and have built brand equity through their distinctive packaging 
shape design.     
 
2.6.1.4 Packaging Typography  
Typography is one of the key elements of packaging since it provides a platform through which 
the brand name and product information are communicated (Hill, 2012). The ease and clarity 
with which the text communicates, determine the ability of the packaging to connect to the 
end-user. Generally, poor typography creates confusion and customers may switch to another 
product or brand.  Besides, the type size can attract customer’s attention to the brand name, 
highlighting the premium quality of the product and as a result creates visual differentiation 
(Ambrose & Harris, 2011).   
  
A previous study indicates that roughly 72 percent of customers felt that packaging typography 
influences the legibility of the instructions on the package, whilst 42 percent were of the view 
that font size grabs attention to the brand (Vysas, 2015). It is argued that the breadth, depth and 
flexibility of typography suggests its importance in building a brand identity and also highlights 
its critical role in determining the ability of packaging to successfully communicate. 
Additionally, typography is recognized as a vital element for positioning a brand in the market 
(Ambrose & Harris, 2011). Past research also confirms that typography is a useful tool for 
positioning orange juice as affordable and an upper-class product (Ampuero & Vila, 2006).    
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Moreover, a study indicates that easy-to-reach products of an average price were linked with 
sans serif typefaces and in contrast, elegant products were associated with large, bold, upper 
case and roman fonts with bigger characteristics. Typography also transmits information on 
product attributes and benefits to buyers (Hill, 2012). It is suggested that different typefaces 
and typestyles express brand personality. For example, some typefaces appear to be stern and 
conservative, while others are more relaxed and jovial. Therefore, typefaces can be used to 
create the desired attributes and features of the brand as a means to strengthen the brand 
message. The use of typeface personality is an essential means to establish the perceived 
attributes of the brand personality (Ambrose & Harris, 2011).   
  
2.6.2 Informational Elements  
The informational cues of packaging considered in this research are packaging material and 
product information.  
  
2.6.2.1 Product Information  
Product information plays a key role in dispensing pharmaceutical products in healthcare 
delivery. End-users of herbal medicines sold at the over-the-counter require readily accessible 
and reliable information to ensure rational and safe use of the drugs (Raynor et al., 2015). It is 
recommended that the information provided on the package must be legible and easily 
assimilated to avert any risks of confusion and medical errors (European Medicine Agency, 
2011). Product information aids patients and other users to understand the content of the drug. 
The label, together with the package leaflet or insert, is the key source of information for 
patients relating to the correct use of the medicinal product, potential drug adverse reactions 
and interactions, storage conditions as well as the expiry date. With regard to non-prescription 
drugs, the printed information may constitute the only pharmaceutical instructions that the 
patient receives (WHO, 2002a).   
  
Empirical evidence demonstrates that customers depend largely on printed information on the 
package when deciding on OTC drug purchases rather than prescription medicines (Kim & 
King, 2009). Additionally, a study indicates that 40.2% of customers relied on printed 
information when making a decision to purchase OTC medicines whilst 30.5%, 9.4%, 7%, 
4.7%, 2.3% and 5.9% depended on family and friends, pharmacists, medical doctors, radio/TV 
advertisements, journals and books and the others respectively (Sansgiry et al., 2001).  
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It is also emphasized that written information on the package facilitates the easy recognition of 
the medicinal product (Lalor, 2011). Dransfield, Zamora, and Bayle (1998) pointed out that 
product information has a critical influence on perceptions of quality and preference. Past 
research also reveals that product information is used to infer the quality of the product (Silayoi 
& Speece, 2007). Indeed, printed information on the package has the potential to reduce risks 
inherent in purchases, signals quality and directly aids customers in making buying decisions. 
This becomes possible as written information on the package conveys search, experience and 
credence attributes of the product (Dimara & Skuras, 2005).   
  
It is argued that when customers are faced with array of product choices (Wright, 1997), 
customers search for a message that can reassure them that their purchases will meet their 
expectations (Dimara & Skuras, 2005). Written information on the package provides such 
assurance to customers by supporting the advertising claims (Wright, 1997), establish the 
brand`s identity and enhance name recognition (Mahajan, Vaisha, Gupta, & Dholle, 2013).  
Product information is of great importance in constructing an image that customers may recall 
when making brand choice (Dimara & Skuras, 2005).   
  
Silayoi and Speece (2007) are of the view that the package layout is essential for presenting 
information. In their view, the label can be a source of confusion by conveying large volumes 
of information or inaccurate and misleading messages. In most cases, in order to maximize the 
message on the product package, designers use too small text sizes which impair readability. 
This can adversely affect the quality of the decision-making process and customers` rights to 
safety and information. Underwood and Ozanne (1998) pointed out that when the written 
information on the package does not communicate well, customers` frustration increases, and 
most of them do brand switching and discontinue the use of the brand.    
  
2.6.2.2 Packaging Material  
Packaging materials must adequately provide stability and shelf-life to drugs to preserve the 
product`s identity, strength, quality and prevent contamination (Saha, 2011). Smith and Taylor 
(2002) argued that packaging materials influence perceptions of product quality. Silayoi and 
Speece (2007) also pointed out that the technology image appears to be a peculiar element 
compared to the other informational attributes because it communicates messages that are 
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usually linked to a customer`s lifestyle. Thus, current trends in packaging technology have 
resulted from changes in customer lifestyle and an increase in product innovations.   
  
Furthermore, it has been recommended that the information conveyed through the technology 
of package development must fully satisfy the customer criteria, and more importantly, must 
be presented visually as one of the marketing communications cues. Many functional package 
features, such as the lightweight plastic bottles, aseptic packaging, child-proof seals and no 
drip sprouts, and zip-lock bags have improved the functional and symbolic utility of packaging. 
The symbolism relates to role associations and convenience provided by the product packaging 
(Underwood, 2003). The functional utility, on the other hand, is associated with superior 
performance, ease of disposal, protection and enhanced security. For many non-durable 
customer goods, the added functionality through innovations in packaging can improve the 
brand`s identity and provides a critical source of differentiation in a particular product category. 
For example, blister packaging conveys user functionality with respect to convenience, and 
child and tamper resistance. Moreover, it has the potential to provide quality protection to the 
environment in addition to aesthetic presentation, information, and identification (Pilchik, 
2000; Chirag et al., 2012).   
  
Silayoi and Speece (2007) highlighted that innovations in packaging have become increasingly 
important because customers who are busy and convenience-oriented pay more attention to the 
convenience features conveyed by the packaging technology. An empirical evidence also 
suggests that packaging innovations can increase a customer`s likelihood of buying a product 
(ibid). In similar research, the participants felt that packaging innovation has an effect on 
convenience and the actual product (Silayoi & Speece, 2004).        
  
2.7 Brands and Products  
Designing and producing a product to meet the desires of customers is the heart of marketing. 
A product itself is regarded as an essential aspect of brand equity. This is because it creates 
an impression about the brand and is what the firm conveys to customers with regard to the 
brand in its marketing communications (Keller, 2013).               
  
In a broader perspective, products relate to physical goods, services, ideas, persons and places 
that offer both intangible and tangible benefits desired by individuals and organizations for 
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which something valuable is exchanged for them (Brassington & Pettit, 2003). Alternatively, 
Kotler et al. (2002) describe a product as anything brought to the marketplace for acquisition, 
attention, consumption or use that satisfies a need.  According to the authors, customers tend 
to perceive products as a set of complex bundles of benefits that meet their wants or needs.   
  
In contrast, the word brand was obtained from Old Norse language “brandr”, meaning “to 
burn” which provided a means of identifying domestic animals (Keller, 2013). Kotler and 
Keller (2009) defined brand as anything that is used to identify and distinguish products of a 
firm or group of firms from those of competitors (Kotler & Keller, 2009).  It has been suggested 
that the meaning of a brand extends beyond a product as it possesses other attributes that 
distinguish it from a product. These attributes could be tangible and rational which may relate 
to the product functionality or more symbolic, emotional, and intangible which represent the 
meaning associated with the brand (Keller, 2013). In addition, Kotler and Keller (2009) noted 
that many practitioners are of the view that a brand conveys meaning over and above just 
designing a logo, symbol and generating a name for a new product. A brand therefore 
represents something that has substantially gained some degree of awareness, prominence and 
reputation in the market place.   
  
In addition, de Chernatony, McDonald, and Wallace (2011:18) pointed out that the major 
distinction between a brand and product is the “added values” which indicate the intangible or 
extra attributes perceived by customers which are embodied in the product. In their view, a 
brand consists of emotional and functional benefits which give companies power to assure 
customers about the peculiar and delightful exposure they will receive from the brand. A brand 
therefore transmits a bundle of benefits to customers that satisfy their rational and emotional 
needs.  
  
2.7.1 Branding in the Drug Industry   
The concept of branding has lasted for many years as a tool to differentiate a firm`s offering 
from competing products by creating an image that can easily be recognized and remembered 
(Smith, 2007). Over the years, firms that produced traditional customer goods have sustained 
themselves in the market by branding their products (Ladha, 2007). It has been suggested that, 
one of the possible ways for companies to survive and continuously grow in the marketplace 
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is to create and carefully manage the value of their products and services. Firms can create this 
value through their product brands (Dlaćic & Kezman, 2007).   
  
However, traditionally, the sources of value creation in the drug industry as whole have been 
continuous research and development and aggressive sales efforts (Blackett & Harrison, 2001). 
The drug industry has been typically dominated by science and its success has been largely 
dependent on the invention of superior products beneficial to mankind (Blackett & Robins, 
2001a). Hence, the industry had focused on products rather than brands. They serve as a major 
source of competitive strength and huge investments were made to create them (Moss, 2001; 
Sanyal, Datta, & Banerjee, 2013).   
  
Since a firm`s products can easily be reproduced, products are therefore not unique and they 
earn a rate of returns on investment that is commensurate with those of competitors. Dickov 
and Igić (2013) suggested that brand equity was virtually non-existent in the pharmaceutical 
industry since the value of a product was indicated by its therapeutic value and the duration of 
the patent expiration.   
  
Coupled with this, the development of the discipline of branding in the drug industry has been 
slow and has not gained the strategic attention relative to their counterparts in the traditional 
customer goods industry (Shuiling & Moss, 2003). The authors further argued that the critical 
success factors in the industry until recently, used to be aggressive research and development, 
strong patent protection and strong sales agents. Thus, the industry has been well-noted for 
being product, research and development driven but not market-oriented.   
  
However, Moss and Shuiling (2004) emphasise that the industry is not growing as it used to in 
the past, partly, because the traditional success factors are less effective in today`s competitive 
marketing environment. Moreover, differences in product performance are getting closer and 
generic competition is intensifying and this constitutes a major threat to the industry.   
Firms in the industry are now searching for new ways to consolidate themselves in the market. 
Over the years, several mergers and acquisition were undertaken with the view to optimising 
productivity from research and development to gain economies of scale within the industry 
(Dickov & Igić, 2013).    
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Ladha (2007) is of the view that due to the harsh competitive nature of the industry, the idea of 
branding would be more significant and of strategic importance to the industry. However, there 
are several factors that constrain branding and marketing practices in the pharmaceutical 
industry compared to the traditional customer packaged goods industry. Blackett and Robins 
(2001a) emphasized that brands thrive in a marketplace where direct and open relationships 
exist, as well as where availability of a product and choice is unrestricted. Few of these factors, 
however, really exist within the ethical drug industry. In the ethical drug industry, the 
relationship between the buyer and the seller is heavily mediated, while regulatory bodies 
impose sanctions and restrict the availability of a product and direct communication about a 
product`s attributes to customers (Blackett & Robins, 2001a).    
  
According to Moss and Schuiling (2004), the drug market is a highly regulated market globally 
and, unlike other customer products, the brand name is not transferable to a new product when 
the patent expires. In view of this, it has been concluded that it is not worth investing in 
pharmaceutical brands due to their short life cycle. Another major problem lies in the constant 
cycle of product innovations which gives rise to the rapid launching of new brands at the cost 
of older brands.  In spite of this, the authors further emphasized that drug companies have not 
worked proactively to determine and communicate the brand identity of their products to 
customers in order to make their brands distinct from competitors. Moreover, it is argued that 
there is lack of brand focus in the ethical drug industry (Shuiling & Moss, 2003).   
  
Nonetheless, the industry possesses some well-established and strong brands of which a large 
number enjoy little or no patent protection (Blackett & Robins, 2001b). Furthermore, the OTC 
market which operates in a similar fashion as the traditional customer goods industry has 
embraced brand logic and its practices as prevailing in the customer packaged goods industry 
(Dickov & Igić, 2013; Blackett & Harrison, 2001). Most functional and alternative medicines 
are also managed like traditional FMCGs as they are accessible, and the power of choice largely 
depends on the customer (Blackett & Robins, 2001a).   
  
Dickov and Igić (2013) asserts that many successful OTC brands, such as Aspirin and Strepsils 
are recognized as international brands and are comparable to iconic brands like Coca Cola in 
the customer retail markets. Recognizing the critical role of branding in the OTC market, many 
ethical pharmaceutical companies are now producing and investing in non-prescription drugs 
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with a view to creating strong brands as they represent new a source of business value (Blackett 
& Robins, 2001a).   
  
 
2.7.2 Branding Strategies in the Drug Industry   
Branding is recognized as an important aspect in the product strategy that requires huge long 
term investment. Keller (2003) highlighted that branding is concerned with building mental 
structures to enable buyers to organize their product knowledge in a manner that is consistent 
with their buying decisions to enable firms gain financial value.  
  
Shuiling and Moss (2003) highlighted that competition in the pharmaceutical market has been 
very keen, coupled with the fact that, after patent expiration, the health care practitioners may 
opt for generics which may speed up the decline of the sale of branded products. In their view, 
pharmaceutical companies can manage themselves differently in the market by building strong 
brands as they create new competitive advantage. Branding could also assist to optimize return 
on investment for new products whilst insulating the brands against the irresistible increase in 
generics, by building brand loyalty (Ladha, 2007; Shuiling & Moss, 2003). It has been noted 
that the basic concepts and procedures for branding pharmaceuticals are just similar to any   
customer goods.  However, the way in which pharmaceuticals are regulated in terms of 
marketing and sale poses a challenge to drug companies to recognize branding strategies and 
practices crucial to the health care industry (Ladha, 2007).   
  
 Although some drug companies have been investing to create brands in recent years, brands 
in the pharmaceutical industry are not well described, built and managed (Shuiling & Moss, 
2003). According to the authors, a brand consists of intangible and tangible set of benefits 
stored in customers` minds. The choice of these benefits requires the complete analysis of 
customers, market, other environmental factors and competition. This will help to determine 
the right target group to create a distinctive brand identity that will distinguish the brand so as 
to gain competitive advantage in the market (ibid).  
  
Blackett and Harrison (2001) highlighted that brand positioning is also a vital strategy for 
effective branding. Positioning involves an analytical process that defines the competitive 
space that the brand can occupy, and subsequently determining how branding activities can 
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help fill this space. Thus, the brand must have defining features considered to be relevant, 
unique and attractive to customers. This requires customer insight, combined with product 
benefits as well as resources to make the brand position distinctive and generally recognized. 
More importantly, the perception created by the brand must be demonstrated in the product`s 
actual characteristics (Ladha, 2005). Indeed, the most powerful brands occupy positions in the 
customer`s memory that are defensible and unique (Blackett & Harrison, 2001).   
  
Furthermore, pharmaceutical companies can build strong brands by combining the brand 
attributes, such as packaging, symbols, characters, slogans, logos and names, to identify and 
differentiate the products from others (Keller, 2013; Ladha, 2005). Keller (2013) is of the view 
that the companies must opt for elements that are transferable, meaningful, memorable, likable, 
protectable and adaptable in order to build and maintain brand equity.  
  
Another important aspect of branding for pharmaceutical companies is the choice of brand 
name for the medicinal product (Ladha, 2005). The brand name must be easy to pronounce, 
short, memorable, unique and difficult to imitate. It can also be linked to the corporate brand 
name as an umbrella or full name to prolong the brand`s lifespan which is usually short. It is 
suggested that the corporate brand names must be clear and also have positive meaning in the 
minds of customers. This is often more effective than product brand name especially for ethical 
drugs (Shuiling & Moss, 2003; Ladha, 2005).   
  
Kotler (2003) is, however, of the view that building a branded product does not merely involve 
creating a name, logo, colours, symbol or tagline. Essentially, it involves a marketer making a 
promise to consistently transmit tangible benefits, services and features to a customer. 
Branding becomes successful only when companies deliver their promises made to their 
customers to encourage them to respond favourably to the brand (De Chernatony et al., 2011). 
According to Kotler (2003), brand bonding occurs only when buyers experience the 
organization as meeting the benefits promised to the customers. The author further suggested 
that advertising also has the potential to create a brand name recognition, some degree of mental 
knowledge about the brand and, in effect, to elicit brand preference.  
  
According to Ladha (2005), a key aspect of branding that is usually ignored by health care 
companies is emotional branding. This involves building strong emotional brand attachment 
with customers and matching the brand`s personality with that of the customers` self-images 
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(Malar, Krohmer, Hoyer, & Nyffenegger, 2011).  A brand has some personality traits and these 
can be aligned with the aspirations of the target group. The feelings elicited by a brand can 
provide a platform for positioning the brand in the market (Blackett & Harrison, 2001).  
  
Moss and Schuiling (2004) also suggested that drug companies can develop brands by first 
identifying the brand identity through in-depth research, communicating this in a coherent 
manner to target audience and consistently monitoring and managing the brand`s image. Other 
pertinent elements for branding relates to communicating the product`s differentiation from its 
competing products, pricing it competitively and highlighting its performance to end-users 
(Ladha, 2005).    
 
2.8 Definition of Brand Equity   
In a competitive business environment, practitioners and researchers have recognized that the 
most enduring and invaluable assets of a firm are the names of brands linked to its market 
offerings due to their strategic role in the success of the business. Fundamentally, the essence 
of branding is to endow products with strong brand equity. Nevertheless, brands convey 
different levels of value and power to products in the market place (Keller, 2013).  
  
It has been highlighted that positive brand equity conveys numerous advantages to a company, 
such as, greater loyalty, resilience to competitive attacks and marketing crises, higher margins 
and licensing opportunities which generate sustainable cash flow (Farquhar, 1989; Keller, 
2013). Furthermore, it is argued that competitors can reproduce the production process and 
layout of a factory but it is not simple to copy brands because they are a deeply held set of 
intangible and tangible benefits in customers` minds (Keller, 2013; Shuiling & Moss, 2003). 
Obviously, the most invaluable property a company possess is the brand it has built over time 
(Keller, 2013).   
  
However, since the theory of brand equity was put forward, it has been conceptualized and 
operationalised for various purposes in different ways. This has led to different methods for 
conceptualizing and measuring the construct in the marketing literature (Christodoulides & de 
Chernatony, 2010). The authors further suggested that, though there is large amount of 
literature on brand equity, it is substantially inconclusive and fragmented.   
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It has been highlighted that brand equity relates to extra value conferred to a product by 
branding (Farquhar, 1989). In the author`s view, the additional value a physical product gains 
from a branding extends beyond the product`s performance. Though there is no generally 
agreed conceptualization of brand equity, a review of the literature indicates that many authors, 
at least, agree to the definition proposed by Farquhar (1989). For example, Keller (2013) 
defined brand equity as marketing effects exclusively attributed to the name of the brand. The 
author further suggested that brand equity occurs due to differences in outcomes emanating 
from selling branded product compared to analogous generic version. The existence of 
differences in outcomes is as result of the value accrued to a product arising from the previous 
brand`s marketing activities.   
  
Alternatively, Aaker (1991) proposed that brand equity consists of assets and liabilities that are 
connected to the name of a brand which enhance or diminish the value of a marketing offering 
to a company and its clients. Here, the firm is not the only recipient of the brand value but also 
its customers. For Aaker, brand equity can add or subtract value from the product. Brands can 
therefore create positive or negative impressions about a product due to customers’ exposure 
to the branded product over time (Kapferer, 2012). Hence, a brand`s equity attached to a brand, 
its symbol and/or name can either be positive or negative. Negative brand equity indicates that 
the brand has negligible effect on the product compared with unbranded and private label 
brands (Trott & Sople, 2016). Thus, brand equity can increase or reduce the gains provided by 
branding to a firm and its customers (Campbell, 2002).   
 
2.8.1 Perspectives of Brand Equity   
Traditionally, the concept of brand equity has been conceptualized and measured in two major 
different perspectives in the marketing literature. Christodoulides and de Chernatony (2010) 
noted that some researchers have conceptualized and evaluated the value of a brand based on 
a financial perspective (Simon & Sullivan, 1993; Farquhar, 1989) whilst others have 
approached brand equity on basis of customer perspective (Keller, 1993; Keller & Lehmann, 
2004; Aaker, 1996; Pitta & Katsanis, 1995). The financial approach to brand equity describes 
the value that a brand brings to the company and is commonly referred to as firm-based brand 
equity (FBBE).   
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In contrast, customer-based approach to brand equity discusses the relationship customers have 
with the brand and relies on customer perceptions (Kapferer, 2008; Christodoulides & de 
Chernatony, 2010). However, the worth of a brand is engendered by customers’ response to a 
brand name. Essentially, the outcome of customer perceptions of brand equity is the financial 
value contributed by a brand to a firm because it enhances profitability and market share 
(Lassar, Mittal, & Sharma, 1995; Christodoulides & de Chernatony 2010). Basically, brand 
equity results from immense confidence that customers have on a particular brand compared 
to its competing brands (Lassar et al., 1995).   
  
Kapferer (2008) attempted to relate the dimensions of CBBE to brand value via brand strength 
(CBBE outcomes like premium price and market leadership). The author defined brand value 
as net present value of a firm`s future cash flows due to branding after meeting the interest on 
capital used for production, cost of running the business and marketing. Thus, the value of a 
brand is a measure of earnings that the brand assets can generate through the mediating role of 
brand strength. To the author, it is important for a brand to deliver cash value if it really has 
positive equity.   
  
However, a third approach to brand equity which combines customer perceptions and FBBE 
has also been documented in the brand literature (Motameni & Shahrokhi, 1998; Kim, Kim, & 
An, 2003). Consequently, brand equity has been conceptualised and evaluated in three different 
ways in the marketing literature, that is, financial-based, customer-based and hybrid-based 
measures as exhibited in the Figure 2.2 below.  
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Figure 2. 2: Approaches of Brand Equity Measures            
 
Source: Developed from Extant Literature   
  
 
2.8.2 Customer – Based Brand Equity   
Customer-mind set measures of brand equity include everything that relates to the brand which 
resides in the customers` memory (e.g. perceptions, images, experiences, feelings, thoughts, 
attitudes and beliefs (Keller & Lehmann, 2003). Keller (2013) suggested that customer mind 
set measures can be summarized into five important elements which include; brand awareness, 
associations, attachments, attitudes, and activity. These measures of customer- based brand 
equity have led to much of academic research (Keller, 1993; Yoo et al., 2000; Aaker, 1996; 
Pappu et al., 2005; Asif et al., 2016; Buil et al., 2013) and industry studies (Young and 
Rubicam Asset Valuator, Research International`s Equity Engine, Millward Brown Brandz) 
(Ailawadi, Lehmann, & Neslin, 2003).  
  
The conceptualization of CBBE is built on cognitive psychology and focuses on buyers` 
memory-based brand associations (Keller, 1993; Aaker, 1991). For example, Keller (1993:2) 
discusses CBBE based on customer cognitive psychology and described it as “the differential 
effect of brand knowledge on customer response to the marketing of the brand”. The focus of 
this definition is on the individual buyer and the customer responses to the marketing activity 
of the product. Alternatively, Aaker (1991; 1996) identified four elements of brand equity that 
reflect customer perception and reaction to the brand; brand loyalty, brand association, 
perceived quality and brand awareness.   
Brand Equity 
Customer-Based 
Measures 
Financial-Based 
Measures 
Hybrid-Based 
Measures 
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Cobb-Walgren et al. (1995) highlighted that researchers have operationalized CBBE on 
customer-buying behaviour (Kamakura & Russell, 1993) or customer perceptions (Pappu et 
al., 2005; Keller, 1993) or both (Aaker, 1991; 1996; Yoo et al., 2000; Yoo & Donthu, 2002). 
Similarly, Lassar et al. (1995:12) defined CBBE as “the enhancement in the perceived utility 
and desirability a brand name confers on a product”. In their view, brand equity is the 
customers` judgement of the superiority or excellence of a market offering due to the brand 
name compared to similar unbranded product. The authors suggested that social image, 
performance, trustworthiness, attachment/identification and value/price as the customer-mind 
set measures of brand equity.  
  
Yoo et al. (2000:196) also proposed that brand equity is the difference in customer choice 
between a branded and an identical generic version. In their view, customer- based brand equity 
is seen as an extra value conveyed by the brand name of a product compared with an identical 
product without a brand name. Customer-based brand equity was operationalized as the 
differences in customer choice with respect to preference for or intention to buy a branded 
product in comparison with its generic version. The authors employed brand loyalty, perceived 
quality, brand awareness with strong associations of the dimensionality of Aaker`s (1996) 
model to measure brand equity. The authors further extended Aaker`s (1991; 1996) model by 
including another construct, known as overall brand equity. The overall brand equity measures 
how the individual dimensions of brand equity influence or contribute to enhance brand equity. 
The authors concluded that the value of a brand can be developed, managed and increased by 
fortifying the brand equity elements. Consequently, high brand equity suggests that customers 
have strong associations, perceived the brand to be of high quality and are loyal to the brand.   
  
Dlaćic and Kezman (2014) also proposed perceptions of quality, brand awareness and trust as 
the brand equity dimensions when investigating how customer loyalty is affected by the brand 
equity of OTC orthodox pain killer drugs in the pharmaceutical market. Furthermore, Kapferer 
(2008) discusses CBBE along these elements: brand consumption, evoked set and brand 
awareness.   
  
However, Erdem and Swait (1998) studied CBBE from a different viewpoint relying on 
signalling theory from information economics, explicitly focusing on the imperfect and 
asymmetrical information structure of the market. In this perspective, CBBE is defined as “the 
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value of a brand signal to the customers” (p.132). The authors suggested that clarity, content 
and credibility of a brand are the determinants of CBBE and emphasized that credibility is the 
most key dimension of CBBE. These dimensions of brand equity as a signal of a product`s 
position can enhance perceptions of quality, reduce information costs and customer`s 
perceptions of risk. These effects, in turn, can enhance CBBE.   
  
Although, the dominant research approach to CBBE is grounded in cognitive psychology, the 
two perspectives are considered to be complementary (Christodoulides & de Chernatony, 2010; 
Erdem & Swait, 1998). Hence, Christodoulides and de Chernatony (2010:9) defined CBBE 
that encompasses the basic premises of both viewpoints, thus, “a set of perceptions, attitudes, 
knowledge, and behaviours on the part of customers that results in increased utility and allows 
a brand to earn greater volume or greater margins than it could without the brand name.”   
  
Ailawadi et al. (2003) are of the view that perceptual measures of brand equity are significant 
in the sense that they offer numerous sources of brand equity, have good diagnostic power, and 
can serve as a tool to forecast the health of the brand. Customer-based brand equity also 
provides useful information to establish and also to evaluate the effectiveness of strategic 
marketing decisions as well as the tactical decisions of the company (Ailawadi et al., 2003; 
Keller, 1993). However, it is argued that this technique is typically based on customer surveys 
of preferences, attitudes, and intentions to buy. As result, the major drawback of CBBE 
approach is that it does not provide for any objective measure for transforming customer 
perceptions into reliable estimates of financial value for a company (Ailawadi et al., 2003; 
Simon & Sullivan, 1993).   
   
2.8.3 Financial Perspective of Brand Equity  
The financial valuation of brand equity focuses on revenue generated by a brand, and such a 
measure considers a brand as a financial asset (Ailawadi et al., 2003; Simon & Sullivan, 1993). 
As a result, brands are viewed as assets like plant and equipment that can be sold and bought. 
From a company`s perspective, the value of a brand relates to the price that a brand can be 
traded in the financial market (Keller & Lehmann, 2006).   
Keller (1993) emphasized that financial-based measures of brand equity has gained popularity 
due of its role in accounting, merger and acquisition or divestiture purposes. Aaker (1991) 
discusses the sources of financial-based brand equity and suggested brand loyalty, brand 
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quality, brand association, brand awareness and proprietary assets like patents and channel 
relationships. Simon and Sullivan (1993) present numerous techniques that were employed to 
estimate the financial-based brand and their relative weaknesses. The first method is related to 
price premium generated by a product and is used as a proxy of elasticity of demand and/or a 
measure of brand loyalty. The authors are of the view that this technique relies on a single 
element to evaluate the FBBE and may result in biased estimates.   
An alternative method is brand replacement cost, that is, the expenditure incurred to launch a 
product under a new brand name. This technique has also been criticised on the grounds that it 
provides only one source of financial valuation of a brand.   
  
However, the authors employed financial-market value measure to assess a company`s 
perspective to brand equity. In their view, brand equity relates to net additional cash value that 
is generated by branded product above the unbranded identical version. By this methodology, 
the cash value of a firm`s brand is obtained by subtracting the value of the brand from the 
company`s other property. Here, the stock price is used as a measure of the value of a brand of 
the firm.    
  
Ailawadi et al. (2003) pointed out the disadvantage of using stock market price to assess the 
future potential of a brand is that it is highly volatile and does not provide immediate 
importance to marketing because many factors other than marketing activities can affect it. 
Keller (1993) also suggested that the financial measure of brand equity is less important unless 
the underlying value of the brand can be built or practitioners has the expertise to harness the 
value by working out meaningful brand strategies.  
  
2.8.4 Hybrid Approach to Brand Equity  
Kim et al. (2003) highlighted that both customer perceptions and financial perspectives to 
brand equity are combined to allow for a comprehensive perspective to address the 
inefficiencies which may occur when just one of the two research streams is used.  It has been 
highlighted that the financial-based measures of brand equity offer a broad approach only and 
do not permit managers to identify the sources of brand equity (Srinivasan et al., 2005).   
  
In addition, Marketing Science Institute (2002) cited by Srinivasan, Park, and Chang (2005) 
stated that CBBE is used to evaluate products or services rather than the financial value of these 
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utilities. This measure is considered less important to management given the increasing demand 
for better results and performance in marketing. Hence, Motameni and Shahrokhi (1998) 
proposed a global measure of brand equity valuation which consists of both financial and 
customer perspectives to brand equity. The authors are of the view that the combined approach 
offers a more accurate measurement of brand equity and its sources.   
  
Furthermore, Srinivasan et al. (2005: 1446) combined customer survey and financial-based 
measures and defined brand equity as “the incremental contribution per year obtained by the 
brand in comparison with the underlying product (or service) with no brand-building efforts.” 
The authors further suggested non-attribute preference, attribute perception and brand 
awareness as the key dimensions of brand equity.   
 
Motameni and Shahrokhi (1998) emphasized that the foundation of all the perspectives of 
brand equity lies on the dimensionality of Aaker`s brand equity framework. Similarly, 
Ailawadi et al. (2003) commented that neither of the two perspectives of brand equity possesses 
all the features that are ideal to measure brand equity that marketers` desire. In view of this, 
the authors proposed revenue premium that combines strong conceptual grounding, high 
external validity, ease of calculation and completeness.   
 
Parallel to the academic research on brand equity measurement, an industry brand analyst 
known as Interbrand Group has developed a brand strength model along these factors: 
understanding, protection, commitment, clarity, responsiveness, relevance, authenticity, 
differentiation, presence and consistency. These factors are then combined with some in-depth 
financial model of the business to determine the brand`s present and future ability to create 
economic value for the shareholders (Rocha, 2014). However, Pitta and Katsanis (1995) 
highlighted that customer perceptions of brand equity are appropriate for marketers to study 
the concept of brand equity. Therefore, the current study relied on customers` perceptions to 
evaluate the potential role of packaging in supporting brand equity of herbal medicines in the 
OTC medicine market.   
  
2.8.5 Empirical Measures of Brand Equity   
According to Kamakura and Russell (1993), brand equity is seen as the value of the brand to 
the firm and its customers. In their view, brand equity has been conceptualized in many ways 
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and hence, there is a lack of consensus about how brand equity is measured. Table 2.3 provides 
some earlier authors` work on measures of brand equity and the context of their studies in the 
brand management literature. It could be observed from the Table 2.3 that the most frequently 
used brand equity dimensions are those proposed by Aaker (1991; 1996) and Keller (1993) and 
have also been used in many research contexts.  
  
Table 2. 3: Empirical Studies on Brand Equity Measures  
Author (s) and Year         Research Area  Dimensions   
Atilgan, Aksoy, and Akinci (2005)  Beverage Industry   Brand loyalty, Perceived quality, 
Brand awareness, Brand associations  
Mohan and Sequeira (2016)  Household care, Food & 
Beverages, Personal Care   
Brand awareness, Brand loyalty, 
Perceived quality, Brand association  
Chi, Yeh, and Yan (2009)  Cellular phone industry  Brand awareness, Perceived quality, 
Brand loyalty   
Buil et al. (2013)  Sportswear, Customer  
Electronics   
Perceived quality, Brand loyalty, 
Brand awareness, Brand association  
Christodoulides, Cadogan, and 
Veloutsou (2015)  
Goods, Services, Internet  
Brands  
Brand awareness, Brand associations, 
Perceived quality, Brand loyalty  
Cobb-Walgren et al. (1995)  Hotel (Services), Goods  
(Household cleansers)   
Brand awareness, Brand associations, 
Perceived quality  
Dlaćić and Kezman (2014)  Pharmaceutical market  
 Self-medication Products   
Customer loyalty, Brand awareness, 
Perceived quality, Trust  
Gordon, Calantone, and di Benedetto 
(1993).   
Electrical products, 
Components market  
(Industrial market)  
Brand awareness, Brand associations, 
Brand loyalty, Perceived quality  
Hyun and Kim (2011)  Chain Restaurants Industry   Brand awareness, Brand image,  
Perceived quality, Brand loyalty  
Kim and Kim (2004)  Food Services Industry  Brand awareness, Brand image, Brand 
loyalty, Perceived quality  
Kim, Jin-Sun, and Kim (2008).   Hospitality industry  Brand loyalty, Brand awareness/ 
association, Perceived quality,   
Lassar et al. (1995)  Television monitors, 
Watches  
Performance, Social image, Value, 
Trustworthiness, Attachment  
Panchal et al. (2012)  Pharmaceutical Products   Brand awareness, Brand loyalty, 
Perceived quality  
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Pappu et al. (2005)  Cars, Television  Brand awareness, Brand loyalty, 
Perceived quality, Brand association  
Pike, Bianchi, Kerr, and Patti  
(2010)  
Tourism destination  Brand salience, Brand image,  
Brand loyalty, Perceived quality   
Jalilvand, Samiei, and Mahdavinia 
(2011)  
Automobile industry  Brand awareness, Brand association, 
Perceived quality, Brand loyalty  
Gil et al. (2007)  Milk, Toothpaste, Olive oil  Perceived quality, Brand awareness, 
Brand loyalty, Brand association  
Tong and Hawley (2009)  Sportswear Industry  Brand awareness, Brand associations, 
Perceived quality, Brand loyalty  
Krishnan and Hartline (2001)  Services (Movie theatres,  
Hair salons, Pest control,  
Television)   
Brand loyalty, Name awareness, 
Perceived quality, Brand associations   
Washburn and Plank (2002)  Six pairs of products   Perceived quality, brand loyalty, Brand 
associations, Brand awareness   
Yoo et al. 2000  Athletics shoes, Camera 
films, Colour television sets   
Perceived quality, Brand loyalty, 
Brand awareness/ Brand associations  
Netemeyer et al. 2004  10 different products   Perceived value for cost, Perceived 
quality, Brand uniqueness, Willingness 
to pay premium price  
Ailawadi et al. (2003)  Packaged goods categories  Revenue premium measures  
Erdem and Swait (1998)  Jeans, Juice  Clarity, Credibility, Content   
Kamakura and Russell (1993)  Powered laundry detergent 
category  
Brand dominance ratio, Intangible 
value, Perceived value   
 
Source: Compiled by the Researcher   
  
2.8.5 Brand Resonance Model   
Building powerful brands has become top priority of many firms as it conveys greater financial 
value to the firm. Keller (2001; 2013) presented a customer-based brand building model called 
the Brand Resonance Model, otherwise known as the CBBE framework to aid practitioners to 
develop healthy brands.  The fundamental principle underlying this framework is that the health 
of a brand resides in the minds of customers. The Brand Resonance Model serves as a useful 
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guide for assessing a firm`s brand-building efforts, marketing research initiative as well as 
interpretation, planning and implementing brand strategies.   
  
According to the framework, building a strong brand consists of four logical processes: creating 
proper brand identity, brand meaning, brand responses, and forging brand relationships with 
customers. Essentially, building a healthy brand requires: establishing the breadth and depth of 
brand awareness; creating strong, favourable and unique brand associations; eliciting positive, 
accessible brand responses; and forging intense, active loyalty. To successfully accomplish all 
the four logical stages, in turn, demands creating six brand-building blocks: brand salience, 
brand performance, brand imagery, brand judgements, brand feelings and brand resonance.   
  
To reach the final level involves addressing specific objectives at each stage for both existing 
and potential customers. The six brand-building blocks are represented by a pyramid, 
indicating that developing positive brand equity entails getting the brand to the top of the 
pyramid. The brand-building process is shown in the Figure 2.3 below.   
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Figure 2. 3: Brand Resonance Pyramid  
      Source: Keller (2001:7; 2013:108)  
  
2.8.2.1 Brand-Building Blocks  
According to Keller (2013) most strong brands are built by reaching the top of both sides of 
the pyramid. The author suggested four stages of developing strong brands with positive equity. 
These include;    
  
 Brand Identity  
According to the model, the initial stage for creating a vibrant brand is to develop appropriate 
brand identity. This relates to establishing brand salience in the marketplace. Brand salience 
describes customers’ awareness of the brand (Keller, 2001). Brand awareness involves 
connecting the symbol, brand name and logo to some associations in the mind. Establishing 
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the breadth and depth of awareness is important for a healthy brand with the view to influencing 
customers to consider the brand in a different buying setting. Depth of awareness indicates how 
well customers can recognize or recall the brand whilst the breadth of awareness describes the 
ability to retrieve the brand from memory in different buying and usage settings.  
  
 Brand Meaning    
According to the author, brand salience is the foundation of building brand equity, but it does 
not create substantial value for a brand. For most customers, the image of the brand is 
paramount when faced with some buying situations. Building brand meaning requires creating 
a positive brand image which relates to perceptions customers have with the brand. Brand 
meaning is made up of brand imagery and brand performance. Brand performance is related to 
the intrinsic brand attributes which transfer functional utility to customers. In contrast, brand 
imagery describes the extrinsic features of the product and represents the intangible 
characteristics of a brand which satisfy the psychological and social needs of customers. 
Successful outcomes of these dimensions elicit favourable brand response which produces 
intense and active loyalty.    
  
 Brand Responses   
Successful brand response depends on brand meaning and relates to the thoughts and feelings 
of buyers towards the brand. Brand response is composed of brand feelings and brand 
judgement. Brand judgement describes customers’ overall impression and assessment of the 
brand and is formed through the combination of various aspects of meanings linked to the 
brand. On the contrary, brand feelings indicate a customer`s emotional response and reaction 
to the brand as well as a sense of belongingness evoked by the brand. Customers’ feelings and 
judgement about a brand can positively influence their buying behaviour if they respond 
favourably when exposed to the brand.   
     
 Brand Relationships   
Brand relationships is the last stage of brand-building efforts and indicates the degree of 
attachment to the brand. Brand resonance describes the kind of attachments that exists between 
the buyers and the brand, including the way customers accept that they are “in sync” with the 
brand. This can be seen by the intensity or the depth of the psychological bond that customers 
have with the brand as well as the nature of behaviour elicited by brand loyalty. Brand 
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relationships are broadly composed of two major elements: intensity and activity. Intensity of 
brand relationships is the strength of the attitudinal attachment and sense of belongingness the 
customer has with the brand. The activity of brand relationships, on the other hand, refers to 
the frequency at which the brand is bought and consumed in addition to repeated participation 
of activities independent of purchases and consumption of the brand. Brand resonance is the 
uttermost objective of the model and can be a focus of marketing actions and means of 
interpreting brand-related marketing activities.    
  
2.9 Chapter Summary  
The chapter presents an overview of traditional herbal medicine and over-the-counter 
medications and their renewed global interest, including their potential adverse events. The 
chapter also explains packaging together with its functions and components in the over-the 
counter drug market. Furthermore, the dichotomy between brands and products is explained as 
well as the branding and brand strategies in the drug industry are well discussed. The concept 
of brand equity, its dimensions and perspectives as well as the model designed to guide brand 
building efforts of firms are also explained in this chapter. This has helped to identify gaps 
which justify the research, and ultimately, the invaluable nature of the study. The ensuing 
chapter focuses on the theoretical and conceptual models that guide the study.                                    
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CHAPTER THREE 
  
THEORETICAL AND CONCEPTUAL FRAMEWORK 
  
3.1 Introduction  
The previous chapter presented the relevant literature underling the research to provide the 
theoretical basis of the study and also to justify the research problem which the research seeks 
to address. The current chapter provides the theoretical and conceptual framework of the thesis. 
First, the key theories of customer-based brand equity (CBBE) and packaging will be examined 
after which a conceptual model of the study will be developed. This will be guided by the 
relevant literature reviewed in the previous chapter. Though several theories have been 
proposed over the years to investigate CBBE, a review of marketing literature in the previous 
chapter reveals that the basic underlying theories of CBBE are those propounded by Keller 
(1993) and Aaker (1991; 1996). Buil et al. (2013) also confirmed that the foundation of all 
models of CBBE developed later by other authors originated from Aaker (1991; 1996) and 
Keller (1993). Hence, the theoretical models of CBBE proposed by Aaker (1991; 1996) and 
Keller (1993) will be discussed in this chapter.   
  
3.2 Keller`s Brand Equity Theory    
Keller (1993) approached CBBE from the view point of an existing or a prospective individual 
customer or organization. The fundamental principle of this theory is that the health of a brand 
depends on what resides in customers` memory as result of their past exposures to the brand 
(Keller, 2001). Customers` experiences with the brand relates to what they have heard, seen, 
felt, and learned about the brand. Keller (1993:2) defined CBBE as “the differential effect of 
brand knowledge on customer response to the marketing of the brand”. The author also 
emphasized that a brand has high value if customers` responses to the market offering and its 
marketing activities are favourable compared to identical but unbranded product.  
  
Generally, favourable customer response and strong brand equity can engender lower costs, 
higher revenue and ultimately greater profits. Here, the differential effect is defined in terms of 
differences in how customers react to the marketing of a brand name compared with an 
unbranded version of the product. Secondly, customers` reactions to the marketing of a brand 
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is shown by preferences, behaviour and perceptions resulting from all aspects of the firm`s 
marketing actions.    
According to the author the key antecedent of CBBE is brand knowledge and comprises brand 
image and brand awareness as shown in the Figure 3.1 below. Thus, Keller (2013) noted that 
customer-based brand equity is developed when the buyer demonstrates strong awareness and 
familiarity with the brand and has some strong, favourable and unique mental associations with 
the brand. The author relied on an associative network memory model and defined brand 
knowledge as the brand`s information stored in memory which reflects a variety of 
associations.   
  
Brand awareness relates to the strength of the brand node or trace in memory (Rossiter & Percy, 
1987 cited by Keller, 1993). Brand awareness is distinguished into brand recognition and brand 
recall performance. Brand recognition reflects the customer`s ability to confirm previous 
experiences with the brand when given as a cue. In contrast, brand recall is related to the ability 
of customers to generate the brand from their mind. Once a sufficient level of brand awareness 
has been created, marketers can concentrate on building brand image.   
  
Brand image relates to perceptions about the brand and can be seen as customers` mental 
associations with the brand. Brand association is described as “the other informational nodes 
linked to the brand node in memory and contain the meaning of the brand for customers” 
(Keller, 1993:3). Brand associations can take different forms but usually consist of features of 
the product or aspects that are distinct from the product. Essentially, brand associations are 
composed of attributes, benefits and attitudes in an increasing scope.   
  
Brand attributes are characteristics that describe market offerings and are categorized into 
intrinsic and extrinsic attributes depending upon how directly they relate to the product 
performance. Intrinsic features relate to the physical composition or requirements of the 
product that are essential for the products` performance sought by buyers. In contrast, non-
product-related attributes describe extrinsic characteristics of a market offering that are linked 
to its purchase or consumption. Extrinsic attributes consist of packaging, usage imagery, price 
and user imagery (ibid).   
  
Brand benefits are also concerned with the meaning and value which buyers associate with the 
product features. Brand benefits could be symbolic, experiential and functional depending upon 
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the underlying motivations to which they relate. Brand attitudes, on the other hand, are seen as 
customers’ perceptions of the quality of the brand (Zeithaml, 1988 cited by Keller, 1993). All 
these brand associations vary according their favourability, uniqueness and strength.  
 
 
 
 
  
Figure 3. 1: Keller`s Customer-Based Brand Equity Model  
Source: Keller (1993: 7)  
  
3.3 Aaker`s Brand Equity Theory    
Aaker (1991:15) defined brand equity as a “set of brand assets or liabilities linked to a brand, 
its name and symbol that add to or subtract from the value provided by a product or service to 
a firm and/or to the firm`s customers." For brand equity to occur, brand assets or the liabilities 
must influence the symbol and /or name of the brand.   
  
The assets that provide value to brand include: perceptions of brand quality, brand awareness, 
brand loyalty, brand association and other proprietary brand elements such as, channel 
relationship, trademarks, and patents. This is shown in the Figure 3.2 below. The author is of 
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the view that the individual dimensions of brand equity generate value for the firm and its 
customers.    
  
For example, perceived quality provides the basis for reason-to-buy, price premium, brand 
extension, channel members` interest in the brand, and positioning and differentiation which 
ultimately improves the brand`s performance in the market. However, brand equity can add or 
subtract value from customers. More essentially, brand equity adds value to customers by 
assisting them to interpret, process and store product information as well as providing 
assurance while making purchasing decisions and user satisfaction.   
  
Similarly, brand equity generates value for companies by improving the efficiency and 
effectiveness of marketing programs, brand extensions, prices, loyalty, trade leverage and 
competitive distinctiveness. However, Aaker (1996) confirmed that brand awareness, brand 
associations, brand loyalty and perceived quality represent perceptual dimensions of brand 
equity as shown in Figure 3.2 below, while the other brand assets are derived not directly from 
customers but rather from market-based information.   
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Figure 3. 2: Aaker`s Brand Equity Model    
Source: Aaker (1991: 270)  
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3.3.1 Adopted Customer-Based Brand Equity Theory   
Though the two aforementioned models are fundamental theories of CBBE in the marketing 
literature, this thesis is closely guided by Aaker`s CBBE model. Cobb-Walgren, Ruble, and 
Donthu (1995) stated that CBBE has been operationalized into customer perceptions (brand 
awareness, perceived quality, brand associations) and behaviour (willingness to pay a high 
price, loyalty). The authors further argued that “there are advantages of combining both 
customer perceptions and actions into a single marketing measure of brand equity” (p. 27). It 
has also been highlighted that attitude alone is fundamentally a poor predictor of marketplace 
behaviour. Alternatively, customers’ perceptions are obviously a precursor of behavioural 
indications of a brand equity.   
  
Aaker and Biel (1993:71) also confirmed that “a successful brand depends upon customer 
behaviour, which is, a root, driven by perceptions of a brand”. In their view, behavioural 
dimensions indicate that brand equity exists, yet they are unable to demonstrate what resides 
in the minds and hearts of customers that really influence equity. However, while Keller`s 
(1993) framework is based solely on customer perceptions, Aaker`s (1996) model incorporates 
both perceptual and behavioural measures of CBBE. Moreover, a review of the literature in 
Chapter Two indicates that Aaker`s (1996) CBBE model is most popular and has been 
extensively used by many researchers to study customer–based brand equity. This position is 
also supported by Christodoulides et al. (2015) who pointed out that the dimensionality of 
Aaker`s (1996) brand equity model has been used in several empirical studies and contexts. 
Further, the importance of Aaker`s (1996) model has been documented in the pharmaceutical 
marketing theory (Moss, 2007; Sanyal & Datta, 2011; Panchal et al., 2012; Dlaćic & Kezman, 
2014).    
  
For example, Moss (2007) stated that developing brand name awareness is a key strategic 
objective in the pharmaceutical market. Sanyal and Datta (2011) also concluded that, though 
the significance of perceived quality and the roles of quality attributes in influencing perceived 
quality has been analysed in many contexts, it can also be extended to pharmaceutical products 
in general. In addition, Moss (2007) confirmed that most of the advantages of brand loyalty in 
the customer market have some level of validity in the pharmaceutical market, especially in 
the OTC market.   
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3.4 Research Hypotheses  
The purpose of the current research was to investigate the influence of packaging and brand 
equity of herbal medicines sold at the OTC market in Kumasi. The research further sought to 
explore the influence of brand equity dimensions on overall brand equity. On the basis of the 
reviewed literature, the hypotheses posited in the study are discussed below.   
  
3.4.1 Relationship between Brand Equity and its Dimensions     
Aaker (1996) concluded that the key brand elements that provide value to a brand are perceived 
quality, brand association, brand loyalty and brand awareness.      
  
Brand awareness  
Creating brand awareness is recognized as one of the core objectives for designing a marketing 
communications strategy for a firm because customers cannot buy a product unless they are 
aware of it (Peter & Olson, 2008). Brand awareness relates to the salience of the brand in 
buyers` memory (Aaker, 1996). Thus, brand name awareness is the ability of a prospective 
buyer to recognize and recall the brand as a member of a specific product category (Aaker, 
1991). It is highlighted that brand awareness does not only indicate that the brand has been 
seen in the past and/or is known but has also been registered in the memory (Hoeffler & Keller, 
2002). Brand awareness is regarded as the basic first step in the process of building brand 
equity because a prospective buyer must first notice and recall the brand while at the market 
place (Buil et al., 2013; Keller, 2013; Hoeffler & Keller, 2002).    
  
Although brand awareness is an essential asset for brand-building efforts, it is usually not 
elevated as one of the elements of brand equity which is capable of creating substantial value 
for a brand (Hoeffler & Keller, 2002; Chen, 2001). For example, Buil et al. (2013) pointed out 
that brand awareness can be positive, but may not have a direct impact on brand equity.  
  
Keller (2013) suggested that brand awareness can be decomposed into brand recognition and 
brand recall. Brand recognition indicates the ability of the customers to generate their past 
experiences with the brand, whilst band recall relates to spontaneous retrieval of the brand from 
the mind (Hoeffler & Keller, 2002; Keller, 1993). Aaker (1996), however, operationalized 
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brand awareness as brand recognition, brand recall and top-of-awareness.  Keller (2013) 
emphasized that brand familiarity is an important ingredient of brand awareness.   
Alba and Hutchinson (1987) defined brand familiarity as the total number of customers` 
exposures with the brand. The author further pointed out that previous exposures the customer 
has had with the brand might not enhance brand recognition, but it is usually the most recent 
experiences that significantly influences brand awareness.  
  
Though the importance of brand awareness in supporting brand equity is sometimes 
undervalued (Hoeffler & Keller, 2002; Chen, 2001), it can positively influence customers` 
purchase intentions and loyalty (Aaker, 1996). Keller (1993) is also of the view that high brand 
awareness indicates that the brand will be considered among handful of brands the customer 
wishes to buy. Secondly, strong brand awareness can affect customers’ buying decisions in the 
consideration set.   
  
Furthermore, it has been emphasized that brand awareness supports the favourability of brand 
associations and brand quality (Keller, 1993; Keller & Lehmann, 2003). Aaker (1991) also 
pointed out that customers usually buy well-known brands as these brands are often considered 
to be of good quality, reliable and in business to stay. An empirical research suggests that brand 
awareness influences overall brand equity (Asif et al., 2015).  
 
Hence, the following hypothesis is proposed:     
  
H1b:  Brand awareness positively and significantly influence overall brand equity  
  
Brand association   
After creating brand awareness, a manager`s task is to create a set of strong, desirable and 
distinctive brand associations in the minds of customers. Brand association is also regarded as 
another core element of CBBE (Aaker, 1991; 1996; Keller, 1993). Brand association relates to 
anything that the buyer links to the brand, and it connects the customer to the brand which 
includes use situations, user imagery, symbols, organizational characteristics, product features 
and brand personality (Campbell, 2012; Aaker, 1991).    
  
Aaker (1996) suggested that brand association is made up of brand personality, organizational 
associations and perceived value. Perceived value relates to the basic functional benefits that a 
101  
  
brand conveys to customers. Zeithaml (1988) also suggested that perceived value is the 
subjective assessment of utility of a product in terms of what is received and given out.   
  
Brand personality can be defined as human traits that are linked to a brand (Aaker, 1997), and 
it tends to reflect the emotions and feelings evoked by the brand (Keller, 1993). Aaker (1997) 
suggested five elements of brand personality: sophistication, excitement, sincerity, ruggedness 
and competence. For some brands, brand personality provides symbolic and self-expressive 
benefits which, in turn, support differentiation and customer-brand relationships (Aaker, 1996). 
While product-related attributes tend to serve a utilitarian function, extrinsic product features 
provide personality for the brand (Keller, 1993; Aaker, 1997).   
  
Finally, the organizational association relates to the organizational elements (values, programs 
and people) that are connected to the brand. Organizational associations have the potential to 
drive choice and differentiation. Organizational characteristics that are usually associated with 
brands include concern for customers, innovativeness, quality, corporate social responsibility, 
success and a global orientation (Aaker, 1996).  
  
Chen (2001), however, categorized brand associations into product associations and 
organizational associations. Product association is further divided into functional attribute 
association (functional benefit, perceived quality and product attribute) and non-functional 
attribute association (price/value, emotional associations, use/usage situation, and symbolic 
associations). The non-functional attribute association seems to coincide with the non-product 
related attributes proposed by Keller (1993). Organizational association is also grouped into 
corporate social responsibility associations and corporate ability associations.    
  
Low and Lamb (2000) also identified perceptions of quality, brand attributes and brand image 
as antecedents of brand associations. This contrasts sharply with the position of Keller (1993: 
3) who viewed brand image as “a set of associations linked to the brand”. Hence, according to 
the author`s position brand image is not a dimension of brand association.   
  
Aaker (1991) pointed out that brand associations can be used to position, differentiate and 
extend brands as well as evoke positive feelings toward the brand, and provide the reason for 
buying the brand. Nor is this all, customers depend on brand associations to retrieve, organize 
and process information stored in the memory to assist in making buying decisions.  Chen 
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(2001) is of the view that strong and unique brand association would increase brand equity and 
ultimately creates a strong competitive edge for a firm. Yoo et al. (2000) also suggested that 
brand association can serves as an indicator of quality which may influence the buyer to 
consider the brand in the store, and ultimately build a positive attitude towards the brand. 
Hence, strong brand equity suggests that buyers have positive perceptions of the brand (Atilgan 
et al., 2005). An empirical study also reveals that brand association significantly enhances 
brand equity (Yoo et al., 2000).  
 
Hence, the following hypothesis is postulated:  
  
H2b: Brand association positively and significantly influence overall brand equity  
  
Perceived quality  
Another component of brand equity is customer perceptions of the quality of the brand (Aaker, 
1996). Perceptions of quality are concerned with subjective assessment of the overall 
excellence of a good (Zeithaml, 1988). The author further stated that perceived quality contrasts 
sharply with objective quality. Actual product quality, however, relates to the extent to which 
the product provides excellent performance. A further distinction is made between 
manufacturing-based quality and product-based quality. Gavin (1987) stated that product-
based quality relates to the nature and amount of particular attributes that make up the product, 
whilst manufacturing-based quality refers to conformity to production or service requirements.  
It has been emphasized that customers’ perceptions of superiority of a product can be enhanced 
if the actual quality of the product is improved (Gil et al., 2007). In addition, the company 
needs to convey the superiority of the brand via its marketing activities to customers.   
  
According to Aaker (1992), perceived quality creates value for a brand by being the basis for 
differentiation, reason to buy, line extensions, channel member interest and price premium, and 
overall contributing to the profitability of the firm.  As a result, perceived quality is regarded 
as a strategic competitive weapon and therefore many companies have now turned to customer- 
driven quality to create value to delight their customers. Customers’ perceptions of product 
quality has been recognized as an element of perceived value (Zeithaml, 1988), and ultimately, 
superiority of a brand can drive a buyer to choose the brand in place of alternative brands (Yoo 
et al., 2000).   
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Although perceived quality is recognized as a distinct dimension of brand equity (Aaker, 1996), 
some authors consider it as one of the elements of brand association (Campbell, 2002; Keller, 
1993; Chen, 2001). However, Aaker (1996) is of the view that, though perceived quality is 
usually considered as an aspect of brand association, it has been elevated as a distinctive 
dimension of brand equity due to the following reasons:   
 
 amidst brand associations, perception of quality is the only dimension that contributes 
significantly to enhance financial strength of a firm   
 perceived quality is usually of great importance for a company   
 perceived quality in most cases influences the other elements of brand equity and has 
relationship with them.  
  
Gavin (1987) suggested that customers perceive the quality of a product along the dimensions 
of product features, performance, conformance, reliability, durability, image, aesthetics and 
serviceability. Alternatively, Aaker (1991) proposed performance, reliability, durability, 
serviceability, fit and finish, product features and conformance to specification as the 
dimensions of quality of a product. It has however been suggested that safety, 
efficacy/efficiency, convenience, affordability, availability, side effects, package design and 
advertising are recognized as quality dimensions in the drug industry (Dickov & Igić, 2013; 
Osemene, Elujoba, & Ilori, 2011).   
  
Moss (2007) pointed out that the way quality is perceived in the pharmaceutical industry is 
different from that of traditional customer goods industry. The quality of prescription drugs is 
not determined by users but by a third-party group prior to their commercial viability. In theory, 
quality itself is not an important factor that drives the purchase of drugs, but in practice, health 
care providers and patients recognize quality as an essential cue in usage.   
  
Zeithmal (1988) stated that “perceived quality” model is based on customers` judgment of 
product quality but not a manager`s or an expert’s point-of-view. Thus, the viewpoint expressed 
in this research is related to a user-based perspective which is different from product-based and 
manufacturing-based approaches suggested by Moss (2007).   
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Moss (2007) argued that the pharmaceutical industry does not discuss quality issues in detail 
and also integrates it in the promotion strategy, yet it is relevant for stakeholders in the industry 
to consider aspects of quality when selecting pharmaceutical brands. Awareness of quality is a 
growing concern in recent years due to the threat of counterfeit medicines globally. Studies 
also confirm that perceived quality has a significant effect on brand equity (Yoo et al., 2000; 
Buil et al., 2013).  
 
As a result, the following hypothesis is posited:  
  
H3b: Perceived quality positively and significantly influence overall brand equity  
  
Brand loyalty    
Brand loyalty is regarded as a strategic element of a brand`s equity and measures the attachment 
of customers to a particular brand (Aaker, 1991). However, brand loyalty is often recognized 
as the outcome of brand equity and it is really affected by the other elements of brand equity 
(Campbell, 2012; Aaker, 1991). Aaker (1991) pointed out that brand loyalty is an antecedent 
of brand equity and is also influenced by brand equity. The author further stated that brand 
loyalty is substantially influenced by other constructs of brand equity and for that matter, it is 
one of the many sources that brand equity creates value for a company.   
  
Many authors have also concluded that brand loyalty is the behavioural effect of brand equity 
rather than a brand equity dimension (Lassar et al., 1995; Kim et al., 2003; Cobb-Walgren et 
al., 1995; Erdem & Swait, 1998). Aaker (1991) is of the view that brand loyalty qualitatively 
differs from the other antecedents of brand equity in the sense that it occurs prior to purchases 
and use experience. On the other hand, brand awareness, associations and perceived quality are 
features of several brands which have not been used before by potential buyers.   
  
Oliver (1999: 34) defined loyalty as “a deeply held commitment to rebuy or re-patronize a 
preferred product/service consistently in the future, thereby causing repetitive same-brand or 
same-brand-set purchasing, despite situational influences and marketing efforts having the 
potential to cause switching behaviour”. In the author`s view, customers develop loyalty to a 
brand through a logical process of cognitive-affective-conative and action stages.    
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Ferrel and Hartline (2008: 198) are also of the view that brand loyalty is a “positive attitude 
toward a brand that causes customers to have a consistent preference for the brand over all 
other competing brands in product category”. The authors distinguished three stages of brand 
loyalty: brand recognition, brand preference and brand insistence. Brand recognition relates to 
the minimum degree of brand loyalty and exists when target customers demonstrate awareness 
of the brand, and include the brand among alternatives when making buying decisions. In 
contrast, brand preference is a stronger degree of brand loyalty, and occurs when a customer 
considers a brand as a first choice in relation to analogous brands. Brand insistence is, however, 
the highest level of brand loyalty, and it occurs when the customer chooses a particular brand 
even if alternatives are available (Trott & Sople, 2016). However, Keller (2001) examined 
brand loyalty under brand resonance.   
  
Chaudhuri and Holbrook (2001) categorized brand loyalty into behavioural and attitudinal 
loyalty. Behavioural loyalty indicates customers` re-patronage of a brand, whilst attitudinal 
loyalty describes a customer`s commitment to a brand. Empirically, behavioural and attitudinal 
brand loyalty influence brand equity (Chaudhuri & Holbrook, 2001). Customer satisfaction is 
also a key indicator of loyalty for a particular product category where purchase and 
consumption represent repeated behaviour (Aaker, 1996). A loyal customer base has been 
demonstrated to have significant influence on market share, price premium, a barrier to 
competitor entry, and the overall profitability of the brand (Chaudhuri & Holbrook, 2001; 
Aaker, 1996).   
  
Aaker (1991) highlighted that brand loyalty relatively reduces the marketing cost involved in 
retaining customers to winning new ones, improves trade leverage and insulates against 
competitor attacks. However, Moss (2007) pointed out that trade leverage is much less 
important in the prescription drug market than in the OTC market, as distribution channels of 
the ethical drugs offer a delivery service rather than playing a gate-keeper role. Empirical 
studies suggest that brand equity is substantially influenced by brand loyalty (Atilgan et al., 
2005; Yoo et al., 2000).  
 
In this regard, the following hypothesis is proposed:  
  
H4b: Brand loyalty positively and significantly influence overall brand equity   
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3.4.2 Relationship between Packaging and Brand Equity Dimensions 
In today`s market place, firms design marketing programs for their market offerings in a 
number of ways to build strong brands with positive equity. Brand equity, one of the strategic 
objectives of marketing, is significantly influenced by packaging, and is the single most 
influential marketing communications tool for conveying a brand`s core identity for most 
customer products (Hanzaee, 2009; Wallace, 2001). Nowadays, packaging also plays an 
important role in brand management as the distinctive design of packaging does not only 
identify and distinguish brands but also enhance the meaning, likeness and memory of the 
brand (Keller, 2013; Kotler & Keller, 2009). Garber et al. (2000) emphasized that packaging 
can either strengthen or harm a brand`s equity by enhancing or stifling brand identification and 
the retrieval of valuable brand associations.   
  
A well-designed packaging serves as platform for building brand equity (Keller, 1993) by 
enhancing brand recognition and recall (Underwood, 2003). Peter and Olsons (2008) suggested 
that a distinctive package design can potentially create brand awareness by attracting and 
sustaining customer`s attention to the brand while in the store. Keller (2013) is of the view that 
brand awareness occurs when customers have greater familiarity with the brand via repeated 
experiences with the brand.   
  
Essentially, any marketing activity that exposes the brand to customers can enhance familiarity 
and awareness. While in the store, packaging serves as a “visible billboard” that generates 
immediate recognition of the brand (Kotler & Keller, 2009; Keller, 2013).  It is also argued 
that an attractive packaging design appears to be the primary medium of communication 
between the customer and product at the point-of-purchase. Hence, it is regarded as a “silent 
salesman” which has the potential to create brand differentiation and identification (Gonzalez 
et al., 2007).   
  
More importantly, the role of packaging as a medium of advertising does not only occur in the 
store, but also at moment-of-consumption, thus, playing a leading role in advertising (Keller, 
2013). Packaging is also considered as the only form of the marketing communications tool 
which a customer takes home after purchase (Dodson & Yadav, 2012), implying that it 
continues to advertise the brand after the product is bought (Keller, 2013).   
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It has been emphasized that packaging colour is a vital element that creates brand awareness 
(Kotler, 2013) because it is more vivid, memorable, and evokes customers` emotions about the 
brand (Garber et al., 2000a). Past research also confirms that a distinctive and appealing 
packaging contributes significantly to brand awareness (Pieterse, 2001).  
 
In this regard, the following hypotheses are posited:  
  
H1a: Packaging positively and significantly influence brand awareness 
 
According to Farhana (2012) packaging significantly strengthens associations customers 
linked to the brand. Underwood (2003) highlighted that the structural and visual features of 
packaging such as colours, fonts, brand logo, packaging materials, shapes, product description 
and other elements convey brand personality which provides rich brand associations. A 
customer`s mental associations with a brand is due to idiosyncratic personal exposures and 
previous marketing activities of the firm and its competitors.   
  
Visual, verbal and tactile elements of packaging communicate implicitly by evoking images of 
product performance features, product quality, usage situations, and past experiences into 
customer`s memory (Garber et al., 2000a). Gardner (1981) noted that a product`s package is a 
symbol of communication that penetrates the mind and evokes meanings that actually affects 
a customer`s sensory response to the product.   
  
Keller (1993) proposed that brand knowledge is the key dimension that underlies brand equity, 
and ultimately the power of brand resides in customers` memory. Packaging therefore serves 
as a powerful source of the brand associations because it conveys the potential meaning of the 
brand (Underwood, 2003). For many non-durable customer goods, packaging contributes 
significantly by transmitting symbolism and image of the brand, thus, effectively 
distinguishing the brand from its competitors (Underwood & Ozanne, 1998).  A study suggests 
that product image on the package can attract attention to brands that are less familiar and 
transfer experiential benefits (Underwood et al., 2001) and thus reinforcing valuable brand 
associations (Pieterse, 2001).  
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Hence, the following hypotheses are formulated:   
  
H2a: Packaging positively and significantly influence brand associations   
 
Pitta and Katsanis (1995) highlighted that quality products are wrapped in quality packages. 
Hence, well-designed packaging is perceived to contain a quality product, whilst an inferior 
packaging signals a poor quality product (Silayoi & Speece, 2004). It has also been emphasized 
that, customer perceptions of quality of pharmaceutical product depends largely on the quality 
of the package (WHO, 2002a).   
  
Visual elements of packaging design such as graphics, typeface, colours, size and logos are 
important inputs of customer quality judgment of food products and brands. The results of an 
empirical study also indicate that visual packaging attributes significantly contribute to enhance 
brand preference and perceived quality of food products (Edward, 2013).  
  
Products are made up of an array of intrinsic and extrinsic elements (Miyazaki, Grewal, & 
Goodstein, 2005), and customer perception of product quality lie in these attributes (Zeithaml, 
1988; Na, Marshall, & Keller, 1999).  It has been highlighted that intrinsic quality cues play a 
key role in the ethical drug market, and in contrast, extrinsic product features are more 
important in the OTC market (Sanyal & Datta, 2011; Kuappinen-Raisanen, 2010).   
  
Miyazaki et al. (2005) are of the view that customers often used extrinsic attributes as a risk 
reduction cue during product evaluation and choice. Packaging is recognized as an element 
which is indirectly related to the physical product (Keller, 1993), but forms the basis for a 
customer`s perception of product quality (Pitta & Katsanis, 1995).    
  
However, packaging is viewed as both intrinsic and extrinsic features of a product that signals 
quality (Zeithaml, 1988; Underwood, 2003). Zeithaml (1988) emphasized that customers 
however rely greatly on extrinsic attributes to infer quality of a product when they have no or 
little experience or insufficient time and difficulty to evaluate intrinsic attributes. Hence, at the 
selling points, extrinsic elements are often used as quality indicators because customers usually 
do not have ample time to consider the intrinsic characteristics of the product.  Past research 
indicates that packaging designs that contain pictures signal high perceived quality 
(Underwood & Klein, 2002).  
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In this regard, the following hypotheses are proposed:  
  
H3b: Packaging positively and significantly influence perceived quality      
 
Underwood (2003) is of the view that packaging is a key element that potentially conveys 
functional, experiential and symbolism brand benefits which often establish a relationship 
between the customer and brand. In order to establish this relationship, manufacturers must 
create a balance between the need for packages to grab attention and persuade as well as the 
need to transmit truthful, sincere, comprehensible and legitimate product information. 
Designing packages that conveys authentic information can strengthen brand loyalty and brand 
relationships (Underwood & Ozanne, 1998).   
  
Smith and Taylor (2002) also noted that the packaging can create competitive strength by 
adding value to the product, building stronger shelf presence, positioning the brand and 
strengthening the loyalty to the brand. A distinctive packaging is described as “a visual magnet” 
that attracts the buyer to purchase the brand and ultimately become loyal to the brand (ibid). It 
has also been emphasized that packaging provides a platform for building and enhancing 
customer product satisfaction which underlies enduring brand loyalty and profitability (Hess, 
Singh, Danes, & Metcalf, 2014).   
  
Raghubir and Krishna (1999) commented that the container shape influences the preference 
and post-consumption satisfaction of customers. Past research also indicates that brand loyalty 
is significant and positively influenced by packaging (Dhurup, Mafini, & Dumasi, 2014; Khan, 
2012). Brand loyalty, in turn, contributes to strengthen overall brand equity (Aaker, 1996). 
Previous studies also demonstrate that brand equity is strongly influenced by brand loyalty 
(Atilgan et al., 2005; Tong & Hawley, 2009; Yoo et al., 2000).  
 
As a result, the following hypotheses are postulated:  
  
H4a:  Packaging positively and significantly influence brand loyalty  
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3.4.3 Study Conceptual Model    
According to Miles and Huberman (1994), the focus of a conceptual framework is to explain 
graphically or narratively the main factors, concepts and variables in a study, and the presumed 
relationships among them. The main variables that are discussed in this study include brand 
awareness, brand loyalty, brand quality, brand association, packaging and overall brand equity.  
This framework relied on Yoo et al. (2000) extension of Aaker`s (1996) brand equity model to   
include overall brand equity construct in order to determine how the individual dimensions of 
brand equity are related to brand equity. The authors are of the view that brand equity is the 
value of a brand name which can be low or high and therefore, specifying a separate brand 
equity construct will help to determine the relationship between the dimensions of brand equity 
and brand equity. Overall brand equity is defined as the difference in customer choice between 
a branded and an identical generic version (ibid).  
 
Figure 3.3 below depicts the conceptual framework of this study.  In the model below, 
packaging is recognised as an independent variable, whilst the dimensions of CBBE are 
mediating variables and overall brand equity is considered as a dependent variable. It can be 
observed in Figure 3.3 that overall brand equity is influenced by packaging through the 
mediating impact of brand loyalty, brand awareness, perceived quality and brand association. 
Thus, a well-design packaging creates instant identification and recall of the brand from the 
mind which ultimately enhance awareness of the brand. This is a necessary first step for 
establishing associations with a brand.   
 
Furthermore, distinctive packaging design provides a cue for customers to evaluate the quality 
of the product, particularly where it is difficult to infer quality from the intrinsic features of the 
product. Packaging is also well-acknowledged in the literature as both intrinsic and extrinsic 
product attributes that signal the customers` perception of quality of the brand. Finally, an 
innovative packaging design is a platform for creating and strengthening loyalty of customers 
to the brand. In turn, brand awareness, brand association, brand quality and brand loyalty 
significantly influence overall brand equity. Thus, high brand name awareness, positive brand 
image, enhanced perceptions of quality and loyalty can increase the overall brand equity of 
herbal medicines.   
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Packaging is also seen as the container for a product, including the physical appearance of the 
container (Arens, 1996 cited by Deliya & Parmar, 2012).  Brand awareness is defined as 
customers` ability to identify and retrieve the brand under different circumstances, and it is 
determined by brand recognition and brand recall (Keller, 2001; Keller, 2013). Brand 
association relates to customers` mental associations linked to the brand which conveys 
meaning to customers. Perceived value, organizational associations and brand personality are 
considered as dimensions of brand association (Aaker, 1996). Perceived quality also indicates 
customers’ perception of a product`s overall excellence or superiority relative to the 
alternatives and its intended purposes (Keller, 2013).    
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          H4a 
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Figure 3. 3: Study Conceptual Framework 
Source: Developed from Extant Literature 
 
3.5 Chapter Summary  
The present chapter employed Aaker`s (1991; 1996) customer-based brand equity model to 
develop the conceptual framework of the study. As a result, the chapter explains the theories 
relating to CBBE and their dimensions. More specifically, Keller`s (1993) and Aaker`s (1991; 
1996) CBBE models were discussed. While Keller (1993) relied on brand knowledge, which 
is made up of brand image and brand awareness as dimensions of brand equity, Aaker (1996) 
proposed brand awareness, brand association, brand quality and brand loyalty. Aaker`s CBBE 
model was used to develop the conceptual framework of this study. The current research model 
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demonstrates that packaging enhances overall brand equity through the mediating impact of 
brand loyalty, brand association, perceived quality and brand awareness. Packaging is 
considered as an independent construct, brand equity dimensions are regarded as mediating 
factors, whilst the brand equity is the dependent variable in the study`s conceptual framework. 
The next chapter will discuss the methodology to be used to carry out the research.  
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CHAPTER FOUR 
  
RESEARCH METHODOLOGY  
  
4.1 Introduction  
The previous chapter presented the theoretical and conceptual models to provide the basis for 
the study. The chapter also offered an explanation of the proposed hypotheses drawn from the 
study`s conceptual framework that will be later tested to achieve the objectives of the research.  
The current chapter discusses the methodology suitable for testing the hypotheses to meet the 
objectives of the research. This comprises the research philosophy, approach and design, 
sampling strategy, data sources and collection procedures, data analysis and procedures, and 
data quality controls.    
  
4.2 Research Problem  
The following is the problem statement in this study:  
The introduction of packaging in the strategic brand practices may result in improved 
performance of brands of herbal medicines sold at OTC drug market in Kumasi.     
  
4.2.1 Purpose of the Study   
The purpose of the research was to examine the influence of packaging and customer-based 
brand equity in the OTC medicine market. As a result, the following specific objectives have 
been carved to achieve the purpose of the research.  
  
4.2.2 Specific Objectives   
The specific objectives of the research were:  
 To examine customers` perceptions of packaging of herbal medicine in the OTC market 
in Kumasi   
 To examine the brand equity of herbal medicines in the OTC drug market in Kumasi.    
 To examine the influence of packaging on brand awareness in the OTC drug market in 
Kumasi.  
 To examine the influence of packaging on brand associations in the OTC drug market 
in Kumasi.  
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 To examine the influence of packaging on perceived quality in the OTC drug market in 
Kumasi.  
 To examine the influence of packaging on brand loyalty in the OTC drug market in 
Kumasi.  
 
4.2.3 Research Questions  
Based on the research objectives, the research questions that guided the study were:  
 
 What is the customers’ perceptions of packaging of herbal drugs in the OTC market in 
Kumasi?   
 What influence does a brand of herbal medicine have on overall brand equity in the 
OTC drug market in Kumasi?   
 To what extent does packaging influence brand awareness in the OTC pharmaceutical 
market in Kumasi?  
 How does packaging influence brand associations in the OTC medicine market in 
Kumasi?  
 To what extent does packaging influence perceived quality in the OTC drug market in 
Kumasi?  
 How does packaging influence brand loyalty in the OTC pharmaceutical market in 
Kumasi?  
 
  4.2.4 Research Hypotheses   
On the basis of the research objectives, the following hypothesized relations were proposed:  
   
H1a:  Packaging positively and significantly influence brand awareness  
H2a:  Packaging is positively and significantly influence perceived quality   
H3a:  Packaging positively and significantly influence brand associations   
H4a:  Packaging positively and significantly influence brand loyalty   
H1b:  Brand awareness positively and significantly influence overall brand equity   
H2b:  Perceived quality positively and significantly influence overall brand equity  
H3b:  Brand association positively and significantly influence overall brand equity    
H4b:  Brand loyalty positively and significantly influence overall brand equity   
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4.3 Research Philosophy  
The research philosophy is concerned with the important assumptions about the world view 
which determines the selection of the research design and specific methods to transform the 
approach into reality. Thus, the choice of research methods reflects the paradigm that guides 
the study, more particularly the belief about the nature of reality and humanity, the body of 
knowledge that informs the research, and how that theory of knowledge may be translated into 
practice (Tuli, 2010). Additionally, the type of belief system held by an individual researcher 
becomes the basis for using either quantitative, qualitative or mixed method research (Mertens, 
2015).    
  
Guba and Lincoln (1994:105) described the research paradigm as “the belief system or world 
view that guides the investigator, not only in choice of method, but in ontologically and 
epistemologically fundamental ways”. Creswell (2014) highlighted four world views that are 
widely discussed in the literature: post-positivism/positivism, constructivism, pragmatism and 
transformative paradigms. The philosophical assumptions that guide this research is the 
positivist/post-positivist paradigm. The aim of the current research is to test the theory of CBBE 
and packaging through a priori hypotheses with empirical data to either confirm or refute the 
relationship between packaging and brand equity.   
  
It has been emphasised that the aim of inquiry of the positivist/post-positivist paradigm is to 
test theories by specifying a priori hypotheses to determine the functional relationships in order 
to predict and control social phenomena (Guba & Lincoln, 1994; Creswell, 2014). The authors 
also highlighted that the research questions and/or hypotheses are stated as quantitative 
propositions and are subjected to empirical test to verify or falsify them.   
  
4.3.1 Positivist Paradigm  
The positivism paradigm is often known as the “scientific method” or “science research” that 
reflects a rationalistic, empiricist world view and was authored by Aristotle, Francis Bacon, 
John Locke, Auguste Comte and Emmanuel Kante (Mertens, 2015; Creswell, 2014).   
  
The positivist stance is that the social world can be studied in a similar manner as the natural 
environment and therefore the approach for studying the social world is based on objective 
realism (Mertens, 2015). The author is also of the view that cause-effect relationships can also 
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be explained in the social environment as it is done in the natural world. Creswell (2014) 
suggested that the knowledge that is developed by the positivist approach is through accurate 
investigation and the value-free assessment of reality in the natural environment.   
  
Positivists hold the view that the scientific method of inquiry permits the use of experiments 
and analysis of what is observed, with the view to making general laws to determine the 
relationships among variables. Moreover, positivists argue that there are laws or theories that 
govern the social world, and these laws or theories can be tested or verified and if necessary, 
refined by applying natural science methods. The positivist philosophical stance is 
deterministic in nature and, thus, causes perhaps determine outcomes, and also reductionist in 
the sense that the intent is to reduce the ideas into measurable variables that are stated in the 
form of hypotheses as well as research questions.   
  
Although, positivist claims that scientific information is highly cogent, objective, accurate and 
reliable (Crotty, 1998 cited by Mertens, 2015), and that the focus on objective and empirical 
knowledge has some level of application, it is limited to the study of human behaviour 
(Mertens, 2015). It is argued that much of the human experience that is observed is ignored but 
is still significant.   
  
Consequently, post-positivism emerged and rejected the narrow claim of positivists that what 
could be studied is independent of what could be observed, and also questions the logic of 
establishing generalizable laws applicable to human behaviour. However, post-positivists still 
maintain the significance of value-free inquiry and generalizability but propose that 
investigators need to reshape their claim on understanding the “truth” based on probability 
rather than on certainty (ibid).   
  
It is also argued that it is impossible to completely avoid the inclusion of the value system of 
the researcher from the research. This is because the researcher`s decision to adopt positivist 
stance, the issues to study, the research objectives to pursue and data collection suggest the 
existence of certain value positions (Saunders, Lewis,  & Thornhill,  2007).     
Positivist and post-positivism researchers are mostly aligned with quantitative methods of data 
collection and analysis (Mackenzie & Knipe, 2006). Guba and Lincoln (2005) referenced by 
Mertens (2010) identified four basic ingredients of belief system that define positivist and post 
positivism paradigm, which are axiology, ontology, epistemology and methodology.  
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 Axiological Assumptions  
Axiology indicates the assumptions about the ethics that guides the researcher. According to 
the positivist`s point of view ethics is inseparable from methodology simply because the 
investigator is ethically obliged to maintain intellectual honesty, unbiasedness, accuracy and 
the careful presentation of data and the sincere acknowledgement of the limits of the research 
(Mertens, 2015). However, Guba and Lincoln (1994) suggested that, although ethical 
considerations are important to the positivist and post-positivist researcher, it is extrinsic to the 
research process itself. As a result, ethical behaviour is most often enforced by external 
mechanism such as a professional code of conduct and a human subjects committee.  
 
 Ontological Assumptions  
The ontological stance interrogates what the nature of reality is and how the researcher makes 
meaning of this reality (Mertens, 2010). The basic ontological position of the positivist is that 
reality is assumed to exist which is governed by unchangeable laws and theories (Guba & 
Lincoln, 1994) and the knowledge of social reality lies on testing these laws and theories to 
apprehend the reality (Creswell, 2014).  Mertens (2015) noted that post-positivists support the 
view that reality does exist, but it cannot be perfectly understood due to intellectual constraints. 
Hence, the nature of reality can be comprehended within some degree of possibility, and the 
researcher cannot “prove” the theory, but at least, present a strong case to nullify the alternative 
proposition.        
  
 Epistemological Assumptions  
The epistemology indicates the nature of knowledge and the relationship that exists between 
the researcher and participant in the study (Mertens, 2010). The early positivist perceives that 
the researcher and participant in the study are independent entities, and that the researcher is 
assumed to be capable of investigating the object of the study by neither influencing it nor 
being affected by it (Guba & Lincoln, 1994).   
  
However, post-positivists abandoned this view of dualism (Guba & Lincoln, 1994) as the 
researcher can strongly influence what is observed (Mertens, 2015). Notwithstanding, 
objectivity still remains the critical tradition of this paradigm in that investigators do not allow 
personal values and biases to influence the outcomes so long as the researchers strive to remain 
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neutral by following prescribed procedures more rigorously (Guba & Lincoln, 1994; Mertens, 
2015).    
  
 Methodological Assumptions  
The methodological assumptions deal with the appropriate methods that the inquirer should 
follow to obtain the desired knowledge and understanding. The methodological stance of the 
positivist is true experimental designs commonly used by the natural scientist but this stance 
has been modified by the post-positivists and has then highlighted less rigorous experiments 
known as quasi-experimental methods that could be applicable to people (Creswell, 2014; 
Mertens, 2015). It is argued that, although qualitative methods can also be utilized within this 
paradigm, the quantitative research method tends to dominate in post-positivist research 
(Creswell, 2014; Mackenzie & Knipe, 2006; Mertens, 2015).       
  
4.4 Research Approaches  
Research approaches are “plans and the procedures for research that span the steps from broad 
assumptions to detailed methods of data collection, analysis and interpretation” (Creswell, 
2014: 31). According to the author, research approaches that could be used by researchers 
include mixed method, qualitative and quantitative research as illustrated in Figure 4.1 below.   
  
  
Figure 4. 1: Research Approaches      
 
        Source: Creswell (2014: 33)  
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It has been highlighted that the choice of a research approach depends on the nature of the 
research problem, personal experiences of the researcher, and the participants in the research. 
In this research, a quantitative research method is used because it is aligned with the positivist 
philosophy which underlies this research (Mertens, 2015; Guba & Lincoln, 1994; Creswell, 
2014; Mackenzie & Knipe, 2006). Furthermore, the primary aim of the research is to examine 
the impact of packaging on brand equity of herbal medicines sold at the OTC drug market. 
Hence, a quantitative research methodology is suitable in order to generate data that can be 
presented numerically and apply statistical procedures to test the hypotheses formulated to 
achieve the purpose of the research.   
  
4.4.1 Quantitative Research Method   
The quantitative research method relates to the approach that involves the collection, analysis 
and presentation of information that is numeric (Teddlie & Tashakkori, 2009).  The basic aim 
of quantitative research is to test objective theory by formulating hypotheses to either refute or 
confirm the hypotheses (Creswell, 2014: 48). Teddlie and Tashakkori (2009) also highlighted 
that quantitative researchers typically employ a hypothetico-deductive model. This involves 
the a priori deduction of hypotheses from a conceptual framework or a theory and testing the 
propositions by using numerical data and statistical analysis with the goal to generalize and 
replicate the findings (Creswell, 2014; Teddlie & Tashakkori, 2009).   
  
This contrasts sharply with the qualitative research where information is usually presented in 
words or narrative form rather than numbers by using open-ended questions rather than closed 
ended questions (Creswell, 2014). Johnson and Onwuegbuzie (2004:18) also highlighted that 
quantitative researchers “focus on deduction, confirmation, theory/hypothesis testing, 
explanation, prediction, standardized data collection, and statistical analysis”.   
  
It has also been emphasised that the quantitative approach is associated with different research 
designs which include experimental, survey, quasi-experimental and correlational designs 
(Creswell, 2014; Teddlie & Tashakkori, 2009). Johnson and Onwuegbuzie (2004) stated that 
the potential strengths of the quantitative research approach are that it is suitable for studying 
larger populations and that the research findings are objective and can also be generalised when 
it is replicated with many different populations. However, in their view, knowledge generated 
120  
  
through quantitative research may be abstract and general for direct application to particular 
contexts, situations and individuals.       
 
4.5 Research Design  
Research design is a blueprint which is used as a guide in gathering and analysing the data 
(Churchill, 1996). It also details procedures suitable for implementing the research approach 
(Malhotra & Birks, 2007). Easterby-Smith, Thorpe, and Jackson (2012) described research 
design as an organization of research activity, including data-gathering, in a way to achieve the 
aim of the research. It explains and justifies what, how and where the data will be collected, as 
well as how the data will be analysed to address the research questions. In this study, a survey 
research design has been used.   
  
4.5.1 Survey Research Strategy    
There is a wide variety of research strategies that are available to a researcher to aid data 
collection in a study. Saunders et al. (2007) suggested that the choice of a specific strategy is 
guided by the research questions and objectives, the degree of existing knowledge, time and 
other resources available, and the philosophical underpinnings of the study.    
  
In the present research, a survey method is employed as it is aligned with the positivist approach 
to research and for that matter quantitative methodology which underlies this research 
(Saunders et al., 2007; Bryman, 1984; Creswell, 2014). Furthermore, survey research will 
allow for the gathering of quantitative data from a sample of the target population (Fowler, 
2014). The responses obtained can also be analysed quantitatively through descriptive and 
inferential statistics (Saunders et al., 2007) with the view to generalizing from the sample to a 
population (Fowler, 2008 cited by Creswell, 2014).   
   
The survey research strategy relates to “the use of standardized questionnaires or interviews to 
collect data about people and their preferences, thoughts, and behaviour in systematic manner” 
(Bhattacherjee, 2012: 73). This means that survey research is associated with open-ended and 
closed-ended questionnaires as tools of data collection. The author is of the view that survey 
research method is suitable for studies that have individual participants as a unit of analysis.    
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It has also been emphasized that the survey research method has several advantages over the 
other research methods. First, survey research is best suited for gathering data from population 
that is too large to observe directly (bid).  
 
Saunders et al. (2007) also highlighted that the survey strategy provides an excellent means of 
collecting a large quantity of data from a sizeable population at a relatively low cost. Not only 
this, data collected can be used to suggest the possible reasons underlying a particular 
relationship between variables in order to produce models from the relationships. However, it 
is argued that the researcher lacks control over non-systematic variations in the variable of 
interest. Thus, lack of control over the key variables can lead to interesting, but scientifically 
inconclusive results (Bhattacherjee, 2012).   
 
Survey research strategy is categorized into two methods: cross-sectional and longitudinal 
(Creswell, 2014). Longitudinal methods relate to the gathering of data at two or more points in 
time from the sampled population with the view of assessing change or development over time. 
On the other hand, cross-sectional surveys are used when the researcher desires data from the 
sample of the population at one point in time. Neuman (2007) is of the view that the inherent 
strength of cross-sectional survey is that it is a simple and less costly alternative.   
  
Mann (2003) suggested that cross-sectional survey is cheap because only one group is used. 
Data is gathered only once and multiple results can be studied. Thus, it does not require follow 
up, and less resources are needed to conduct the study. The author further highlighted that the 
cross-sectional method is best suited for examining prevalence as well as identifying 
relationships that can be studied rigorously. However, it does not capture change or social 
process. As a result of the aforementioned advantages, coupled with the time and resources 
available as well as the purpose of the research, the cross-sectional survey method is used in 
this research.    
 
4.6 Kumasi Metropolis in Ghana 
Kumasi Metropolis is a cosmopolitan city and is characterized by cultural diversity. According 
to Ghana Statistical Service (2014), Kumasi is found in the transitional forest zone and lies 
about 270 kilometres north of Accra, the nation`s capital. It is situated between latitude 6.350 
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N and 6.400 S and longitude 1.350 W and 1.350 E with an elevation ranging from 250 to 300 
metres above sea level (ibid).   
  
It has a total land area of 254 square kilometres and a population density of 9 434 persons per 
square kilometre. Kumasi Metropolis is one of the thirty administrative districts in the Ashanti 
region and accommodates about 36.2 percent of the population in the region.   
The metropolis has a population of 2 034 064 million with an annual growth rate of 4.8 percent. 
Roughly, 52.7 percent are below 15 years of age while the remaining 47.3 percent are above 
the age of 15 years. The majority of the population are female who constitute approximately  
52.22 percent of the population while 47.78 percent are male. Ghanaians by birth comprise 
95.4 percent of the population whilst 0.6 percent are naturalized, and 2.1 percent are non-
Ghanaians (KMA, 2014).  
 
The metropolis consists of different ethnic groups, with the largest ethnic group being the 
Akans (80.7%), followed by Mole Dagbon (8.7%) and Ewe (3.6%).  Essentially, almost all the 
other ethnic groups in Ghana reside in the metropolis. The city has 919 pre-schools, 967 
primary schools, 597 junior high schools, 52 senior high schools and 10 tertiary institutions. 
The percentage of literate population at the age of 11 years and older is about 89.5 percent 
whilst roughly 10 percent cannot read and write.  
   
According to Kumasi Metropolitan Assembly (2014), the metropolis has a number of health 
care institutions in both public and private sectors. Moreover, the city has six major public 
hospitals including a teaching hospital, four quasi-health institutions, and six mission hospitals, 
thirteen industrial clinics, 180 private health institutions, 54 trained Traditional Birth 
Attendants (TBAs), nine maternal and child health centres and 168 outreach sites. The 
metropolis is not entirely urban but it is estimated that 48%, 46%, and 6% of the population 
are urban, peri-urban, and rural respectively.   
  
The economic activities that sustain the population in the metropolis are services, industry and 
agriculture. The services sector is the lifeblood of the people, employing approximately 72 
percent of the economically-active population. The various activities carried out in this sector 
include wholesale and retail and this has made the city the commercial hub of the country.   
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There are also scattered pockets of industries in the metropolis ranging from agglomerated 
small-scale food processing, mechanical garages, construction firms and wood processing 
companies. The sector employs about 23 percent of the population in the city. Finally, less than 
10 percent of the population in the metropolis are engaged in agriculture.  
 
Kumasi Metropolis was selected as a study site because it is the second largest commercial city 
in Ghana and is endowed with a wide variety of medicinal plants (GSS, 2014), which have 
engendered the establishment of a large number of plant-medicine companies in the metropolis. 
 
 
4.7 Study Population  
The population of a study comprises a full set of elements that possess the needed information, 
whilst the sampling frame is a complete list of all the elements in the population from which a 
sample can be drawn (Malhotra & Birks, 2007; Saunders et al., 2007). The population of the 
study consists of herbal shops, herbal medicines and customers of herbal medicines.   
  
The sampling frame comprises 80 licensed herbal shops, of which twenty (20) offer wholesale 
activities whilst 60 provide mainly retail services (Records of Traditional Medicine Practice 
Council, Kumasi, 2017). Three thousand, seven hundred and ten (3 710) customers (patients) 
who buy herbal medicines from the herbal shops on a daily basis (Records of 80 herbal shops, 
2017) in the metropolis. The herbal medicines are mainly made up of ointments, mixtures 
(liquids) and capsules.   
  
The licensed herbal shops are limited by law to sell only herbal medicines (Traditional 
Medicine Practice Council Act, 2000; ACT, 575). Although OTC chemical shops can retail 
both herbal medicinal products and orthodox medicines (Pharmacy Act, 1994; ACT 489), 
identification of customers who buy herbal medicines would have been difficult, and hence 
herbal shops were chosen  
  
4.8 Sampling Strategy    
Malhotra and Birks (2007) noted that a sample is a sub-group of the targeted population to be 
included in a study. Saunders et al. (2007) highlighted that researchers frequently use sampling 
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when they have tight timelines and also when it is impracticable and costly to collect data from 
the entire population.   
  
Sampling techniques that are available to a researcher include non-probability and probability 
sampling. Probability sampling procedure indicates that the chance of each case in the 
population to be chosen can be determined and is equal for all the elements in the population.   
Conversely, non-probability sampling suggests that the opportunity for each case in the 
population to be picked is not known, and the researcher has to rely on personal judgment to 
select sample elements. In addition, it cannot be used to answer research questions and achieve 
objectives by making statistical inferences about the characteristics of the population. 
Nonprobability sampling techniques include quota sampling, purposive sampling and 
convenience sampling.   
  
In this study, probability sampling was employed with the aim of achieving a statistically 
representative sample and also to test the hypotheses framed in the study (Ritchie & Lewis, 
2003). Again, probability sampling was employed so that the results could be generalized to 
the population in the study (Malhotra & Birks, 2007) which the present study sought to achieve.  
 
4.8.1 Sample Size Determination  
This research relied on the framework proposed by Krejcie and Morgan (1970) on sample size 
determination to choose the number of participants of the research as well as the herbal shops 
to be included in the study.   
  
 Herbal Medicine Customers   
The total number of customers who usually buy herbal medicines on a daily basis from the 80 
herbal shops in Kumasi stands at 3 710 (Records of 80 OTC herbal shops, 2017). Following 
the guidelines of Krejcie and Morgan’s (1970) model with 95 % confidence level and 5% 
margin-of-error and the National Education Association (1960) cited by Krejcie and Morgan 
(1970) formula for determining sample size, a sample of 348 respondents was obtained. The 
95 percent confidence level of certainty indicates that if the sample is selected hundred times, 
at least 95 percent of these samples would be certain to represent the characteristics of the 
population. The margin-of-error represents the precision of the estimates of the population 
(Saunders et al., 2007).   
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Thus, the required sample size of the study;  
  
“(S) = X2 N P (1- P) ÷ d2 (N - 1) + X 2 P (1 - P)”,   
Where;  
  
X2 = the table value of Chi-Square for 1 degree of freedom at the desired confidence level   
X2 = 3.841(1.96 ×1.96)  
N = the population size  
P = the population proportion (assumed to be 0.50 since this would provide the maximum 
sample size) d = the degree accuracy expressed as proportion (0.05)  
  
Given, the population size of the study = 3710   
Sample size = X2 N P (1 - P) ÷ d2 (N - 1) + X 2 P (1 - P),  
Sample size = 3.841 × 3710 × 0.50 (1- 0.50) ÷ 0.052 (3710 - 1) + 3.841× 0.50 (1- 0.50)  
Sample size = 3 562.5272 ÷ 10.23275  
Sample Size = 348  
 
 
 Herbal Shops  
The total number of herbal shops in Kumasi Metropolis providing OTC services were 80, out 
of which 20 were offering both wholesale and retail services at the same time while 60 were 
engaging in only retailing. Considering the Krejcie and Morgan (1970) framework, by using 
95 percent confidence level and 5 percent   margin-of-error, a sample size of 19 was obtained 
from 20 wholesale herbal shops while 52 were also derived from 60 retail herbal shops. 
Consequently, a total sample size of 71 herbal shops was selected in this study.   
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Table 4. 1: Selected Wholesale Herbal Shops  
No.  Herbal Shops   Location  No.  Herbal Shops  Location   
1  Dannie Herbal Shop  Mbrom  11  Gilgal Herbal Shop  Ashanti New Town  
2  Angelus Herbal   Ashanti New Town  12  Dannie Herbal Shop  Ashanti New Town  
3  Blessed Requah  Ashanti New Town  13  Taabea Herbal Shop  Ashanti New Town  
4  Fredimens Herbal    Adehyeman  14  Appi-Dank Herbal  Ashanti New Town  
5  K & G Herbal Shop  Ashanti New Town  15  Collinak Herbal  Ashanti New Town  
6  Ikof Herbal Centre  Ashanti New Town   16  Tops-High Herbal  Atonsu Monaco  
7  Misty Herbal Shop  Ashanti New Town   17  Star Herbal Shop  Ashanti New Town  
8  Sam & Co.  Herbal    Kejetia   18  Top-Amazing Herbal  Tafo  
9  Kyevic Herbal Shop   Ashanti New Town  19  Gidisas Herbal   Tafo  
10  Collinak Herbal  Mbrom        
  
    
 Table 4. 2: Selected Retail Herbal Shops  
No.  Herbal Shops   Location  No.  Herbal Shops   Location  
1  St. Michael Herbal   Old Tafo  27  McGee Herbal Shop  Santasi  
2  Okai Herbal Ventures  Mpatasie  28  Nana Yaw Herbal  Amakom  
3  Quality Health Care  Asawasi  29  Nananom Herbal  Tafo  
4  Ofori Basoa Herbal  Central Market  30  Navel Osei Herbal  Pankrono  
5  Savanna Health Shop  Aboabo  31  Star Markus Herbal  Tafo  
6  St. Valentine Herbal  Bantema  32  Ponak Herbal Shop  Buokrom  
7  Nananom Herbal  Tafo  33   Obrempomah Herbal  Kronom  
8  Baseman Herbal Shop  Atonsu  34  My Queen Healing  Kronom Market  
9  Fawus Herbal Shop  Nkontwima  35  Mojisto de Herbal  Ayigya  
10  Costa Herbal Shop  Kejetia  36  Mr Boamah Herbal   Kejetia Market   
11  Fosua Herbal Shop  Asafo  37  Vintex Herbal   Tafo  
12  Dynasty Herbal Shop  Tafo Nhyiaso  38  B.T Royal Herbal   Dr Mensah  
13  Favour of God Herbal  Kronom  39  Akyiaa & Asiedu Herbal  Tafo Market  
14  Adutwumwaa Herbal   Asawasi  40  Eno Wireko Herbal   Amakom  
15  Healing Herbal Shop  Atonsu Monaco  41  M. P Herbal Centre  Adehyeman   
16  King Edward Herbal  Afrancho Market  42  Angel Herbal Shop  Ashanti New Town  
17  Elshadai Herbal Shop  Breman U.G.C  43  Fawohobo Awurade  Amakom  
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18  Bemakosa Herbal   Buokrom Estate  44  Samkwof Herbal Shop   Tafo  
19  K - Boat Herbal Shop  Atonsu Monaco  45  Mercifos Herbal Centre  Nkwatwimma  
20  PBI Herbal Shops  Suame  46  Menaj Herbal Shop  Aboabo  
21  Universal Care Herbal  Bantema  47  Action Herbal Shop  Asafo  
22  A & C Herbal Shop  Ayigya  48  Angel Herbal Shop  Ashanti New Town  
23  Caesar Herbal Shop   Kwadaso  49  K & G Herbal Shop  Atonsu Monaco  
24  Young & Old Herbal   Dichemso  50  O & A Herbal Shop  Kentikrono  
25  Wiselyn Herbal Shop  Buokrom Estate  51  Lukanji Herbal Shop  Atonsu Monaco  
26  Solak Herbal Centre  Ayigya  52  Samkwof Herbal  Tafo  
 
Source: 2017 Records of Traditional Medicine Practice Council (TMPC), Kumasi  
  
4.8.2 Sampling Techniques   
In the present study, the probability sampling techniques used consisted of systematic sampling 
and stratified random sampling.   
  
4.8.2.1 Sampling I: Herbal Medicine Customers  
Systematic sampling technique was employed to choose a sample of customers of herbal 
medicines to be included in the study. Systematic sampling involves choosing a sample at 
successive intervals from the sampling frame that are arranged in some respect. Thus, the 
sample is picked by choosing a random starting point and then subsequent elements are selected 
systematically by using the sampling fraction to determine the frequency of the selection. The 
sample fraction is determined by dividing the total population by the actual sample size 
(Saunders et al., 2007; Malhotra & Birks, 2007).  In the current study, the sample interval was 
determined by dividing the total population of 3 710 by the sample size of 348 (3 710 ÷ 348 = 
10.66). Here, the first respondent was randomly selected and subsequently, one of every eleven 
cases entering the herbal shop was contacted until a sample size of 348 respondents was 
obtained.   
Systematic sampling technique was chosen because it is less costly and saves time, more 
reliable and representative when the size of the population is large. More importantly, it can be 
used “without the knowledge of the elements in the sample frame” (Malhotra & Birks, 2007). 
The use of this sampling procedure in the current research is consistent with past research 
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(Pappu, Quester, & Cooksey, 2006), where systematic sampling was used to select participants 
of the study in a busy shopping mall in an Australian State Capital City.   
  
4.8.2.2 Sampling II:  Herbal Shops   
Stratified random sampling was employed to pick the number of herbal shops to be included 
in the study. Here, stratified random sampling was used to obtain a sample size of 71 herbal 
shops in Kumasi Metropolis. Stratified random sampling involves dividing the population into 
relevant strata based upon specific characteristics of the elements of the population. A simple 
random sampling is taking from each stratum in a number proportional to the size of the stratum 
relative to the population. In this study, the strata were 20 wholesale and 60 retail herbal shops. 
The number of cases in the retail and wholesale shops was selected at random to obtain a 
sample size of 19 and 52 respectively. Stratified random sampling was chosen to ensure that 
each stratum is well-represented in the sample to increase the precision of the sample at lower 
cost (Malhotra & Birks, 2007).  
 
Table 4.3 below provides the summary of the study population, sample frame, sample size and 
sampling strategies used in this research.   
  
Table 4. 3: Summary of Sample Size and Method  
    Target Population Sampling  
Frame   
Confidence  
Interval   
Margin–of  
– Error  
  
Sample  
Size  
Sampling 
Techniques   
Herbal medicine  customers   3 710       95%     5%  348  Systematic 
Sampling   
Wholesale Herbal shops        20     95%     5 %    19  Stratified  
Sampling   
 Retail Herbal shops       60     95%     5%    52  
 
Source: Developed by the Researcher    
  
 
4.9 Data Sources   
Secondary data were gathered from industry records, books, journals and the internet, and were 
used to obtain relevant literature for the study to refine the research questions and objectives 
as well as interpret the findings from the data analysis. Primary data were gathered from the 
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selected customers of herbal medicines in the herbal shops to address the research questions to 
achieve the objectives.    
  
  4.9.1 Data Collection Instruments   
It has been argued that the choice of appropriate research data gathering, and analysis methods 
depend on the paradigm and research questions employed in a study. The present study is 
designed to use the quantitative data collection method as it is aligned with the positivist/post 
positivist research paradigm (Mackenzie & Knipe, 2006). In this regard, data were gathered 
through questionnaires to ascertain the effect of packaging and the dimensions of brand equity 
on overall brand equity of herbal medicines sold at the OTC pharmaceutical market.    
  
According to Malhotra and Birks (2007) a questionnaire is a structured procedure of data 
collection comprising a series of questions either in writing or verbal that a respondent answers. 
Questionnaires can be closed-ended, open-ended and a combination of closed-and open-ended 
questions. Open-ended questions permit participants to provide their own responses whilst 
closed-ended questions offer a number of alternative responses from which the participant is 
instructed to select (Clifford, French, & Valentine, 2010; Saunders et al., 2007). Though, it is 
argued that open-ended questions provide in-depth and rich information, it is generally 
associated with qualitative research methodologies (Clifford et al., 2010; Creswell, 2014).  
  
Consequently, the present study relied on closed-ended questions because they are mostly 
associated with quantitative research methods (Creswell, 2014; Mertens, 2015). It has been 
highlighted that close-ended questions are a highly cost-effective data collection tool because 
they permit a sizable amount of data to be gathered from a larger population at a relatively 
lower cost. The data gathered also lends itself more to statistical analysis and interpretations 
(Fink, 2003 cited by Saunders et al., 2007; Creswell, 2014; Mackenzie & Knipe, 2006). More 
importantly, the shoppers did not have time and therefore the pre-determined alternative 
answers made it easier and quicker for them to respond to the questions.     
  
4.9.2 Questionnaire Design   
The questionnaire was designed on the basis of the stated research questions with the view to 
achieving the stipulated research objectives. The initial section of the questionnaire captures 
the demographic characteristics of the participants which include age, sex, income, educational 
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and occupational background. The test instruments used to measure the income levels of the 
participants were taken from Fink, Weeks, and Hill (2012).  
  
The second part of the questionnaire relied on a seven-point Likert scale ranging from 
extremely good (1) to extremely bad (7) to ascertain the respondents perceptions of packaging 
design of packaging in the OTC medicine market.    
  
The next section of the questionnaire employed a five-point Likert scale anchored on strongly 
disagree (1) to strongly agree (5) to capture the perceptions of the research participants on 
packaging, perceived quality, overall brand equity, brand associations, brand loyalty and brand 
awareness. Six items were designed to measure customers` perceptions of packaging of herbal 
medicines. However, the test items for measuring overall brand equity and its constructs were 
obtained from previous test responses and modified. Table 4.4 below displays the test items of 
brand awareness, associations, loyalty, perceived quality and overall brand equity and their 
sources.  
 
Five items employed to measure brand awareness were taken from Gil et al. (2007), Tong and   
Hawley (2009) and Yoo et al. (2000), while four test items of perceived quality were borrowed 
from Gil et al. (2007) and Yoo et al. (2000) and modified. 
Moreover, five test items of brand associations were borrowed from Aaker (1996) and Tong 
and Hawley (2009), whilst six indictors of brand loyalty were designed by Tong and Hawley 
(2009) and Yoo et al. (2000) and modified.  Finally, five test items of overall brand equity were 
obtained from Tong and Hawley (2009), Gil et al. (2007) and Yoo et al. (2000) and modified.  
 
It has been emphasized that existing questionnaire with evidence of reliability and validity is 
cost-effective relative to developing new instrument (Kimberlin & Winterstein, 2008). All the 
questions were pre-coded including the response categories before the data collection in order 
to save time for coding after the data collection.    
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Table 4. 4: Test Items Development  
  Latent Constructs Sources Adapted  
Brand Awareness 
1 I can easily recognize X among other competing brands   Yoo et al. (2000) √ 
2  Some characteristics of X come to my mind quickly  " √ 
3  I am aware of X  " √ 
4 When I think about this product, X is the first brand that comes to 
my mind 
Gil et al. (2007) √ 
5   I am familiar with X brand     Tong &  Hawley (2009)   √ 
Perceived Quality 
1 The likelihood that X would functional is very high     Yoo et al. (2000) √ 
2 The likelihood that X is reliable is very high   " √ 
3  The quality of X is very high Gil et al. (2007) √ 
4 I can always trust on X if I want a product of high quality   " √ 
Brand Associations 
1   The brand provides good value for the money Aaker (1996) √ 
2 I like the brand image of X Tong & Hawley (2009) √ 
3 X has very unique brand image, compared to competing brands    " √ 
4 I like and trust the company, which makes X products " √ 
5 I respect and admire people who wear X " √ 
Brand Loyalty 
1 When buying athletic shoes, X would be my first choice " √ 
2 I would love to recommend X to my friends " √ 
3 I am still willing to buy X even if its price is a little higher than 
that of its competitors 
" √ 
4 I will keep on buying X as long as it provides me satisfied 
products 
" √ 
5 I consider myself to be loyal to X  Yoo et al. (2000) √ 
Overall Brand Equity 
1 Even if another brand has same features as X, I would prefer 
to buy X. 
" √ 
2 If another brand is not different from X in any way, it seems 
smarter to purchase X 
" √ 
3   If there is another brand as good as X, I prefer to buy X " √ 
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4 It makes sense to buy X instead of any other brand, even if they 
are 
the same in quality or price 
 Gil et al. (2007) √ 
5 X is more than a product to me Tong & Hawley (2009) √ 
 Source: Compiled by the Researcher 
 
 
4.9.3 Questionnaire Pilot–Testing  
In order to generate reliable and valid data, the questions were pilot-tested prior to its 
administration. Saunders et al. (2007) suggested that the number of pre-tests to be conducted 
and participants selected in the pilot studies depend on the research questions and objectives, 
time and financial resources available, the sample size and the quality of pilot questionnaires.  
Malhotra and Birks (2007) are of the view that the initial pilot-test sample size could be small 
ranging from 15 to 30 respondents. Fink (2003) cited by Saunders et al. (2007) also 
recommended that the least pilot sample size of 10 participants is adequate for most student 
questionnaire.      
  
First, a pilot questionnaire was drafted and presented to the researcher`s University Peer 
Review Ethics Committee for preliminary assessment. This helped the researcher to establish 
the representativeness and suitability of the questionnaire in relation to the research questions. 
Subsequently, the questionnaire was distributed randomly to a pilot sample of 15 respondents 
in the field with the aim to identifying whether the responses to the questions corresponded to 
the intended purposes of the questions.   
  
4.9.4 Questionnaire Administration  
The questionnaires were administered face-to-face to the 348 respondents on the floor of 71 
herbal shops in Kumasi. Here, the first customers entering the herbal shop was randomly 
selected and subsequently, one in every eleven customers entering the shop was intercepted 
until a sample size of 348 was obtained. The questions were also read to respondents who 
continued shopping while the responses provided were ticked.     
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4.9.5 Data Quality Control  
It has been highlighted that the key determinants of quality of a data are reliability and validity 
of the data collection instruments (Kimberlin & Winterstein, 2008).  
  
4.9.5.1 Test Instruments Reliability  
Test instruments reliability relates to the ability of the instruments to yield stable and consistent 
outcomes when repeated measurements are made (Malhotra & Birks, 2007). Test reliability is 
also seen as the extent to which the test items of a construct is consistent or dependable 
(Bhattacherjee, 2012).   
  
Kimberlin and Winterstein (2008) outline three approaches to evaluate reliability; test re-test, 
internal consistency and inter-rater reliability. Internal consistency is concerned with “the 
extent to which all the items in a test measure the same concept or construct and hence it is 
connected to the inter-relatedness of the items within the test” (Tavakol & Dennick, 2011: 53). 
Bhattacherjee (2012) also highlighted that internal consistency reliability is a measure of 
consistency between different test items of the same construct.   
  
Nunnally (1975:10) stated that “reliability estimates based on internal consistency ignores 
changes over relatively short periods of time, but such estimates proved to be surprisingly 
accurate in most situations.” Consequently, the present study relied on internal consistency 
reliability to provide an objective measure of reliability of the data collection instruments. It is 
also argued that the most frequently used coefficient alpha for estimating the degree of internal 
consistency is Cronbach`s alpha coefficient (Saunders et al., 2007; Nunnally, 1975; Kimberlin 
& Winterstein, 2008; Tavakol & Dennick, 2011). Hence, the Cronbach`s alpha was employed 
to estimate internal consistency reliability in this study.   
  
Nunnally (1975) suggested an acceptable cut-off Cronbach`s alpha coefficient of 0.70 as a 
measure of internal consistency reliability of test instruments. However, it has been highlighted 
that a higher coefficient indicates a high level of internal consistency reliability of the 
instrument. Tavakol and Dennick (2011) concluded that the acceptable reliability values lie 
between 0.70 and 0.90, whiles values less than 0.70 indicate poor internal consistency 
reliability. On the contrary, Kline (2005) is of the view that reliability values close to 0.90 can 
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be considered as excellent, around 0.80 is very good whiles close to 0.70 is considered 
adequate.  
   
Furthermore, the composite reliability was conducted to determine the construct reliability in 
the confirmatory factor analysis. Composite reliability is commonly used in conjunction with 
the structural equation model and it provides slightly superior scores of internal consistency 
reliability. It is computed as the sum of squared standardized regression weights for each latent 
variable and the sum of the error variance terms for a construct (Hair, Black, Babin, & 
Anderson, 2010). Likewise, the Cronbach alpha, the value of 0.70 or above indicates good 
construct reliability but scores between 0.6 and 0.70 are recognised as adequate (Bagozzi & 
Yi, 1988; Hair et al., 2010). 
 
4.9.5.2 Test Items Validity   
Not only should test instruments be internally consistent but they should also demonstrate their 
ability to measure what they are purported to measure (Kimberlin & Winterstein, 2008; 
Saunders et al., 2007).   
  
In the current study, content validity and construct validity were employed to investigate the 
test instruments` validity. First, content validity was established by indicating that each item in 
the instrument adequately covers the domain of the constructs used in this research. The main 
constructs examined in this research include brand loyalty, brand awareness, perceived quality, 
brand association, packaging and brand equity. In order to ensure that the test items accurately 
cover these constructs, a careful definition of the test items through extensive examination of 
the relevant literature was undertaken.   
  
Additionally, construct validity was undertaken to demonstrate the degree at which the test 
responses actually measure their respective constructs (Saunders et al., 2007). Construct 
validity were established through exploratory and confirmatory factor analysis (Floyd & 
Widaman, 1995; Kline, 2005).   Here, discriminant and convergent validity were established 
to provide evidence of construct validity.  
 
Convergence validity indicates that multiple items that measure the same construct are strongly 
inter-related (Lehmann, 1988). Average Variance Extracted (AVE) was used to check the 
convergence validity   of each of the constructs in the confirmatory factor analysis in this study. 
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Average variance extracted is calculated as the total of all the squared standardized factor 
loadings of the construct divided by the number of items. As a rule of thumb, the value of 
average variance extracted of 0.50 or higher suggests convergent validity (Fornell & Larcker, 
1981; Hair et al., 2010).  
 
In contrast, discriminant validity relates to the degree at which a test items of theoretically 
distinct construct correlate less with items of other constructs from which it intends to differ 
(Malhotra & Birks, 2007). Discriminant validity was analysed by calculating the square root 
of the AVE and the squared correlation between a construct and any other constructs (Hair et 
al., 2010). Discriminant validity is supported when the square root of the AVE is higher than 
the squared correlation estimates between a construct and any other constructs in the con model 
(ibid). 
 
4.10 Exploratory Factor Analysis       
Exploratory factor analysis (EFA) is commonly used procedure to develop and measure latent 
variables. Fabrigar and Wegener (2012) described factor analysis as set of statistical tools 
designed to identify the latent constructs underlying a battery of indicator items. The focus of 
the factor analysis is to determine the few latent variables that can replicate the original data 
(Gorsuch, 1997).  
  
In this study, the questionnaire designed to answer the research questions to achieve the 
objectives were made up of multiple indicator items and unobserved variables. Hence, factor 
analysis was undertaken to identify the number of common factor underlying these multiple 
test items. It has also been emphasized that exploratory factor analysis can also guarantee 
reliable results of confirmatory factor analysis (Floyd & Widaman, 1995). As stated earlier, 
exploratory factor analysis was employed to establish test items` validity (Floyd & Widaman, 
1995; Kline, 2005).   
  
This is achieved by selecting those measured variables that are highly related to a specific 
construct (Gorsuch, 1997). Factor analysis procedure produces factor loadings which represent 
the correlations among the measured items and the constructs. It has been generally 
acknowledged that factor loadings exceeding 0.30 or 0.40 are considered significant in 
exploratory factory analysis (Floyd & Widaman, 1995). The authors further stated that, in 
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practice, coefficients at this level and above are often regarded as meaningful when the 
participants-to-variable ratio is between 5 and 10.   
  
However, Hair, Black, Babin, and Anderson (2010) are of the view that loadings within the 
range of 0.30 or 0.40 are recognized as the lowest for the interpretation of the factor structure. 
The authors are of the view that loadings of 0.50 or above provide practical significance for 
factor analysis, while loadings exceeding 0.70 is regarded as a well-defined factor structure. 
However, in this study the factor loadings ranging between 0.30 and 0.40 or above were used 
due to a relatively large sample size and participants- to-indicator ratio (Hair et al., 2010; Floyd 
& Widaman, 1995).   
  
In order to keep the factor solution simple for easy interpretation, researchers have been using 
either orthogonal rotation methods which produce latent variables that are uncorrelated, or 
oblique rotation procedures which permit the constructs to correlate (Floyd & Widaman, 1995). 
In the present study, oblique rotation using oblimin and promax methods were considered 
suitable to achieve simple factor structure which is the core objective of factor rotation.    
  
4.10.1 Confirmatory Factor Analysis   
Confirmatory factor analysis (CFA) is a procedure for measuring the extent to which a 
proposed factor solution provides a good fit to the data and whether the model fits well, as 
parsimoniously as other models. In the current research, CFA was utilized to support a priori 
hypotheses generated from the findings of the exploratory factor analysis (Floyd & Widaman, 
1995). As noted earlier, it was also used primarily to evaluate the construct validity measures 
in the study. Brown and Moore (2012) concluded that confirmatory factor analysis approaches 
to construct validity is preferable to conventional analytical methods, in that the resultant 
estimates of discriminant and convergence validity account for measurement errors.   
  
Evidence of construct validity is indicated by the factor structure of the scale being consistent 
with the variables that the test items attempt to measure. The factor structure needs to be clearly 
hypothesised and then evaluated to determine its fit with the observed covariance structure of 
the measured variables.  
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Brown and Moore (2012) highlighted that CFA relates to the measurement model in the 
structural equation modelling, and it deals typically with the relationship between the indicator 
variables and the common factors. Floyd and Widaman (1995) also noted that the adequacy of 
confirmatory factor analysis can be evaluated through a number of goodness-of-fit indices.   
  
Goodness-of-fit relates to how well the parameter estimates are able to replicate the 
relationships that are identified in the sample data (Brown & Moore, 2012). The overall model 
fit can be assessed through multiple absolute fit indices which underpin any facture model 
(Floyd & Widaman, 1995). However, Hooper, Coughlan, and Mullen (2008) highlighted that 
there is no consensus not only on the specific goodness-of-fit indices but also their cut-off 
criteria to adequately measure the plausibility of the model. In general, the common indices 
reported in the literature include chi-square statistic, goodness-of-fit index (GFI) and adjusted 
goodness-of-fit index (AGFI).   
  
While, most recommended global goodness-of-fit indices are standardized root mean square 
residual (SRMR), root mean square error of approximation (RMSEA), Tucker-Lewis index 
(TLI), and comparative fit index (CFI) for one-time analysis (Floyd & Widaman, 1995; 
Schreiber, Stage, King, Nora, & Barlow, 2006).   
  
4.11 Data Analysis Plan  
After the data collection, all the questionnaires were edited to obtain clean and reliable data. 
The questionnaires were screened to identify and eliminate incomplete, poorly recorded and 
inconsistent or ambiguous responses to ensure completeness and accuracy. Since all the 
questions were pre-coded, the collation of responses for data analysis was made easier.  
 
The data entry and final analysis were carried out by using IBM SPSS Amos (Analysis of 
Moment Structures) version 22. Covariance-based structural equation model, (in this case 
Amos) was adopted because it is recognized as an efficient method of analysing not only 
reflectively but also formatively-measured constructs (Diamantopoulos, 2011; Jarvis, 
Mackenzie & Podsakoff, 2003; MacCallum & Browne, 1993).  
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4.11.1 Data Analysis Procedure  
Descriptive and inferential statistics were the main statistical tools used in this study.   
  
4.11.2 Descriptive Statistics  
It has been established that the purpose of descriptive statistics is not to make predictions but 
rather to describe and make comparison of the variables in a study. Data generated through the 
use of descriptive statistics are usually displayed by using graphs and tables, and computation 
of measures of central tendency and variability (Sheskin, 2004).   
  
In the present study, descriptive statistics were utilized to explain and compare the demographic 
characteristics, perceptions of packaging and brands of plant medicines purchased by the 
participants through the use of frequency distribution tables. In addition, cross-tabulation was 
used to measure the interdependence between levels of participants` education, income and 
patronage of herbal medicines.   
  
Chi-square test (Х2) was also employed to examine the likelihood that associations among 
education, income and frequency of patronage of herbal medicines could occur by chance 
factors. More importantly, it was used to test the statistical significance of the observed 
interdependence among participants` education, income and patronage of herbal medicines 
(Malhotra & Birks, 2007). According to Saunders et al. (2007), a probability value of 0.05 or 
less (p < 0.05) shows that the relationship that exists between the variables is significant. This 
implies that there is at least 95 percent certainty that the association between the two variables 
could not have occurred by chance alone.  
  
4.11.3 Inferential Statistics  
Sheskin (2004) emphasised that the employment of inferential statistics allows predictions or 
conclusions to be drawn from the larger population from which the sample was obtained. As a 
result, inferential statistics was employed through the use of factor analysis and structural 
equation modelling to test the significance of the hypotheses stated in the research.  
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4.11.3.1 Structural Equation Modelling   
Structural equation modelling (SEM) has been increasingly used across many disciplines by 
researchers as a vital statistical technique and ingredient for testing theory as well as its building 
(Babin & Svensson, 2012). In their view, the structural equation modelling is a multivariate 
analytical tool used for specifying and assessing linear and /or “causal” relationships between 
multiple independent and dependent variables through a simultaneous multiple equation 
process. Byrne (2016) pointed out that SEM is a statistical tool that relies on a confirmatory 
procedure to measure structural theory relating to some phenomena. Hoyle (1995) described 
structural equation modelling as a statistical technique which offers a comprehensive approach 
of testing hypothesised relationships among indicators and latent factors.    
  
Weston and Gore (2006) also highlighted that structural equation modelling is made up of two 
analytical procedures; the measurement model and structural model. The authors are of the 
view that, in the SEM procedure, the measurement model is the precursor of the structural 
model. Confirmatory factor analysis (CFA) is often used to analyse the measurement model. It 
defines the relationship between the indicator items and the respective latent factors that they 
are purported to measure. On the other hand, the structural model spells out the “causal” 
relations among the constructs as proposed in the theory. Essentially, the structural model 
defines the degree at which specific unobserved factors directly or indirectly influence changes 
in the estimates of other constructs in the model (Byrne, 2016).   
  
The author further noted that the structural relations are indicated by a set of regression 
equations and are depicted pictorially to provide better conceptualization of the theory under 
the study. Thus, structural equation modelling is usually shown by a path diagram. The path 
diagram provides the summary of the hypothesized relationships among common factors and 
observed variables as well as the non-directional (correlational) and directional (regression) 
relationship among the unobserved factors (Bowen & Guo, 2012). In the path diagram, the 
indicator items are shown by rectangles while common factors are indicated by circles. In 
addition, the single-headed arrows illustrate the effect of one variable on another, whilst the 
double-headed arrows explain the correlations among the latent constructs.   
  
Structural equation model analysis presents path coefficients to examine the statistical 
significance of individual structural paths which indicate the impact of a latent variable on 
another or a latent variable on an observed variable. The test of statistical significance of path 
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coefficient is determined by either t-statistic or z-statistic (Schreiber et al., 2006). In this study, 
the test of statistical significance of the parameter estimates was determined at critical ratio 
greater than 1.96 at probability value of 0.05 or less, or at critical ratio greater than 2.58 at 
probability value of 0.001 or less (Timothy & Moore, 2012).   
  
Furthermore, the maximum likelihood estimation method was used when conducting the 
structural equation modelling in the current study. Hu and Bentler (1999) highlighted that the 
maximum likelihood estimation procedure is widely used as it produces the best model-fit 
comparable to other estimation methods. It has also been emphasized that the maximum 
likelihood method has proven to offer reliable parameter estimates and is robust even under the 
violation of the assumption of normality (Hair et al., 2010).     
  
The present study relies on structural equation modelling to test the hypothesized relations 
posited in this research. It is most appropriate for the current research because the focus of the 
research is to analyse the relationship among multiple latent variables, each of which is 
represented by several indicators. These multiple constructs could be independent variable in 
one relationship and at the same time act as dependent in another relationship (Hair et al., 
2010). In the current research, packaging, brand equity and its dimensions are latent variables, 
each is represented by multiple indicator variables. The relationship between packaging and 
brand equity is mediated by the dimensions of brand equity.   
  
In addition, structural equation modelling was employed because of the following advantages 
it has over the other conventional methods of analysing multivariate data. Long (1983) 
emphasized that structural equation modelling is a flexible technique that can deal with a 
variety of essential statistical applications. Byrne (2016) highlighted that while the 
conventional multivariate methodologies are unable to either assess or eliminate measurement 
errors, the SEM procedures offer clear estimates of these error variances in the parameters. 
Secondly, structural equation modelling permits the entire model to be tested statistically 
through a simultaneous analysis to examine the degree at which it is consistent with the data. 
The author further argued that the model is deemed plausible if the goodness-of-fit is adequate 
while the model is rejected if the goodness-of-fit indices are inadequate.   
 
Besides, whereas traditional methods of analysing data is based on the measurement of 
indicator variables only, SEM models can combine both latent variables and indicator 
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variables. Moreover, Bowen and Guo (2012) established that SEM permits the simultaneous 
regression of equations in which the relationship between the exogenous variable and the 
endogenous variable is hypothesized to be partially or fully explained by mediating variables.  
The authors further stated that, unlike traditional regression models, SEM can estimate 
regression relationships among common factor and between indicator variables and 
unobserved factors simultaneously. Moreover, as a confirmatory method, SEM provides a 
comprehensive procedure to evaluate and modify theoretical models which has the potential to 
further theory development (Anderson & Gerbing, 1988).    
  
4.12 Ethical Considerations  
The consent of all the participants of the research was obtained by engaging them to complete 
informed consent forms to indicate their desire to participate in the research. The informed 
consent document specified the nature and purpose of the research, and also provided the 
address of the researcher as well as the institution where the researcher was studying, to the 
participants for any further queries. The purpose of the informed consent form was to ensure 
that the participants understood fully what they were participating in.  
  
Furthermore, the researcher assured the participants that the data provided by them would not 
be used for any other purposes other than academic research, and that their names and identity 
would not be disclosed in the research without their full consent. The participants were also 
made to understand that they could withdraw anytime from participating in the study. This 
assurance served as catalyst for obtaining credible and honest data from the respondents. More 
importantly, in consonance with the rules of the university, ethical clearance certificate 
(Reference No: HSS/1922/017D) was obtained which served as a pre-condition for conducting 
the research within the confines of the university. Finally, authors whose publications were 
used in the research were acknowledged by referencing their work in the thesis.   
  
 
4.13 Chapter Summary  
This chapter explains the research methodology used for the study. The research paradigm, 
research design and approach as well as the data collection instrument used have been 
discussed. Not only this, the chapter also provided a detailed explanation of the procedure 
employed to select participants of the research for the purpose of gathering data from them, 
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while highlighting ethical issues considered during the research. In addition, statistical tools 
used during the data analysis were highlighted. Validity and reliability of the test responses 
were also examined in order to generate accurate and consistent results with different 
population samples. The ensuing chapter will present the analysis of the data gathered with the 
view to generating information useful to answer the research questions.      
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CHAPTER FIVE 
  
DATA ANALYSIS AND PRESENTATION OF RESULTS  
  
5.1 Introduction  
The study investigated the influence of packaging and brand equity of herbal medicines in the 
OTC medicine market. In this regard, customers` perceptions of packaging of medicinal herbal 
products sold at the OTC pharmaceutical market were examined. The study further sought to 
determine the brand equity of herbal medicines in the OTC drug market. Based on the 
research`s conceptual framework, hypotheses were formulated and later tested.   
The current chapter provides the findings of the analysis of the data gathered through the survey 
questionnaire completed by 348 respondents in the OTC medicine market in Kumasi 
Metropolis, Ghana. Specifically, this chapter provides the results of the demographic 
characteristics of the respondents, perceptions of the participants on the packaging of plant 
medicines, examines and validates the test instruments and analyses the proposed hypotheses 
drawn from the study`s conceptual model. This chapter provides the findings generated from 
descriptive and inferential statistics, specifically, exploratory factor analysis and structural 
equations modelling using IBM SPSS Amos 22, to provide the basis for discussions in Chapter 
Six. It is pertinent to add that this chapter does not draw any implications from the results nor 
does it discuss the results as these will be addressed in Chapter Six.   
  
5.1.1 Research Objectives   
The objectives of the research were:  
  
 To examine customers` perceptions of packaging of herbal medicine in the OTC market 
in Kumasi   
 To examine the brand equity of herbal medicines in the OTC drug market in Kumasi.    
 To examine the influence of packaging on brand awareness in the OTC market in 
Kumasi.  
 To examine the influence of packaging on brand associations in the OTC drug market 
in Kumasi.  
 To examine the influence of packaging on perceived quality in the OTC drug market in 
Kumasi.  
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 To examine the influence of packaging on brand loyalty in the OTC drug market in 
Kumasi.  
 
5.1.2 Research Questions  
Based on the research objectives, the research questions that guided the study were:  
 
 What is the customers’ perceptions of packaging of herbal drugs in the OTC market in 
Kumasi?   
 What influence does a brand of herbal medicine have on overall brand equity in the 
OTC drug market in Kumasi?   
 To what extent does packaging influence brand awareness in the OTC pharmaceutical 
market in Kumasi?  
 How does packaging influence brand associations in the OTC medicine market in 
Kumasi?  
 To what extent does packaging influence perceived quality in the OTC drug market in 
Kumasi?  
 How does packaging influence brand loyalty in the OTC pharmaceutical market in 
Kumasi?  
 
5.1.3 Study Hypotheses   
   H1a:   Packaging positively and significantly influence brand awareness 
   H2a:    Packaging positively and significantly influence brand association  
   H3a:    Packaging positively and significantly influence perceived quality  
   H4a:    Packaging positively and significantly influence brand loyalty  
   H1b:    Brand awareness positively and significantly influence overall brand equity  
   H2b:    Brand association positively and significantly influence overall brand equity  
   H3b:    Perceived quality positively and significantly influence overall brand equity  
   H4b:    Brand loyalty positively and significantly influence overall brand equity  
 
5.2 Response Rate   
Out of a total number of 348 questionnaires that were administered to respondents in the OTC 
drug market in Kumasi Metropolis, a total of 316 were returned.  A total of 307 were deemed 
usable for the analysis which represents 88 percent out of the total of 348. Table 5.1 illustrates 
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the summary of the responses of questionnaires administered to participants in the OTC 
medicine market.   
  
Table 5. 1: Summary of the Response Rate 
No. of Questionnaires  Total Number  Valid 
Percent  
Total number of questionnaires distributed   348  100  
Total number of questionnaires returned   316  90.8  
Usable questionnaires  307  88.0  
Source: Developed by Researcher   
  
5.3 Data Quality Controls  
In order to ensure that the data collection instruments achieve their intended purpose in a 
consistent manner, issues of data validity and reliability were undertaken.  
  
5.3.1 Reliability of Test Instruments  
Malhotra and Birks (2007) highlighted that the test instruments for measuring constructs in a 
study need to undergo a reliability test to determine whether the test responses yield stable and 
consistent outcomes when repeated measurements are made. As result, the internal consistency 
reliability of the test instruments for measuring the latent constructs in this study were analysed 
by Cronbach`s alpha and composite reliability statistics.   
  
5.3.2 Reliability of Test Instruments of Packaging and Brand Equity    
Table 5.2 below presents the results of the Cronbach`s alpha and composite reliability statistics 
of test instruments of packaging, brand awareness, brand association, brand quality, overall 
brand equity and brand loyalty. First, the internal consistency reliability of the test responses 
of overall brand equity, brand awareness, brand association, brand loyalty, perceived quality 
and packaging that were produced by the exploratory factor analysis were analysed through 
Cronbach`s alpha statistics. The Cronbach`s alpha value of brand awareness is 0.770, brand 
association is 0.724, perceived quality is 0.848, brand loyalty is 0.803, packaging is 0.845 and 
overall brand equity is 0.857. The results in this sample demonstrate that all the indicators of 
packaging, overall brand equity, brand association, brand awareness, perceived quality and 
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brand loyalty have Cronbach’s alpha coefficient above 0.70, indicating that all the test items 
have good internal consistency reliability (Hair et al., 2010; Kline, 2005).   
  
Moreover, composite reliability statistics was employed to determine the construct reliability 
of the confirmatory factor analysis (Bagozzi & Yi, 1988; Hair et al., 2010). It is recommended 
that a value of 0.70 or above indicates good reliability but values between 0.6 and 0.70 are 
regarded as adequate (Bagozzi & Yi, 1988; Hair et al., 2010). The results from Table 5.2 show 
that the composite reliability coefficient of brand awareness is 0.770, brand association is 
0.685, perceived quality is 0.851, brand loyalty is 0.807, packaging is 0.756 and overall brand 
equity is 0.823. These results show that all the constructs in the confirmatory factor analysis 
have satisfactory levels of construct reliability. This outcome is consistent with the results of 
an empirical study (Tong & Hawley, 2009) which indicated that coefficients ranging between 
0.60 and 0.76 satisfied the criteria of composite reliability. This outcome suggests that the 
results of the path estimates are reliable.       
  
Table 5. 2: Results of Reliability Test Items of Packaging and Brand Equity  
Variables  No. of Initial 
Items  
Cronbach`s Alpha 
Estimate  
No. of Final 
Items  
Composite Reliability 
Estimate  
Brand awareness  3  0.770  3  0.770  
Packaging   6  0.845  3  0.756  
Brand association  3  0.724  2  0.685  
Perceived quality   2  0.848  2  0.851  
Brand equity   5  0.857  3  0.823  
Brand loyalty   3  0.803  3  0.807  
Source: Primary Data   
 
5.3.4 Construct Validity of Packaging and Brand Equity Constructs    
The test instruments are not only measured for internally consistency but also to show their 
ability to measure what they are theoretically designed to measure (Kimberlin & Winterstein, 
2008; Saunders et al., 2007). Accordingly, convergent and discriminant validity were measured 
to determine the construct validity of the model. The findings of the exploratory factor analysis 
provided a test of discriminant validity as all the indicator items loaded higher on their 
respective constructs than the remaining constructs in the factor solution (Hair, Ringle, & 
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Sarstedt, 2011). Furthermore, the findings of the CFA offer support for construct validity as all 
the indicators loaded on their specific common factors and their factor loadings were 
statistically significant (Anderson & Gerbing, 1988; Hair et al., 2010; Kline 2005).   
 
Furthermore, AVE was also used to further confirm the convergent validity of brand quality, 
brand awareness, brand associations, overall brand equity, brand loyalty and packaging. The 
summary of the AVE for the constructs are shown in Table 5.3 below. The results show that 
the AVE of brand association is 0.522, brand awareness is 0.528, perceived quality is 0.741, 
packaging is 0.514, brand loyalty is 0.584 and overall brand equity is 0.608. These results 
indicate that all the latent variables have AVE more than 0.50 which suggests satisfactory 
convergent validity (Fornell & Larcker, 1981; Hair et al., 2010).  
 
Table 5.3 also reveals the findings of discriminant validity of the constructs in the measurement 
model.  The results  indicate that the square root of the AVE were higher than the squared 
correlation estimates between a construct and any other constructs which demonstrate 
independence between the constructs (Hair et al., 2010). These results show that brand 
awareness, association, perceived quality, loyalty and brand equity and packaging are valid 
constructs in the measurement model in this sample. 
 
Table 5. 3: Results of Construct Validity of Packaging and Brand Equity   
Constructs    Average 
Variance 
Extracted   
Brand 
Awareness 
Brand 
Association 
Perceived 
Quality 
Brand 
Loyalty 
Brand 
Equity 
Packaging  
Brand Awareness  0.528  0.727**      
Brand Association   0.522  0.346 0.722**     
Perceived Quality   0.741  0.406 0.393 0.861**    
Brand Loyalty   0.584  0.442 0.472 0.527 0.764**   
Brand Equity   0.608  0.581 0.536 0.398 0.656 0.779**  
Packaging   0.514  0.472 0.254 0.243 0.308 0.364 0.717** 
Notes:  ** = Square Root of AVEs; Off-diagonal estimates represent the Squared Inter-     
Construct Correlations 
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5.4 Demographic Structure of Respondents   
The demographic structure of the participants relates to the gender, age, education, occupation 
and income levels of the respondents of the research. This provides a clear understanding of 
the profile of the people who took part in the study.   
  
5.4.1 Gender Characteristics  
Table 5.4 reveals the results of the gender characteristics of the respondents. Out of the total 
number of 304 respondents, 68.4% (208) were male while 31.6% (96) were female. This 
indicates that majority of the respondents were male. However, three of the participants did not 
provided information about their gender characteristics.   
 
     Table 5. 4: Gender Characteristics of Respondents  
Gender  Frequency  Percent  Valid Percent  Cumulative 
Percent  
Valid  Male  208  67.8  68.4  68.4  
Female  96  31.3  31.6  100.0  
 Total  304  99.0  100.0    
Missing       System  3  1.0      
Total  307  100.0      
     Source: Primary Data   
  
5.4.2 Age Structure of Respondents   
Table 5.5 below indicates the age distribution of the respondents. The results show that out of 
the total of 305  respondents who were between the ages of 18 and 25 years were 40.7 % (124), 
between 26 and 35 were 37.7% (115), between 36 and 45 were 10.8% (33), between 46 and 60 
were 5.9% (18) and those above 60 years were 4.9% (15). This reveals that the majority of the 
participants were between the ages of 18 and 25, followed by 26 to 35 and the least were those 
above 60 years.   
  
149  
  
 
Table 5. 5: Respondents` Age Distribution  
Age (Years)  Frequency  Percent  Valid 
Percent  
Cumulative 
Percent  
Valid  18–25  124  40.4  40.7  40.7  
26–35  115  37.5  37.7  78.4  
36–45  33  10.7  10.8  89.2  
46–60  18  5.9  5.9  95.1  
More than 60  15  4.9  4.9  100.0  
Total  305  99.3  100.0    
Missing       System  2  0.7      
Total  307  100.0      
     Source: Primary Data   
  
5.4.3 Educational Characteristics of Respondents    
Table 5.6 below illustrates the educational background of the participants of the study. The 
results show that 12.7% (39) of the respondents had basic education, 39.2% (120) had 
secondary education, 20.3% (62) had diploma education and 27.8% (85) had tertiary education. 
Overall, the results show that majority of the participants of the study had secondary education, 
followed by tertiary education and the lowest was basic education.   
  
Table 5. 6: Educational Characteristics of Respondents  
Educational Distribution  Frequency  Percent  Valid Percent  Cumulative 
Percent  
Valid  Basic  39  12.7  12.7  12.7  
Secondary  120  39.1  39.2  52.0  
Diploma  62  20.2  20.3  72.2  
Tertiary  85  27.7  27.8  100.0  
Total  306  99.7  100.0    
Missing        System  1  0.3      
Total  307  100.0      
  Source: Primary Data   
  
150  
  
 
5.4.4 Occupational Distribution of Respondents  
Table 5.7 indicates the occupational structure of the participants of the study. The results show 
that the number of respondents who were engaged in teaching were 16.0 (48), in trading were  
36.7% (110), in artisanal work were 4.0% (12), in farming were 2.7% (8), in clerical work were 
0.7% (2), in security services were 2.0% (6), in managerial work were 5.0% (15) and others 
were 33.0% (99). This demonstrates that majority of the respondents were traders, followed by 
those in other professions and the least were clerks.    
 
      Table 5. 7: Respondents` Occupational Distribution  
Occupational Distribution  Frequency  Percent  Valid 
Percent  
Cumulative 
Percent  
Valid  Teaching  48  15.6  16.0  16.0  
Trading  110  35.8  36.7  52.7  
Artisan  12  3.9  4.0  56.7  
Farmer  8  2.6  2.7  59.3  
Clerk  2  .7  .7  60.0  
Security  6  2.0  2.0  62.0  
Manager  15  4.9  5.0  67.0  
Others  99  32.2  33.0  100.0  
Total  300  97.7  100.0    
Missing           System  7  2.3      
Total  307  100.0      
Source: Primary Data  
 
5.4.5 Respondents` Expenditure per Day  
Table 5.8 indicates the results of income spent on goods and services by the respondents on 
themselves on a daily basis. The results show that the respondents who spent less than US$1 
in a day were 8.1% (23), US$1 to less than US$2 were 26.7% (76), US$2 to less than US$4 
were 20.7% (59) and greater than or equal to US$4 were 44.6% (127). This reveals that the 
majority of the participants spent US$4 and more, followed by those whose expenditures were 
US$1 to less than US$2 and the least were those who spent less than US$1 in a day. The results 
indicate that 34.7% of the respondents who buy herbal medicines were extremely poor whereas 
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65.3% of the respondents were above the international poverty line of US$1.90 (World Bank, 
2016).   
   
Table 5. 8: Income Spent by Respondents per Day  
Income Spent per Day  Frequency Percent  Valid 
Percent  
Cumulative  
Percent  
Valid  Less than US$1  23  7.5  8.1  8.1  
US$1 to less than US$2  76  24.8  26.7  34.7  
US$2 to less than US$4  59  19.2  20.7  55.4  
Greater than or equal to US$4  127  41.4  44.6  100.0  
Total  285  92.8  100.0    
Missing        System  22  7.2      
Total  307  100.0      
Source: Primary Data  
  
5.5 Herbal Medicines Purchased from the OTC Medicine Market   
This section presents the significant findings of herbal medicines purchased from the OTC 
medicine market in Kumasi Metropolis. The plant medicines were grouped into creams 
(ointments), capsules and mixtures (liquids) as presented below.   
  
5.5.1 Capsules of Herbal Medicines    
Table 5.9 below (as shown in Appendix 1A) indicates the amount of capsules of herbal 
medicines bought by participants from the OTC medicine market in the Kumasi Metropolis. 
The results show that 21.6% of Tinattet capsules was bought, 17.9 % of Givers capsules was 
bought whilst 7.1% of Kingdom, 7.1% of Samenk and 7.1 % Zipman capsules were bought, 
out of a total of 28 capsules of herbal medicines.  The results further indicate that the leading 
brand was Tinattet followed by Givers and least were Kingdom, Samenk and Zipman capsules.      
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     Table 5. 9: Capsules of Herbal Medicines  
Herbal Medicine Capsules   Frequency Valid Percent 
Givers Capsules   5  17.9  
Kingdom Capsules  2  7.1  
Samenk Capsules   2  7.1  
Tinatett Capsules   6  21.4  
Zipman Capsules   2  7.1  
        Source: Primary Data   
  
5.5.2 Creams / Ointment of Herbal Medicines    
Table 5.10 (as depicted in Appendix1B) reveals quantities of herbal medicines in the form of 
ointment bought by respondents from the OTC medicine market in Kumasi. The results show 
that 28.6% of Angel herbal cream was purchased whilst 14.3% of Ebenezer herbal ointment, 
14.3% of Laud herbal ointment and 14.3 % of Mercy herbal cream were bought out of the total 
of 14 creams/ointments. It can be observed that Angel herbal cream was the leading brand 
among the plant medicines made up of creams/ointment sold at the OTC medicine market.       
  
   Table 5. 10: Creams / Ointment of Herbal Drugs  
 Herbal Medicine Creams   Frequency  Valid Percent 
Angel herbal cream  4  28.6  
Ebenezer ointment  2  14.3  
Laud herbal ointment  2  14.3  
Mercy herbal cream  2  14.3  
     Source: Primary Data  
  
5.5.3 Mixtures/ Liquids of Herbal Medicines   
Table 5.11 (as exhibited in Appendix 1C) shows the percentage of mixtures/liquids of herbal 
medicines bought by the participants from OTC market in Kumasi. The results indicate that 
41.0% of Taabea herbal mixture, 16.8% of Time herbal mixture and 9.8% of Adutwumwaa 
herbal mixture were bought from the OTC medicine market. The rest were 4.1% of Adom 
herbal mixture, 3.7% of Solak herbal mixture, 2.0% of Givers herbal mixture, 1.6% of Sparnis 
herbal mixture and 1.2% of Rooter mixture which were purchased out of a total of 244 herbal 
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mixtures. The results further indicate that the brand that leads the market for herbal mixture 
was Taabea herbal mixture followed by Time herbal mixture.  
 
Table 5. 11: Mixtures / Liquids of Herbal Medicines  
Herbal Drug Mixtures  Frequency  Valid Percent 
Adom herbal mixture   10  4.1  
Adutwumwaa herbal mixture  24  9.8  
Givers herbal mixture  5  2.0  
Solak herbal mixture  9  3.7  
Taabea herbal mixture   100  41.0  
Time herbal mixture   41  16.8  
Sparnis Garlic mixture   4  1.6  
Rooter mixture  3  1.2  
   Source: Primary Data   
  
5.6 Herbal Medicines Patronage  
The results from Table 5.12 below show the frequency at which the respondents buy herbal 
medicines from the OTC market. The results indicate that 76.3% (219) of the participants often 
buy plant medicines while 23.7% (68) seldom buy these. This shows that the majority of the 
participants of the study exhibited repeated-buying of herbal medicines.  
  
Table 5. 12: Do you frequently buy herbal drugs?  
Responses  Frequency  Percent  Valid Percent  Cumulative 
Percent  
Valid  Yes  219  71.3  76.3  76.3  
No  68  22.1  23.7  100.0  
Total  287  93.5  100.0    
Missing      System  20  6.5      
Total  307  100.0      
   Source: Primary Data   
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5.6.1 Relationship between Expenditure per Day and Patronage of Herbal Medicines  
Table 5.13 below shows the results of interdependence between the respondents` expenditure 
per day and their patronage of herbal medicines in the OTC market in Kumasi. The results 
indicate that 90.5% of the respondents who spent less than a US$1 in a day often purchased 
plant medicines while 9.5% did not frequently buy.  Moreover, 78.6% of participants who spent 
US$1 to less than US$2 frequently bought herbal medicines from the OTC market but 21.4% 
seldom bought. In addition, 71.9% of the respondents who spent US$2 to less than US$4 
regularly patronized herbal medicines in the OTC market whereas 28.1% did not consistently 
buy herbal medicines from the OTC market. Finally, 77.1% of the participants of the study 
whose expenditures were greater than US$4 in a day repeatedly purchased herbal medicines 
from the OTC market, whereas 22.9% seldom bought. Overall, 77.4% of the respondents across 
all levels of income frequently bought herbal medicines from the OTC drug market while  
22.6% were not regular customers of plant medicine.   
   
Table 5. 13: Cross-tabulation of Income Spend per Day and Patronage of Herbal 
Medicine  
    Do you frequently buy herbal 
drugs?            
  
Total   
Yes  No  
  
  
  
Expenditure 
per Day  
  
Less than US$1  
Count  19  2  21  
% within  90.5%  9.5%  100.0%  
  
US$1 to less than 
US$2  
Count  55  15  70  
% within  78.6%  21.4%  100.0%  
  
US$2 to less than 
US$4  
Count  41  16  57  
% within  71.9%  28.1%  100.0%  
Greater than or equal 
to US$4  
Count  91  27  118  
% within  77.1%  22.9%  100.0%  
  
Total  
 Count  206  60  266  
% within  77.4%  22.6%  100.0%  
Source: Primary Data   
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5.6.2 Chi-Square Test of Income Spent per Day and Patronage of Herbal Medicine  
Table 5.14 presents the results of Chi-square test to determine the association between 
respondents` expenditure per day and their patronage of herbal medicines occurring by chance 
factors alone. The Pearson chi-square test of 4.167 with degree of freedom of 4 and probability 
value of 0.384 demonstrates that the observed relationship between income spent per day and 
frequency of patronage of herbal medicines is not significant at p < 0.05 level (Saunders et al., 
2007). This shows that there is no relationship between the respondents` expenditure per day 
and frequency of purchases of herbal medicines. Thus, participants` repeated patronage of plant 
medicines in the OTC market does not depend on the level of their incomes.  
    
Table 5. 14: Results of Chi-square Test of Income Spent per Day and Patronage of Herbal 
Medicine  
   Value   df Asymp. Sig. (2-Sided)  
Pearson Chi-square  4.167  4  0.384  
No. of valid cases  266      
  Significant at p < 0.05  
 Source: Primary Data   
  
5.6.3 Respondents` Education Level and Frequency of Patronage of Herbal Medicines  
Table 5.15 shows the results of association between the respondent`s educational background 
and their frequency of patronage of herbal medicines. The findings in Table 5.15 demonstrate 
that 91.7% of the participants who had basic education frequently bought herbal medicines 
from the OTC market while 8.3% did not. Moreover, 71.2% of the participants who hold 
secondary education regularly bought herbal medicines whereas 28.8% seldom bought. 
Furthermore, 75.9% of the respondents who had diploma education often bought herbal 
medicines whilst 24.1% did not. Finally, 77.8% of the participants of the research who hold 
tertiary education repeatedly bought herbal medicines from the OTC medicine market whilst 
22.2 % seldom purchased. Overall, a greater majority of the respondents (76.6%) across all 
levels of education frequently patronized herbal medicines from the OTC market.   
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Table 5. 15: Cross-tabulation of Respondents` Education and Herbal Drugs Patronage  
    Do you frequently buy herbal drugs?  Total  
Yes  No  
  
  
Educational  
Background  
Basic  
Education  
Count  33  3  36  
% within  91.7%  8.3%  100.0%  
Secondary  
Education  
Count  79  32  111  
% within  71.2%  28.8%  100.0%  
Diploma  
Education  
Count  44  14  58  
% within  75.9%  24.1%  100.0%  
Tertiary  
Education  
Count  63  18  81  
% within  77.8%  22.2%  100.0%  
Total   Count  219  67  286  
% within  76.6%  23.4%  100.0%  
Source: Primary Data   
  
5.6.4 Chi-square Statistic of Level of Education and Patronage of Herbal Medicines  
Table 5.16 presents the results of chi-square test to determine whether the relationship between 
the level of education of the respondents and their frequency of patronage of herbal medicines 
is statistically significant. The Pearson chi-square test of 3.092 with a degree of freedom of 3 
and probability of 0.378 show that the relationship between participants` level of education and 
frequency of patronage of herbal medicines is not statistically significant at p < 0.05 (Saunders 
et al., 2007). Thus, the repeated-buying behaviour of the respondents of herbal medicines does 
not depend on their levels of education.   
  
Table 5. 16: Results of Chi-square Test of Level of Education and Patronage of Herbal 
Medicine  
   Value            df  Asymp. Sig. (2-Sided  
Pearson Chi-Square  3.092  3  0.378  
No. of Valid Cases  266      
   Significant at p < 0.05  
  
  
157  
  
5.7 Objective One: To Examine Customers` Perceptions of Packaging of Herbal 
Medicines Sold at the OTC Market in Kumasi  
This section provides the results of the participants` perceptions of overall packaging of herbal 
drugs and its elements in the OTC market in Kumasi.   
 
5.7.1 Packaging Colour   
Table 5.17 below depicts the results of the views of respondents on the quality of the packaging 
colour of herbal medicines in the OTC medicine market in Kumasi. The results indicate that 
out of a total of 291, 34.0% (99), 33.7% (98) and 22.3% (65) of the respondents perceive that 
packaging colour of herbal medicines is extremely good, very good and good respectively. 
However, 10.0% (29) of the participants are of the view that packaging colour is neither good 
nor bad. Generally, the impression of a large majority (90%) of the respondents is that the 
packaging colour of herbal medicines is of good quality.   
  
Table 5. 17: Respondents` Perception of Packaging Colour  
Responses  Frequency  Percent  Valid Percent  Cumulative 
Percent  
Valid  Extremely good  99  32.2  34.0  34.0  
Very good  98  31.9  33.7  67.7  
Good  65  21.2  22.3  90.0  
Average  29  9.4  10.0  100.0  
Total  291  94.8  100.0    
Missing     System  16  5.2      
Total  307  100.0      
Source: Primary Data  
  
 5.7.2 Packaging Photography   
Table 5.18 below indicates the participants` perceptions of the packaging photography of plant 
medicines in the OTC medicine market in Kumasi Metropolis. The results show that 17.2% 
(49), 41.1% (117) and 26.0% (74) of the respondents perceived the packaging photography as 
extremely good, very good and good respectively. However, 13.3% (38) of the participants 
consider the packaging photography as neither good nor bad, whereas 1.1% (3) and 1.4% (4) 
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perceive it as bad and very bad respectively. The findings further show that majority (84.3%) 
of the participants perceive packaging photography as good quality whilst 2.5% consider it as 
bad.   
  
Table 5. 18: Respondents` Perception on Packaging Photography  
Responses  Frequency  Percent  Valid Percent  Cumulative Percent  
Valid  Extremely good  49  16.0  17.2  17.2  
Very good  117  38.1  41.1  58.2  
Good  74  24.1  26.0  84.2  
Average  38  12.4  13.3  97.5  
Bad  3  1.0  1.1  98.6  
Very bad  4  1.3  1.4  100.0  
Total  285  92.8  100.0    
Missing      System  22  7.2      
Total  307  100.0      
Source: Primary Data   
  
5.7.3 Printed Information   
Table 5.19 below shows the results of the respondents` perceptions of the printed information 
on the packaging of herbal medicines distributed at OTC market in Kumasi. The results indicate 
that 23.4% (68), 34.5% (100) and 26.2% (76) of the participants are of the opinion that printed 
information on the packaging of herbal medicines sold at the OTC pharmaceutical market is 
extremely good, very good and good respectively. However, 13.1% (38) of the respondents 
perceive the printed information on the packaging as neither good nor bad while 2.8% (8) 
consider it as bad. The results further demonstrate that greater majority (84.1%) of the 
respondents are of the opinion that printed information on the packaging of plant medicines 
sold at the OTC drug market is of good quality whereas 2.8% perceive it as bad.  
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Table 5. 19:  Respondents` View on Printed information  
Responses Frequency Percent  Valid Percent  Cumulative Percent  
Valid  Extremely good 68  22.1  23.4  23.4  
Very good 100  32.6  34.5  57.9  
Good 76  24.8  26.2  84.1  
Average 38  12.4  13.1  97.2  
 Bad 8  2.6  2.8  100.0  
Total 290  94.5  100.0    
Missing              System  17  5.5      
Total  307  100.0      
Source: Primary Data   
  
5.7.4 Packaging Material   
Table 5.20 below provides the results on the views of respondents on the durability of the 
packaging material of herbal medicines sold at the OTC medicine market in Kumasi. The 
results reveal that 17.2% (50), 38.6% (112), 30.3% (88) and 10.0% (29) of the respondents 
perceive the packaging material as extremely good, very good, good and neither good or bad 
respectively. However, 2.4% (7), 1.0% (3) and 0.3% (1) consider the packaging material of 
plant medicines as bad, very bad and extremely bad respectively. Generally, the perception of 
a large majority (86.2%) of the participants is that the materials used for packaging of herbal 
medicines are of good quality but 3.7% are of the opinion that they are bad.      
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Table 5. 20: Respondents` Perception of Packaging Material  
Responses  Frequency  Percent  Valid Percent  Cumulative Percent  
Valid  Extremely good  50  16.3  17.2  17.2  
Very good  112  36.5  38.6  55.9  
Good  88  28.7  30.3  86.2  
Average  29  9.4  10.0  96.2  
Bad  7  2.3  2.4  98.6  
Very bad  3  1.0  1.0  99.7  
Extremely bad  1  0.3  0.3  100.0  
Total  290  94.5  100.0    
Missing        System  17  5.5      
Total  307  100.0      
   Source: Primary Data   
  
5.7.5 Packaging Typography   
Table 5.21 presents the perceptions of respondents on the packaging typography of herbal 
medicines sold at the OTC medicine market in Kumasi Metropolis. The results indicate that  
17.7% (50), 35.0% (99) and 29.7% (84) of the participants are of the opinion that the packaging 
typography is extremely good, very good and good respectively. However, 13.4% of the 
participants are of view that packaging typography is neither good nor bad, while 3.5% (10) 
and 0.7% (2) consider it as bad and very bad respectively. Overall, the results demonstrate that 
a greater majority (82.3%) of the participants perceived the packaging typography as good 
quality, whilst 4.2% are of the view that it is bad.  
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Table 5. 21: Respondents` Perception of Packaging Typography  
Responses  Frequency  Percent  Valid Percent  Cumulative Percent  
Valid  Extremely good  50  16.3  17.7  17.7  
Very good  99  32.2  35.0  52.7  
Good  84  27.4  29.7  82.3  
Average  38  12.4  13.4  95.8  
Bad  10  3.3  3.5  99.3  
Very bad  2  .7  .7  100.0  
Total  283  92.2  100.0    
Missing      System  24  7.8      
Total  307  100.0      
Source: Primary Data   
  
5.7.6 Packaging Shape and Size  
Table 5.22 shows the results of participants` impression on packaging shape and size of plant 
medicines distributed at OTC medicine market in Kumasi. The results show that, out of a total 
of 288 respondents, 18.4% (53), 30.9% (89) and 24.3% (70) consider the packaging shape and 
size as extremely good, very good and good respectively. However, 22.9% (66) of the 
respondents are of the opinion that the packaging shape and size is neither good nor bad 
whereas 3.1% (9) and 0.3% (1) perceive it as bad and very bad respectively. Overall, a greater 
majority (73.6%) of the participants are of the view that the packaging shape and size of herbal 
medicines sold in the OTC pharmaceutical market in Kumasi is of good quality whilst 3.4% 
perceive it as bad.     
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Table 5. 22: Respondents` Perception of Packaging Shape and Size  
Responses Frequency  Percent  Valid Percent  Cumulative Percent  
Valid  Extremely good  53 17.3 18.4 18.4 
 Very good  89 29.0 30.9 49.3 
Good  70 22.8 24.3 73.6 
Average  66 21.5 22.9 96.5 
Bad  9 2.9 3.1 99.7 
Very bad  1 0.3 0.3 100.0 
Total  288 93.8 100.0  
Missing     System  19 6.2   
Total  307 100.0   
Source: Primary Data   
  
5.7.7 Overall Packaging of Herbal Medicine  
Table 5.23 below indicates the impressions of the participants on the overall packaging of 
herbal medicines in the OTC drug market in Kumasi. The results reveal that 25.5% (74), 37.6% 
(109), 25.9% (75) and 9.0% (26) of the respondents are of view that the packaging of plant 
medicines distributed at Kumasi are extremely good, very good, good and neither good nor bad 
respectively. However, 1.4% (4) and 0.7% (2) are of the opinion that packaging of herbal 
medicines is bad and very bad respectively. The results further demonstrate that majority 
(89.0%) of participants perceive the packaging of plant medicines as good quality whilst 2.1% 
are of the view that the packaging design of herbal medicines is bad in the OTC pharmaceutical 
market in Kumasi   
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Table 5. 23: Respondents` Perception of Overall Packaging of Herbal Medicines  
Responses  Frequency  Percent  Valid Percent  Cumulative Percent  
Valid  Extremely good  74  24.1  25.5  25.5  
Very good  109  35.5  37.6  63.1  
Good  75  24.4  25.9  89.0  
Average  26  8.5  9.0  97.9  
Bad  4  1.3  1.4  99.3  
Very bad  2  0.7  0.7  100.0  
Total  290  94.5  100.0    
Missing        System  17  5.5      
Total  307  100.0      
   Source: Primary Data   
  
5.8 Relationship between Packaging and Brand Equity   
Here, the purpose is to investigate the relationship between packaging, brand equity dimensions 
and overall brand equity in the OTC pharmaceutical market. For this purpose, exploratory 
factor analysis and structural equation modelling were conducted.      
 
 5.8.1 Factor Analysis    
Exploratory factor analysis was undertaken to ascertain whether the test responses would 
produce packaging, brand loyalty, brand associations, overall brand equity, brand awareness 
and perceived quality by each test instrument loading on its respective latent variable as it is 
purported.   
  
5.8.1.1 KMO and Bartlett's Test of Sphericity    
The results of the Bartlett`s Test of Sphericity as shown in Table 5.24 reveal that the correlation 
matrix has significant correlations (X2 = 5812.912, df = 465, p < 0.001) with all the variables 
in this sample. Moreover, the KMO of Sampling Adequacy is 0.927 which is higher than 0.70, 
indicating satisfactory level of overall sampling adequacy (Hair et al., 2010). These results 
offer a reasonable basis for the factor analysis in this sample.   
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Table 5. 24: Results of KMO and Bartlett's Test of Sphericity  
KMO and Bartlett's Test   
Kaiser-Meyer-Olkin Measure of Sampling Adequacy.  0.927  
Bartlett's Test of Sphericity  Approx. Chi-Square  5812.912  
df  465  
Sig.  0.000  
Significant at p < 0.001 level  
 
Source: Primary Data  
  
5.8.1.2 Results of Rotated Factor Loadings   
Table 5.25 below provides the summary results of exploratory factor loadings which show the 
relationship between the latent variables and their respective indicators. This was done to allow 
for the further analysis of the constructs and their validity. A total of 31 indicator variables 
were subject to the exploratory factor analysis. However, the factor analysis through maximum 
likelihood factoring with oblimin rotation produced six (6) latent constructs and 22 respective 
test responses as shown in Table 5.36 below. The findings of the pattern matrix are exhibited 
in Table 5.25 below which demonstrate that most of the indicators loaded above 0.30, ranging 
from 0.305 to 0.986 which provided an admissible factor structure (Hair et al., 2010). This 
implies that indicator variables that loaded less than 0.30 were dropped as indicated in the 
research. Both oblique and orthogonal rotational procedures produced similar results after 
several attempts to obtain a simple factor solution.   
  
Table 5.25 and Table 5.26 show the results of latent variables and their respective indicators 
from the exploratory factor analysis. It can be observed from Table 5.25 and Table 5.26 that 
two test instruments loaded on component 1, five on component 2, six on component 3, three 
on component 4, three on component 5 and three on component 6. The six latent constructs 
extracted explained a total of 64.94% of the variance in the explored phenomenon in this 
sample. The six factors extracted were identified with names based on the theory. Furthermore, 
all the corrected item-total correlations coefficients are higher than 0.30, which range from 
0.506 to 0.837, suggesting that the observed items correlate well with the summated score 
(Joiner, Pfaff, & Acres, 2002). Factors 1, 2, 3, 4, 5 and 6 are perceived quality, overall brand 
equity, packaging, brand awareness, brand loyalty and brand association respectively.   
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Table 5. 25: Results of the Factor Loadings of Packaging and Brand Equity  
  Pattern Matrix      
Test  
Items   
  Factor      
Perceived  
Quality  
Factor 1  
Brand  
Equity  
Factor 2  
Packaging  
Factor 3  
Brand  
Awareness  
Factor 4  
Brand  
Loyalty  
Factor 5  
Brand  
Association  
Factor 6  
Corrected  
Item-Total  
Correlation  
PQ2  0.986  ----  ----  ----  ----  ----  0.739  
PQ1  0.552  ----  ----  ----  ----  ----  0.739  
PE2  ----  0.770  ----  ----  ----  ----  0.672  
PE1  ----  0.749  ----  ----  ----  ----  0.635  
PE3  ----  0.600  ----  ----  ----  ----  0.722  
PE4  ----  0.413  ----  ----  ----  ----  0.703  
PE5  ----  0.408  ----  ----  ----  ----  0.837  
P3  ----  ----  0.796  ----  ----  ----  0.653  
P5  ----  ----  0.713  ----  ----  ----  0.729  
P4  ----  ----  0.699  ----  ----  ----  0.623  
P1  ----  ----  0.559  ----  ----  ----  0.620  
P2  ----  ----  0.538  ----  ----  ----  0.573  
P6  ----  ----  0.468  ----  ----  ----  0.559  
A5  ----  ----  ----  0.700  ----  ----  0.610  
A4  ----  ----  ----  0.531  ----  ----  0.635  
A3  ----  ----  ----  0.362  ----  ----  0.568  
PL4  ----  ----  ----  ----  0.458  ----  0.643  
PL5  ----  ----  ----  ----  0.428  ----  0.679  
PL2  ----  ----  ----  ----  0.305  ----  0.644  
PAS1  ----  ----  ----  ----  ----  0.589  0.539  
PAS2  ----  ----  ----  ----  ----  0.545  0.599  
PAS3  ----  ----  ----  ----  ----  0.309  0.506  
Extraction Method: Maximum Likelihood  
Source: Primary Data  
Table 5. 26: Packaging and Brand Equity Constructs and their Indicators  
Packaging   
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P1  The packaging offers better protection for this brand  
P2  The packaging preserves the contents of this brand  
P3  The packaging provides enough information about this brand  
P4  The packaging of this brand makes this brand environmentally-friendly  
P5  The packaging of this brand makes this brand convenient to use  
P6  This brand`s packaging makes this brand portable  
Perceived Quality  
PQ1  The packaging of this brand makes this brand function well     
PQ2  The packaging of this brand makes this brand very reliable  
Brand Association   
PAS1  This brand`s packaging makes this brand offer good value for money  
PAS2  This brand`s packaging makes me like the image of this brand  
PAS3  The packaging of this brand makes the image of this brand unique compared to its competing 
brands    
Brand Awareness  
A5  I am aware of the packaging of this brand   
A3  Some characteristics of this brand`s packaging come to my mind quickly  
A4  When I think about this brand, the first thing that comes to my mind is its packaging  
Brand Equity   
PE1  This brand`s packaging gives me reason to buy this brand instead of any other brand, even if 
they are the same in quality or price  
PE2  The packaging of this brand would make me prefer to buy this brand, even if another brand 
has the same features as this brand  
PE3  The packaging of this brand makes this brand more than a product to me  
PE4  This brand`s packaging makes it seems smarter to purchase this brand, if another brand is not 
different from this brand in any way  
PE5  The packaging of this brand makes me prefer to buy this brand, if there is another brand as 
good as this brand  
Brand Loyalty   
PL2  The packaging of this brand would make me recommend this brand to my friends  
PL4  The packaging of this brand makes me loyal to this brand  
PL5  I will keep on buying this brand as long as I am satisfied with the packaging of this brand  
 
5.8.2 Structural Equation Modelling   
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Here, the hypothesized relationship between packaging, brand equity dimensions and overall 
brand equity were analysed by using structural equation modelling. As recommended in the 
literature, the measurement model was analysed before the structural model (Byrne, 2016; 
Anderson & Gerbing, 1988).   
 
5.8.2.1 Results of Confirmatory Factor Analysis  
The measurement model was carried out through the confirmatory factor analysis (CFA) to 
confirm the relationship between the unobserved factors and the observed factors provided by 
the exploratory factor (EFA). The latent variables are overall brand equity, brand awareness, 
packaging, brand association, brand loyalty and perceived quality with their associated 
indicators are depicted in the Table 5.27 and Table 5.28.  
 
In this analysis, packaging formatively-measured construct and in order to conduct an analysis 
that involves formatively-measured construct through the use covariance-based structural 
equation model, the model must be identified to produce consistent parameter estimates and 
interpretable fit indices (Diamantopoulos, 2011). For this purpose, the test items of packaging 
were identified by constraining the residual error variance for packaging to be equal to one. In 
addition, to resolve the indeterminacy associated with the construct level error term, four 
reflectively-measured constructs (brand awareness, association, loyalty and perceived quality) 
were specified as outcomes of the packaging (Jarvis, Mackenzie & Podsakoff, 2003; 
Diamantopoulos, 2011; MacCallum & Browne, 1993). 
  
In order to purify the model to achieve construct validity and better model fit, standardized 
residual values of pairs of measured items above 2.58 were deleted from the model as they 
reflect greater level of error in measurement specification (Hair et al., 2010; Byrne, 2016). 
Moreover, each observed variable with factor loadings below 0.50 were dropped from the 
model with the view to achieving convergent validity (Hair et al., 2010). Hence, the following 
test responses were discarded: PAS3 of brand association, PE1 and PE2 of overall brand equity 
and P1, P3 and P6 of packaging.   
 
The findings of the confirmatory factor analysis in Table 5.28 show that 16 indicators loaded 
on their purported latent constructs in this model. The statistical significance of the relationship 
between packaging, overall brand equity, brand association, brand loyalty, brand awareness 
and their observed variables is determined at the two-tailed significance level of p < 0.001 and 
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C.R  ≥ 2.58  (Hair et al., 2010). Furthermore, although the findings in Table 5.27 display both 
standardized and unstandardized estimates, a standardized regression estimate was used to 
present the results in this sample.  
  
The results in Table 5.27 and Table 5.28 reveal that three indicators loaded on brand awareness, 
three on packaging, three on brand loyalty, three on overall brand equity, two on brand 
association and two on perceived quality and were all statistically significant at p < 0.001 level. 
These results are in line with past studies (Pappu et al., 2005; Gil et al., 2007) where a minimum 
of two indicators were used to perform a CFA.    
  
This shows that the measurement model is satisfactory in explaining the relationship between 
the six constructs and their observed variables in the model. The results also provide support 
for convergent and discriminate validity of the latent factors as each test item loaded on its 
constructs and their factor loadings are statistically significant (Anderson & Gerbing, 1988; 
Hair et al., 2010; Kline, 2005). Furthermore, all the individual standardized factor loadings 
were higher and above 0.50, ranging between 0.575 and 0.893, which also established a test of 
convergent validity (Kline, 2005; Hair et al., 2010).   
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Table 5. 27: Results of Confirmatory Factor Analysis of Packaging and Brand Equity  
 Structural Relations  Unstandardized 
Estimate  
Standardized 
Estimate  
S.E.  
  
C.R.  
  
P-value   
  
A3 <--- Brand awareness 1.000  .670     
A4 <--- Brand awareness 1.088  .719  .104  10.429  ***  
A5 <--- Brand awareness 1.263  .787  .114  
  
11.085  
  
***  
  
PE5 <--- Brand equity 1.000  .746     
PE4 <--- Brand equity 1.093  .827  .079  13.861  ***  
PE3 <--- Brand equity .913  .766  .071  
  
12.892  
  
***  
  
P5 <--- Packaging 1.000  .840     
P4 <--- Packaging .918  .712  .082  11.215  ***  
P2 <--- Packaging .590  .575  .064  
  
9.266  
  
***  
  
PL2 <--- Brand loyalty 1.000  .740     
PL4 <--- Brand loyalty 1.152  .768  .092  12.570  ***  
PL5 <--- Brand loyalty 1.153  .783  .090  
  
12.794  
  
***  
  
PAS1 <--- Brand association 1.000  .698     
PAS2 <--- Brand association .970  .745  .103  
  
9.459  
  
***  
  
PQ1 <--- Perceived quality 1.000  .893     
PQ2 <--- Perceived quality .854  .828  .057  14.970  ***  
 ***Means p < 0.001 at two-tailed significance level.  All factor loadings are significant at 
p < 0.001 level  
 
Source: Primary Data  
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Table 5. 28: Packaging and Brand Equity Constructs and their Indicators  
 Packaging   
P2  The packaging preserves the contents of this brand  
P4  The packaging of this brand makes this brand environmentally-friendly  
P5  The packaging of this brand makes this brand convenient to use  
 Brand Awareness  
A3   Some characteristics of this brand`s packaging come to my mind quickly  
A4  When I think about this brand, the first thing that comes to my mind is its packaging  
A5  I am aware of the packaging of this brand   
 Perceived Quality   
PQ1  The packaging of this brand makes this brand function well          
PQ2  The packaging of this brand makes this brand very reliable  
 Brand Association  
PAS1  This brand`s packaging makes this brand offer good value for money  
PAS2  This brand`s packaging makes me like the image of this brand  
Brand Loyalty   
PL2  The packaging of this brand would make me recommend this brand to my friends  
PL4  The packaging of this brand makes me loyal to this brand  
PL5  I will keep on buying this brand as long as I am satisfied with the packaging of this brand  
Brand Equity  
PE3  The packaging of this brand makes this brand more than a product to me  
PE4  This brand`s packaging makes it seems smarter to purchase this brand, if another brand is 
not different from this brand in any way  
PE5  The packaging of this brand makes me prefer this brand, even if there is another brand as 
good as this brand   
Source: Primary Data  
  
5.8.2.2 Measurement Model Path Diagram     
The path diagram is a visual diagram that presents the relationship between latent factors and 
their underlying observed items, including the relationships among the latent factors.    
Figure 5.1 below show the path diagram of the measurement model of packaging and overall 
brand equity. In the path diagram, the indicator items are shown by rectangles and the common 
factors are depicted by ellipse, whilst the letter “e” indicates the measurement error. The 
structural relationship between unobservable variables and indicators are shown by single 
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headed arrows whilst the correlations among the latent constructs are exhibited by double 
headed arrows.  
The path diagram in Figure 5.1 below also shows the standardized regression weights of the 
structural relationships among the indicators and latent variables, and the correlations among 
the common factors. In addition, the values close to the rectangles depict the squared multiple 
correlations of the indicator items.   
  
 
Figure 5. 1: Path Diagram of Measurement Model of Packaging and Brand Equity    
  
Source: Developed by the Researcher  
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5.8.2.3 Model Fit of Measurement Model of Packaging and Brand Equity   
Floyd and Widaman (1995) highlighted that the measurement model must be investigated to 
ascertain the plausibility of the model through goodness-of-fit indices. Specifically, goodness-
of-fit indexes are employed to evaluate the acceptability or otherwise of a model. In this 
analysis, the goodness-of-fit statistics and fit indexes were employed to evaluate the 
measurement model (Hu & Bentler, 1999).    
  
Table 5.29 below shows the summarized estimates of goodness-of-fit indices of the 
measurement model of the analysis. The results indicate that the Chi-square test (X2) is 
significant (X2 = 200.075, df = 89) at p < 0.001 level, showing that the measurement model 
does not exactly represent the sample data. However, the Chi-square statistic has been 
recognised to have severe limitations for determining the overall goodness-of-fit of a model. It 
has been asserted that the Chi-square statistics is directly related to sample size and hence, any 
model with sample size large enough is virtually rejected as a false model (Kline, 2005; Hair 
et al., 2010). Consequently, alternative model fit indexes have been suggested to evaluate this 
model (ibid).   
  
Table 5.30 shows the suggested model fit indices for evaluating the model fit of confirmatory 
factor analysis in this sample. The findings reveal that all the fit indices are greater than the 
proposed criteria to evaluate the six-factor measurement model and hence, the model is said to 
be satisfactory.   
  
The model has a Normed Chi-square (CMIN/DF) value of 2.248 which is less than three (3) 
showing a good model fit (Hair et al., 2010; Kline, 2005). The Goodness - of -Fit Index (GFI), 
Adjusted Goodness-of-Fit Index (AGFI) and Root Mean Residual (RMR) have values of 0.925, 
0.886 and 0.044 respectively, which show a satisfactory fit of the model (Hair et al., 2010). 
The Standard Root Mean Residual (SRMR) and Root Mean Square Error of Approximation 
(RMSEA) are 0.039 and 0.064, which are both less than 0.08 (Brown & Cudeck, 1993; Hu & 
Bentler, 1999).   
  
Furthermore, the Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), Normed Fit Index 
(NFI) and Incremental Fit Index (IFI) are 0.952, 0.935, 0.917 and 0.952 respectively. These 
estimates are higher than the acceptable value of 0.90 or are close to 0.95 (Hu & Bentler, 1999; 
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Hair et al., 2010). These findings show that the measurement model fitted well with the data 
and therefore provides an admissible solution to the structural model.  
 
Table 5. 29: Model Fit Summary of Confirmatory Factor Analysis   
CMIN  
Model  NPAR  CMIN  DF  P  CMIN/DF  
Default model  47  200.075  89  .000  
  
2.248  
Saturated model  136  .000  0    
Independence model  16  2413.404  120  .000  20.112  
RMR, GFI  
Model  RMR  GFI  AGFI  PGFI  
Default model  .044  .925  .886  
  
.606  
  
Saturated model  .000  1.000    
Independence model  .449  .283  .187  .250  
Baseline Comparisons  
Model  NFI  
Delta1  
RFI 
rho1  
IFI  
Delta2  
TLI rho2  CFI  
Default model  .917  .888  
  
.952  .935  
  
.952  
Saturated model  1.000   1.000   1.000  
Independence model  .000  .000  .000  .000  .000  
Parsimony-Adjusted Measures  
Model  PRATIO  PNFI  PCFI  
Default model  .742  .680  .706  
Saturated model  .000  .000  .000  
Independence model  1.000  .000  .000  
RMSEA  
Model  RMSEA  LO 90  HI 90  PCLOSE  
Default model  .064  .052  .076  .028  
Independence model  .250  .241  .259  .000  
  
        
       Source: Primary Data   
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Table 5. 30: Criteria Used to Assess the Measurement Model Fit  
Goodness-of-Fit Indices   Acronym  Estimates of  
Fit Indices  
Suggested Value  
of Good Fit  
  
        References  
Goodness-of-Fit Statistics          
Chi-Square Degree of  
Freedom Ratio/Normed Chi-
Square  
X2/df  
  
(CMIN/DF)  
  
2.248  
  
1 to 3  
1 to 5  
Hair et al.(2010),   
Kline (2005),   
Hooper et al. (2008)  
Absolute Fit Indices          
Root Mean Square Error of 
Approximation  
  
  
RMSEA  
  
0.064  
  
  
< .60  
< .50 < 0.08  
Hu and Bentler (1999),  
Brown and Cudeck  
(1993)  
Standardized Root Mean  
Residual  
  
SRMR  
0.039  
  
  
< .08  
Hu and Bentler (1999)  
  
Goodness-of-Fit Index    
GFI  
  
0.925  
  
> .90  
Hair et al. (2010), 
Hooper et al. (2008)  
Incremental/Relative Fit 
Indices  
        
Comparative Fit Index  CFI  0.952  > .90 or .95  Hu and Bentler (1999)  
Tucker-Lewis Index  TLI  0.935  > .90 or 0.95  Hu and Bentler (1999)  
Normed Fit Index  NFI  0.917  > .90 or 0.95  Hu and Bentler (1999)  
Incremental Fit Index   IFI  0.952  >.90  Hair et al. (2010)  
  
 Source: Compiled by the Researcher  
 
5.8.3 Path Estimates of Packaging and Overall Brand Equity   
The structural model relates to the structural relations among the latent variables as indicated 
in the literature. The results of the structural model are shown in Table 5.31 below. In addition, 
the results in Table 5.31 exhibit both standardized and unstandardized estimates but 
standardized regression weights were used to present the results in this data set. The test results 
of the proposed hypotheses are statistically significant at either p < 0.05 or p < 0.01 at 1.96     
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5.8.3.1 Objective Two: To Examine the Brand Equity of Herbal Medicines in the OTC 
Drug Market in Kumasi.    
Here, the study examined the influence of brand equity dimensions on the overall brand equity 
of herbal medicines in the OTC medicine market. Consequently, four hypotheses were 
stipulated based upon the literature reviewed in Chapter Three as shown in Table 5.31. In this 
study, brand awareness, brand loyalty, brand association and perceived quality are independent 
variables whilst overall brand equity is the dependent variable.  
 
 H1b: Brand Awareness Positively and Significantly Influence Overall Brand Equity 
The results of structural model in Table 5. 31 demonstrate that brand awareness (ß = 0.331, t = 
3.659, p = 0.000) positively influences overall brand equity at p < 0.001 level.  These results 
support H1b.  
 
 H2b: Brand Association Positively and Significantly Influence Overall Brand Equity 
Furthermore, the results of the structural model in Table 5.31 indicate that brand association (ß 
= 0.273, t = 3.182, p = 0.001) is statistically significant and directly related to overall brand 
equity at p < 0.001 level and confirm H2b.   
 
 H3b: Perceived Quality Positively and Significantly Influence Overall Brand Equity 
Additionally, the results of the structural model in Table 5.31 reveal that the relationship 
between perceived quality (ß = -0.061, t = -0.822, p = 0.411) and overall brand equity is not 
statistically significant at p < 0.001 two tailed level, and therefore H3b is rejected. 
 
 H4b: Brand Loyalty Is Positively and Significantly Influence Overall Brand Equity 
Finally, the test results in Table 5.31 show that brand loyalty (ß = 0.451, t = 4.870, p = 0.000) 
is statistically significant and positively related to overall brand equity at p < 0.001 level and 
support H4b.  The results of structural model further show brand loyalty (ß = 0.451) has greater 
influence on overall brand equity than any other dimensions of brand equity.     
 
5.8.3.2 Objective Three: To Examine the Influence of Packaging on Brand Awareness in 
the OTC Market in Kumasi. 
The results of the structural model in Table 5.31 show that packaging (ß = 0.826, t = 8.256, p 
= 0.000) is statistically significant and positively influences brand awareness at p < 0.001 level 
and support H1a. 
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5.8.3.3 Objective Four: To Examine the Influence of Packaging on Brand Associations 
in the OTC Drug Market in Kumasi.  
The findings of the structural model in Table 5.31 also reveal that packaging (ß = 0.753, t = 
7.608, p = 0.000) is positively related to brand association at p < 0.001 level and confirms H2a.   
  
5.8.3.4 Objective Five: To Examine the Influence of Packaging on Perceived Quality in 
the OTC Drug Market in Kumasi.  
The results of the structural model in Table 5.31 demonstrate that packaging (ß = 0.784, t = 
9.606, p = 0.000) is statistically significant and positively related to perceived quality at p < 
0.001 level and support H3a.  
  
5.8.3.5 Objective Six: To Examine the Influence of Packaging on Brand Loyalty in the 
OTC Drug Market in Kumasi.  
Furthermore, the results of the structural model in Table 5.31 show that packaging (ß = 0.838, 
t = 8.968, p = 0.000) is statistically significant and positively related to brand loyalty at p < 
0.001 level and confirm H4a. The results of structural model further show that packaging (ß = 
0.838) has a greater influence on brand loyalty than any other brand equity dimensions.    
  
In the structural model in this sample, however, no direct path between packaging and overall 
brand equity was specified. Instead, as conceptualized in this study, overall brand equity is 
indirectly influenced by packaging through the mediated dimensions of brand equity. In order 
to ascertain the indirect (mediated) effect of packaging on overall brand equity in this analysis, 
bootstrap was performed with bootstrap samples of 1000 at biased-corrected confidence 
interval of 95%. The results indicate that packaging (ß = 0.809, t = 7.516, p = 0.004) has a 
significant indirect effect on overall brand equity at p < 0.001 two-tailed level.  
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Table 5. 31: Path Estimates of Packaging and Overall Brand Equity  
Structural Relations  Unstandardized 
Estimate  
Standardized 
Estimate  
S.E.  C.R.  P-value   
Brand association  <--  Packaging   .873  .753  .115  7.608  ***  
Brand awareness  <-- Packaging  .997  .826  .121  8.256  ***  
Brand loyalty  <-- Packaging  1.020  .838  .114  8.968  ***  
Perceived quality  <-- Packaging  1.297  .784  .135  9.606  ***  
Brand equity  <-- Brand association  .330  .273  .104  3.182  .001  
Brand equity  <-- Brand awareness  .385  .331  .105  3.659  ***  
Brand equity  <-- Perceived quality  -.051  -.061  .063  -.822  .411  
Brand equity  <-- Brand loyalty  .519  .451  .107   4.870   ***  
  
A3  <-- Brand awareness  1.000  .662     
A4  <-- Brand awareness  1.106  .722  .107  10.331  ***  
A5  <-- Brand awareness  1.284  .790  .117  
  
10.945  
  
***  
  
PE5  <-- Brand equity  1.000  .746     
PE4  <-- Brand equity  1.092  .827  .079  13.888  ***  
PE3  <-- Brand equity  .912  .766  .071  
  
12.925  
  
***  
  
P5  <-- Packaging  1.000  .619     
P4  <-- Packaging  .857  .489  .089  9.588  ***  
P2  <-- Packaging  .693  .497  .094  
  
7.350  
  
***  
  
PL2  <-- Brand loyalty  1.000  .740     
PL4  <-- Brand loyalty  1.161  .773  .092  12.570  ***  
PL5  <-- Brand loyalty  1.144  .776  .091  
  
12.611  
  
***  
  
PAS1  <-- Brand association  1.000  .682     
PAS2  <- Brand association  1.017  .763  .109  
  
9.291  
  
***  
  
PQ1  <- Perceived quality  1.000  .901     
PQ2  <-- Perceived quality  .838  .820  .058  14.536  ***  
 ***Means p < 0.001 at Two-tailed Significance Level  
 
 Source: Primary Data   
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5.8.4 Structural Model Fit Indices of Packaging and Overall Brand Equity   
The goodness-of-fit statistics and fit indices were utilized to evaluate the structural model (Hu 
& Bentler, 1999). Table 5.32 below illustrates the summarized results of fit indices of the 
structural model, while Table 5.33 exhibits the indicators for evaluating these model fit indices.   
However, in order to generate better model fit measures of the path analysis in this sample, test 
items P4 and P5 were modified as exhibited in Figure 5.2.  
  
The Chi-square test (X2) is significant (X2 = 240.948, df = 95) at p < 0.001 level, indicating that 
the structural model does not replicate the sample data. The Chi-square statistic has been, 
however, acknowledged to have some degree of limitations for assessing the overall goodness-
of-fit of hypothesized structure and observed data.   
  
It has been concluded that the Chi-square statistic is sensitive to sample size and for that matter 
almost all models with large sample size are often rejected as false (Kline, 2005; Hair et al., 
2010). For this reason, alternative model fit indexes have been suggested to evaluate the fitness 
of this model in Table 5.32.  
  
The results of fit measures reveal that the model has a CMIN/DF of 2.536 which is less than 3, 
suggesting a better model fit (Hair et al., 2010; Kline, 2005). The RMR, GFI and AGFI are  
0.054, 0.909 and 0.870 respectively, showing reasonable fit of the data (Hair et al., 2010).   
  
The SRMR has a value of 0.049 which is less than the recommended value of 0.08 (Hu &  
Bentler, 1999) and RMSEA is 0.071 which is also less than the proposed limit of 0.08 (Brown 
& Cudeck, 1993; Hu & Bentler, 1999).  Lastly, the CFI, TLI, IFI and NFI are 0.936, 0.920, 
0.937 and 0.900 respectively. These findings demonstrate that the model fitted well with the 
data and is therefore acceptable (Hu & Bentler, 1999; Hair et al., 2010).    
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Table 5. 32: Path Model Fit Summary of Packaging and Overall Brand Equity   
            CMIN  
Model  NPAR  CMIN  DF  P  CMIN/DF  
Default model  41  240.948  95  .000  
  
2.536  
  
Saturated model  136  .000  0    
Independence model  16  2413.404  120  .000  20.112  
             RMR, GFI  
Model  RMR  GFI  AGFI  PGFI  
Default model  .054  .909  .870  
  
.635  
  
Saturated model  .000  1.000    
Independence model  .449  .283  .187  .250  
             Baseline Comparisons  
Model  NFI  
Delta1  
RFI 
rho1  
IFI  
Delta2  
TLI 
rho2  
CFI  
Default model  .900  .874  
  
.937  .920  
  
.936  
Saturated model  1.000   1.000   1.000  
Independence model  .000  .000  .000  .000  .000  
           Parsimony-Adjusted Measures  
Model  PRATIO  PNFI  PCFI  
Default model  .792  .713  .741  
Saturated model  .000  .000  .000  
Independence model  1.000  .000  .000  
           RMSEA  
Model  RMSEA  LO 90  HI 90  PCLOSE  
Default model  .071  .060  .082  .001  
Independence model  .250  .241  .259  .000  
 
    
    Source: Primary Data   
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Table 5. 33: Assessing the Structural Model Fit of Packaging and Brand Equity   
Goodness-of-Fit  Indices    
Acronym  
Actual Values 
of Fit Indices  
Suggested Value of  
Goodness-of-  Fit 
Measures 
  
        References  
Goodness-of-Fit Statistics          
Chi-square Degree of Freedom 
Ratio/ Normed Chi-Square  
X2/df  
  
(CMIN/DF)  
2.536    
1 to 3  
1 to 5  
Hair et al. (2010),  
Kline (2005),   
Hooper et al. (2008)  
Absolute Fit Indices          
Root Mean Square Error of 
Approximation  
  
  
RMSEA  
  
  
.071  
  
< .060  
< .050 to 0.08  
Hu and Bentler (1999),  
Brown and Cudeck 
(1993)  
Standardized Root Mean  
Residual  
  
SRMR  
  
.049  
  
  
< .08  
Hu and Bentler (1999)  
  
Goodness-of-Fit Index    
GFI  
  
.909  
  
> .90  
Hair et al. (2010),  
Hooper et al. (2008)  
Incremental/Relative Fit 
Indices  
        
Comparative Fit Index  CFI  .936  > .90 or .95  Hu and Bentler (1999)  
Tucker-Lewis Index  TLI  
  
  
.920  
> .90 or 0.95  Hu and Bentler (1999)  
Incremental Fit Index   IFI  .937  >.90  Hair et al. (2010)  
Normed Fit Index  NFI  .900  >  .90  Hu and Bentler (1999)  
 
 Source: Compiled by the Researcher   
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5.8.5 Structural Model Path Diagram of Packaging and Overall Brand Equity     
Figure 5.2 below depicts the path diagram of structural model which shows the relationship 
between packaging and overall brand equity. The path diagram provides a visual illustration of 
the relationships among indicator items and unobserved factors, and the relationship among 
common factors.   
  
The indicator items are enveloped by rectangles, the latent variables are depicted by ellipses or 
circles and “e” relates to measurement errors. The structural relationship is shown by one-way 
arrows whilst correlations among common factors are represented by two-way arrows.   
  
The path diagram in Figure 5.2 below also reveals the standardized estimates of the structural 
relationships among the unobserved factors and common factor as well as the relationship 
between the latent variables. Moreover, the values close to the rectangles indicate the squared 
multiple correlations of the indicator items.   
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Figure 5. 2: Path Diagram of Structural Model of Packaging and Brand Equity  
       
              Source: Developed by the Researcher   
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5.9 Summary Results of Hypotheses Testing   
This section provides the summary of the test results of the hypotheses proposed under each 
objective of the study.   
 
5.9.1 Objective Two: To Examine the Brand Equity of Herbal Medicines in the OTC Drug 
Market    
Here, the study investigated the relationship between brand equity dimensions and the overall 
brand equity of herbal medicines in the OTC medicine market. As a result, four hypotheses 
were stipulated as shown in Table 5.34. The results show that three out of the four path 
estimates were statistically significant. All the fit indices also supported the results of the path 
analysis in this sample.   
  
The summarised empirical findings of the hypotheses are shown in Table 5.34. It can be 
observed in Table 5.34 that all the hypotheses tested in this sample are fully supported. The 
overall findings of the relationship between the dimensions of brand equity and brand equity 
are summarized in a conceptual model in Figure 5.3 below.   
  
The results show that brand awareness (ß = 0.331, p < 0.001) significantly contributes to 
support overall brand equity. Likewise, brand association (ß = 0.273, p = 0.001) and brand 
loyalty (ß = 0.451, p < 0.001) are significant and directly related to brand equity. These findings 
confirm H1b, H2b and H4b. However, the relationship between perceived quality (ß = -0.061, 
p = 0.411) and overall brand equity is not statistically significant and hence, H3b was rejected.   
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Table 5. 34: Significant Relationship between Brand Equity and its Dimensions 
                  Hypotheses    Path      S.E    t- value   p- value   Results    
H1b:   
  
Brand awareness significantly  and  
positively influence overall brand 
equity    
 0.331  0.105  3.659  *** Supported  
H2b:   
  
Brand association significantly and 
positively influence overall brand 
equity   
 0.273 0.104  3.182 0.001 Supported  
H3b:   
  
Perceived quality significantly  and 
positively influence overall brand 
equity   
 -0.061   0.063  -0.822 0.411 Unsupported   
H4b:   
  
Brand loyalty significant and positively  
influence overall brand equity  
0.451  0.107    4.870  
 
***  
 
Supported   
***Means p < 0.001 at Two-tailed Significance Level       
         
        Source: Primary Data  
 
 
5.9.2 Relationship between Packaging and Brand Equity Dimensions 
Moreover, the research examined the influence of packaging on brand equity dimensions in the 
OTC pharmaceutical market. The study also employed the dimensionality of Aaker`s (1996) 
CBBE model to investigate the significant relationship between packaging and brand equity 
dimensions in OTC market in Kumasi Metropolis.   
  
In this sample, four hypotheses were posited and later tested. The summarised test results in 
this data set are presented in Table 5.35 and Figure 5.3 below. It can be observed in Table 5.35 
that all the four hypotheses in this sample are fully supported. All the fit measures also 
supported the results of the structural model as exhibited in Table 5.36 below. The results of 
the relationship between packaging and overall brand equity are summarized in the context of 
study`s conceptual model in Figure 5.3 below.   
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5.9.2.1 To Examine the Influence of Packaging on Brand Awareness in the OTC Drug 
Market   
The test results show that packaging (ß = 0.826, p < 0.001) positively influences brand 
awareness which confirms H1a.   
 
5.9.2.2 To Examine the Influence of Packaging on Brand Associations in the OTC 
Medicine Market 
The test results also show that packaging (ß = 0.753, p < 0.001) significantly influences brand 
association which provides support for H2a. 
  
5.9.2.3 To Examine the Influence of Packaging on Perceived Quality in the OTC Drug 
Market  
The test results reveal that packaging (ß = 0.784, p < 0.001) significantly influences perceived 
quality and confirms H3a.  
  
5.9.2.4 To Examine the Influence of Packaging on Brand Loyalty in the OTC Drug 
Market  
The test results show that packaging (ß = 0.838, p < 0.001) positively influences brand loyalty 
which confirms H4a. Finally, the findings of the bootstrap analysis show that packaging (ß = 
0.809, p < 0.001) has a mediated effect on overall brand equity in the OTC pharmaceutical 
market in Kumasi.  
  
Table 5. 35: Significant Relationship between Packaging and Overall Brand Equity    
                              Hypotheses  Path    S.E   t-value  p-value   Results     
H1a:   
  
Packaging significantly and positively 
influence brand awareness  
0.826  0.121  8.256  ***  Supported  
H2a:   
  
Packaging significantly and positively 
influence  brand association    
0.753  0.115  7.608  ***  Supported   
H3a:   
  
Packaging significantly and positively 
influence perceived quality   
0.784  0.135  9.606  ***  Supported  
H4a:   
  
Packaging significantly and positively  
influence  brand loyalty   
0.838  0.114  8.968  ***  Supported   
 ***Means p < 0.001 at Two-tailed Significance Level                          Source: Primary Data   
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                                                                                                              H1b: ß = 0.331, p < 0.001 
 
               H1a: ß = 0.826, p < 0.001 
                                                                                                           H2b: ß = 0.272, p = 0.001 
                                   H2a: ß = 0.753, p < 0.001  
  
                                  H3a: ß = 0.784, p < 0.001 H3b 
 
                      H4a: ß = 0.838, p < 0.001 
                                                                                                 H4b: ß = 0.451, p < 0.001  
 
Note:                Relationship between Perceived Quality and Overall Brand Equity is 
Insignificant 
 
Figure 5. 3: Research Model of Relationship between Packaging and Brand Equity  
 
Source: Primary Data   
  
Table 5. 36: Summary of Model Fit Measures of Packaging and Brand Equity   
Model Fit Indices  Value  
Normed Chi-square Statistics (X2/df)  2.536  
Goodness-of-fit Index (GFI)  0.909  
Root Mean Square Error of Approximation (RMSEA)  0.071  
Standard Root Mean Residual (RMSR)  0.049  
Comparative Fit Index (CFI)  0.936  
Tucker-Lewis Index (TLI)  0.920  
Incremental Fit Index (IFI)  0.937  
Normed Fit Index (NFI)  0.900  
   Source: Primary Data   
Packaging  
Brand 
Awareness 
Brand             
Association 
Perceived 
Quality 
Brand 
Loyalty 
Overall 
Brand 
Equity  
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5.10 Chapter Summary   
This chapter presents the findings of the study in the light of the research questions and 
objectives. First, the reliability of the test instruments was confirmed through Cronbach alpha 
and composite reliability from the results that emerged from the exploratory factor analysis and 
confirmatory factor analysis. Also, evidence of validity of the latent variables was established 
through the average variance extracted and square root of average variance extracted and 
squared correlations between one construct and any other constructs in this study.  
 
Subsequently, descriptive statistics was used to present the results of the profile of the 
respondents, herbal medicines purchased and the perceptions of packaging of plant medicines 
in the OTC market. The hypotheses proposed in the research were tested by using SEM. The 
structural equation model was conducted in two phases. Initially, a measurement model was 
carried out through confirmatory factor analysis to confirm the results of the exploratory factor 
analysis and also to further evaluate convergent and discriminant validity. The structural model 
was then undertaken to test the relationships among the latent constructs. Seven path estimates 
were statistically significant and provided support for the propositions put forward in the 
research. The ensuing chapter presents the discussions of the main results of the research in 
light of past research findings and the existing literature.  
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CHAPTER SIX 
 
DISCUSSIONS OF THE RESEARCH FINDINGS 
  
6.1 Introduction  
The purpose of the research was to examine the influence of packaging and brand equity of 
plant medicines in the OTC pharmaceutical market. In this regard, the study sought to evaluate 
the customers` perceptions of packaging of herbal medicines in the OTC health care market. 
The study also examined the influence of the dimensions of brand equity on overall brand 
equity of plant medicines in the OTC medicine market.   
The previous chapter highlighted the significant findings of the analysis of the data collected 
from the field to address the research questions with the view to achieving the objectives. The 
chapter also presented the results of the demographics of the respondents, customers` 
perceptions of packaging of herbal medicines, the validity and reliability of the test items and 
the entire hypotheses proposed in the study. All the findings were generated through the use of 
descriptive statistics and structural equation model.   
The focus of the current chapter is to offer discussions of the empirical findings presented in 
Chapter Five. Specifically, this chapter provides the discussions of the findings of individual 
research objectives through the proposed hypotheses in order to draw conclusions and 
recommendations as well as offer suggestions for further research in the final chapter of this 
thesis.  
  
6.2 To Examine Customers` Perceptions of Packaging of Herbal Medicines Sold at the 
OTC Market in Kumasi   
The study sought to examine the customers` perceptions of packaging design elements as well 
as the overall packaging of plant medicines in the OTC market in Kumasi. However, this is in 
respect of the fact that packaging of herbal medicines is perceived to be unappealing and not 
durable in the Ghanaian OTC drug market (Kumah et al., 2015).   
  
The study found that 90%, 84.3%, 84.1%, 83.3%, 73.6% and 86.2% of the customers were 
satisfied with the colour, photography, printed information, typography, size/shape and 
material of packaging of herbal medicines respectively. Overall, 89% of the customers 
perceived plant medicinal products distributed at the OTC drug stores as distinctively 
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packaged. This outcome concurs with existing literature (Kraemer & Wunsch-Vincent, 2016), 
which demonstrate that most traditional herbal medicine manufacturers in Ghana have 
improved their practices by producing assorted herbal medicines, including pills, tablets, 
capsules, creams in tubes, and mixtures in bottles for longer shelf-life using quality packaging 
materials with adequate labelling. This indicates that majority of the herbal medicines 
distributed at the OTC pharmaceutical market are well-packaged. As a result of improvement 
in the packaging among other things, most of the herbal medicines are sold in pharmaceutical 
stores and are recommended by physicians in some hospitals, clinics and health posts 
throughout the country.   
  
However, the study also found that 2.5%, 3.7%, 4.2%, 3.4% and 2.8% of the customers were 
dissatisfied with photography, material, typography, size/shape and printed information 
respectively. Overall, it is only 2.1% of the customers who described the packaging of 
medicinal herbal products as unattractive. This outcome is in line with an earlier author (Aniah, 
2015), who found that doses of crushed, squeezed and pounded herbal medicines were 
measured in cups, spoons, glasses, pinch and lids depending upon the age of the patient, 
physical status, severity of the decease and the experience of the individual healer in the Bongo 
District in Ghana.  
 
This position is supported by Kraemer and Wunsch-Vincent (2016) who noted that, despite 
substantial improvement in packaging design and innovations in the herbal medicine industry, 
there are a number of practitioners who are not ready to embrace innovations to enhance the 
packaging of their products. Poor packaging can adversely affect the competitiveness and 
ultimately, the success of a product in the market. It is therefore important for traditional 
medicine practitioners to design packaging that will not only perform logistic functions but 
also marketing purposes to make substantial impact in the OTC health care market. 
Improvement in packaging of herbal medicines comparable to orthodox medicinal products 
can enhance the image and increase the patronage in the OTC drug market in Ghana.  
   
6.3 To Examine the Brand Equity of Herbal Medicines in the OTC Drug Market    
Here, the study sought to examine the brand equity of herbal medicines in the OTC health care 
market. Since brand equity is a multi-dimensional construct, in order to ascertain the value of 
brands of herbal medicines in the OTC medicine market, the dimensions of Aaker`s (1996) 
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CBBE model was employed. Hence, the research investigated the influence of perceived 
quality, brand awareness, brand loyalty and brand association on the overall brand equity of 
herbal medicines in the OTC drug market. The test results of the hypotheses proposed to 
achieve this objective are discussed below.  
  
 H1b: Brand Awareness Positively and Significantly Influence Overall Brand Equity   
The test results indicate that brand awareness (ß = 0.331, p < 0.01) significantly contributes to 
strengthen the overall brand equity in the OTC medicine market.  This result confirms H1b and 
concurs with the previous research findings (Asif et al., 2015; Panchal et al., 2012) which 
suggest that overall value of a brand is positively influenced by brand awareness. This result 
illustrates that brand awareness is one of the sources of brand equity of herbal medicines in the 
OTC health care market. The data set also lends support to the fact that brand awareness creates 
value for brands of herbal medicines in the OTC pharmaceutical market.  
 
 
The data set suggests that customers can easily notice the brand they buy among competitive 
brands, know what the brand looks like and hence, they are very aware of the brand. Consistent 
with Aaker’s (1991; 1996) and Keller’s (1993; 2013) framework of CBBE, this level of brand 
awareness can enhance the overall brand equity. This outcome supports the extensive 
advertising of herbal medicines on radio and television stations by practitioners in the country, 
to create a high level of brand awareness in the OTC pharmaceutical market. This is important 
because customers usually buy well-known and familiar brands in the market. Therefore, 
creating name recognition for new brands and reminding customers of existing brands in the 
market is one of the important ways of creating value for brands in the market.     
  
This result contrasts sharply with the position of Buil et al. (2013) who asserted that brand 
awareness has positive, but does not directly contribute to enhance brand equity. The authors 
further stated that brand awareness is essential for building brand equity, because buyers must 
be able to recognize and recall the brand in the marketplace, but, after that, brand awareness is 
secondary. However, Keller (2013) highlighted that strong brand awareness creates the 
opportunity for the brand to be considered among a set of handful of brands the customers wish 
to buy. Moreover, brands that have a high degree of awareness convey a sense of familiarity, 
positively influence choice and signal commitment to the brand (Aaker, 1992; 1996).      
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 H2b: Brand Association Positively and Significantly Influence Overall Brand Equity  
The test results also reveal that brand association (ß = 0.273, p = 0.001) positively influences 
overall brand equity in the OTC medicine market. This outcome supports H2b and is consistent 
with the findings of previous research (Gil et al., 2007; Tong & Hawley, 2009) which suggest 
that strong and unique brand association strengthens overall brand equity. This result indicates 
that brand association is one of the important brand assets that provides value for brands of 
herbal medicines in the OTC market. The data in this sample also show that the customers 
perceive that the brands they buy at the OTC market offer good value for money and this forms 
the basis for buying those brands other than the other competing brands. Therefore, customers` 
perceptions of greater perceived value and differentiation are important indicators of high 
overall brand equity in the OTC drug market.   
  
This outcome of the study is also in line with earlier authors (Tong & Hawley, 2009; Gil et al., 
2007) who recognized brand association as a distinct dimension but contrasts with previous 
research (Washburn & Plank, 2002; Yoo & Donthu, 2002; Yoo et al., 2000), which considered 
brand awareness and brand associations as a single dimension of brand equity. The results of 
the current study therefore support Aaker’s (1991; 1996) and Keller’s (1993) framework of 
CBBE which suggests that brand association is a brand asset that supports brand equity. As an 
important source of value in the OTC market, traditional herbal medicine companies need to 
create favourable and unique brand associations to strengthen the value of their brands to 
generate a competitive advantage over the competition.     
  
 H3b: Perceived Quality Positively and Significantly Influence Overall Brand Equity   
The test findings also show that the relationship between perceived quality (ß = -0.061, p = 
0.411) overall value of a brand. Consequently, H3b is unsupported and concurs with the result 
of past research (Tong & Hawley, 2009; Gil et al., 2007) which found that perceived quality 
did not have positive and significant influence on overall brand equity in the Chinese 
sportswear market. This outcome of the study did not support Aaker`s (1996) CBBE 
framework which indicates that perceived quality of product determines the value of a brand 
in the market. 
 
This results indicates that producing herbal medicine packaging that makes the brand function 
well and very reliable alone is not a guarantee for successful brand in the OTC pharmaceutical 
industry.  According to Lassar et al. (1995), brand equity occurs when a customer imposes a 
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greater confidence in a brand compared to competing brands. As a result, the medicinal herbal 
products should not only be reliable and function well but also provide safety consistently to 
customers in the OTC drug market. Consistent with previous authors (Gavin, 1987; Dickov & 
Igić, 2013; Osemene et al., 2011), customers’ perceptions of quality of a product depend on 
the performance, reliability, safety and efficacy of the product. Moreover, due to the influx of 
counterfeit medicines in the OTC market, customers are very concerned about the safety, 
potency and reliability of medicines. These quality attributes can provide strong value for a 
brand in the OTC drug market.   
 
 H4b: Brand Loyalty Positively and Significantly Influence Overall Brand Equity   
Finally, the test results in this sample demonstrate that brand loyalty (ß = 0.451, p < 0.001) 
significantly contributes to strengthen overall brand equity. This outcome supports H4b which 
also concurs with the results of past studies (Tong & Hawley, 2009; Buil et al., 2013; Yoo et 
al., 2000) which indicates that brand loyalty positively influences the overall value of a brand.   
 
This result is also in line with the Aaker`s (1996) CBBE model which suggests that brand 
loyalty has a dominant influence on brand equity. The data set also confirms customers` loyalty 
of plant medicines in the OTC market in Kumasi. The data set shows that the loyal customers 
of herbal medicines are prepared to buy their preferred brand no matter its price compared to 
its competitors and would not also purchase similar brands if the brand is in the store shelves. 
This outcome is consistent with existing literature (Aaker, 1992; Trott & Sople, 2016), which 
suggests that loyal customers have strong preference for a brand, and are less sensitive to price 
increases relative to competitors and also insistent on buying the same brand even if other 
alternatives are available in the store. However, this outcome is contrary to previous empirical 
research findings (Dlaćic & Kezman, 2014; Chaudhuri & Holbrook, 2001) which suggest that 
brand loyalty is an outcome of positive brand equity. Moreover, Buil et al. (2013) pointed out 
that brand loyalty is a dimension but is closer to brand equity compared to the other 
antecedents. Additionally, Aaker (1991) concluded that brand loyalty is both an element and 
an outcome of positive brand equity.    
    
Furthermore, the study found that among the elements of brand equity, brand loyalty (ß = 
0.451) has a greater influence on overall brand equity. This outcome is similar to the result of 
a past empirical study (Tong & Hawley, 2009) which indicates that brand loyalty is the major 
brand asset in the sportswear industry. This result is also supported by Aaker (1991; 1992) who 
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highlighted that brand loyalty is a strategic asset of brand equity in that a large loyal customer 
base translates into a predictable sales and profit stream. Recognizing the strategic importance 
of brand loyalty in the OTC drug market, traditional herbal medicine companies stand to benefit 
if brand loyalty is properly managed and exploited in the OTC drug market. Brand loyalty has 
the potential to reduce competitive pressure, the marketing cost of attracting and serving new 
customers and also to generate word-of-mouth advertising from existing customers.   
   
6.4 To Examine the Influence of Packaging on Brand Awareness in the OTC Drug 
Market   
H1a: Packaging significantly and positively influence brand awareness  
 
The test results show that packaging directly influences brand awareness (ß = 0.826, p < 0.001) 
and confirms H1a. This outcome concurs with earlier studies which indicate that packaging 
positively affects brand awareness (Pieterse, 2001; Underwood, 2003). This outcome is also 
consistent with extant literature (Keller, 1993) which suggests that brand equity is enhanced by 
packaging through the influence of brand awareness.   
  
The data set shows that customers quickly retrieve some attributes of packaging when buying 
plant medicines in the OTC drug market. Moreover, the first thing customers’ recall about the 
brand is the product packaging. This outcome establishes that effective packaging design is an 
important marketing tool that potentially creates awareness of herbal medicines in the OTC 
health care market. Designing attractive packaging can grab attention and sustain customers` 
interest in the brand at the point-of-sale. As an important marketing tool, packaging has the 
potential to strengthen overall value of a brand through the impact of brand awareness in the 
OTC pharmaceutical market. Considering the vital role of packaging in the OTC market, 
traditional medicine companies can use packaging to remind customers` of advertising 
messages to create strong awareness and familiarity of their brands to support overall brand 
equity.   
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6.5 To Examine the Influence of Packaging on Brand Association in the OTC Medicine 
Market  
H2a: Packaging significantly and positively influence brand association 
  
The test results of the hypotheses in this sample also show that packaging (ß = 0.753, p < 0.001) 
significantly contributes to enhance brand association in the OTC drug market. This outcome 
supports H2a and is in line with results of earlier research which indicates that packaging has 
direct effect on brand association (Pieterse, 2001; Underwood, 2003). The data of the research 
reveals that packaging enhances the customers` perceptions of value and preference for the 
image of the brands in the OTC drug market. Enhanced brand image can provide customers 
specific reason to buy and use the brands. This result confirms that packaging is one of essential 
brand cues for supporting brand association in the OTC health care market.   
  
Building favourable and unique brand association through distinctive packaging design can be 
a strong barrier to competitors in the OTC drug market. Thus, packaging contributes to the 
value of brands in the OTC market which can insulate them against competing brands. Indeed, 
packaging is the first point of contact between the prospective buyer and the brand which can 
create either positive or negative impressions about the brand. Plant medicine companies 
therefore need to consider packaging in their image-building activities because customers rely 
on packaging to evaluate the perceptions of value and also to develop positive feelings and 
attitudes towards their brands in the OTC market.   
     
6.6 To Examine the Influence of Packaging on Perceived Quality in the OTC Drug 
Market  
H3a: Packaging significantly and positively influence perceived quality   
 
The test results of the proposed hypotheses demonstrate that packaging directly influences (ß 
= 0.784, p < 0.001) perceptions of brand quality. This result supports H3a and is consistent 
with findings of past research (Edward, 2013), which highlighted that packaging has a direct 
influence on perceptions of quality.  
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The data set reveals that customers rely on packaging to determine the efficacy and reliability 
of herbal medicines in the OTC drug market. This result shows that packaging is an important 
attribute which customers use to evaluate the quality of herbal medicines in the OTC market. 
This outcome concurs with existing literature (Zeithaml, 1988; Underwood, 2003) which 
indicates that packaging is an extrinsic attribute which customers use to assess the intrinsic 
product attributes to infer quality, especially when customers are under time pressure or do not 
have experience to judge the intrinsic attributes of the product. It is therefore important for 
herbal medicine companies to consider packaging in their quality decisions as packaging 
influences customers` perceptions of quality of herbal medicines in the OTC health care 
market.  
 
6.7 To Examine the Influence of Packaging on Brand Loyalty in the OTC Drug Market  
H4a: Packaging significantly and positively influence brand loyalty   
 
The test results of the hypotheses show that packaging (ß = 0.838, p < 0.001) positively 
influences brand loyalty in the OTC drug market. This outcome confirms H4a which indicates 
that packaging potentially strengthens brand loyalty. Consistent with the results of past studies 
which show that packaging positively influences brand loyalty (Dhurup et al., 2014). The data 
set in this sample also confirms that the customers would like to recommend the brands they 
buy to their friends, and keep on buying the same brand as long as they are happy with the 
packaging of the product.  
  
This outcome is in line with existing literature (Aaker, 1991) which indicates that customers 
who are highly committed to a brand often demonstrate strong preference and willingness to 
talk positively about the brand to other potential buyers in the market.   
The study also confirmed that, among the brand equity dimensions, packaging (ß = 0.838) has 
a greater impact on brand loyalty in the OTC medicine market. This demonstrates that 
packaging plays a strategic role in supporting the formation of brand loyalty in the OTC market. 
Therefore, herbal medicines companies will gain substantially if packaging takes a centre stage 
in their brand-building efforts in the OTC health care market.   
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6.8 Chapter Summary   
The chapter reported the significant empirical findings of the research by discussing the 
findings in the context of past studies and existing literature. Medicinal herbal product brands 
sold at the OTC market in Kumasi have demonstrated positive brand equity. The major sources 
of the value of the brands of plant medicines in the OTC market are brand loyalty, brand 
association, strong name awareness. Though there are pockets of herbal medicines sold at the 
OTC market which are not well-packaged to make a substantial impact in the market, there are 
a large number of plant medicines which are distinctively packaged. As a result, these well-
packaged brands have contributed immensely to improve perceived quality, brand awareness, 
brand association and brand loyalty of these brands and ultimately, the overall brand equity in 
the OTC drug market. The ensuing chapter will present the summary, conclusion and 
recommendation of this research.      
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CHAPTER SEVEN 
  
SUMMARY, CONCLUSIONS AND RECOMMENDATIONS  
  
7.1 Introduction   
The preceding chapter presented discussions of the main findings of the research in the light of 
the objectives of the research. This chapter now reports on the summary of the thesis, draws 
conclusions and recommendations from the findings consistent with the objectives of the 
research. The chapter further concludes the research by providing the areas for possible future 
research.   
  
7.2 Summary of the Research     
The research examined the influence of packaging and brand equity on herbal medicines sold 
at the OTC market in Kumasi. As a result, the study evaluated customers’ perceptions of 
packaging of medicinal herbal products in the OTC market in Kumasi. The research also sought 
to investigate the key drivers of value of brands of herbal medicines in the OTC product market 
in Kumasi.   
  
The thesis was made up of seven chapters. The First Chapter presented the overview of the 
research problem at hand and its settings by providing the background information, the research 
problem, research objectives and specifying how the thesis was structured. Despite, the 
numerous advantages conveyed by distinctive packaging design and brand equity in today’s 
competitive business environment, it was noted that traditional herbal medicine firms are yet 
to realize the full benefits in the OTC medicine market in Kumasi. Therefore, it was proposed 
that the introduction of packaging in the strategic brand practices of traditional herbal medicine 
companies can lead to improved performance of brands of herbal medicines in the OTC drug 
market in Kumasi and Ghana as a whole. The chapter outlined three-fold research objectives; 
to examine the influence of packaging on brand equity of herbal medicines in the OTC 
pharmaceutical market; to investigate the brand equity of herbal medicines in the OTC drug 
market; and finally, to examine customers` perceptions of packaging of herbal medicines sold 
at the OTC market in Kumasi Metropolis. The research questions were directly deduced from 
the objectives of the study.    
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The second chapter presented a comprehensive review of extant literature on packaging, brand 
equity, OTC medications and traditional herbal medicine. The literature review chapter also 
revealed that herbal medicines have gained popularity in recent years both in the developing 
and developed world. It was well-noted in the literature review that plant medicines are bought 
to fight against chronic and minor ailments as well as for the maintenance of health and are 
often used as non-prescription medications. The literature reviewed also brought to the fore a 
number of attributes of packaging design which include colour, photography, typography, 
size/shape, material and printed information. The literature reviewed indicates that the 
packaging together with its attributes performs three-fold functions: logistic, marketing and 
environmental roles in the OTC drug market. The chapter also pointed out that the concept of 
brand equity has been operationalized in three different ways: financial-based, customer-based 
and hybrid-based perspectives. However, it was very clear from the marketing literature that 
most authors have approached brand equity based on customer memory-based structures 
focusing on customer perceptions of brand equity.   
  
In Chapter Three, theoretical models of CBBE underpinning the study were discussed. It was 
obvious in the literature review chapter that the most widely-used CBBE models were those 
propounded by the Keller (1993) and Aaker (1991; 1996). Relying on the dimensionality of 
Aaker`s (1996) CBBE model, the researcher developed a conceptual model of brand equity of 
herbal medicines and proposed hypotheses to test the plausibility of the model. The model has 
three distinct theoretical constructs: packaging (exogenous variable), brand equity dimensions 
(mediating variables) and overall brand equity (endogenous variable) based upon which the 
research hypotheses were developed to address the purpose of the study.    
  
The fourth chapter presented the account of how the research was conducted. Issues relating to 
validity and reliability of the test instruments were discussed so as to generate reliable and valid 
results of the study. In order to achieve the objectives of the study, quantitative research 
methodology was used to align the research with the positivist assumptions which underlie the 
study. A survey questionnaire, specifically, closed-ended questions, were employed to gather 
data from 348 customers from 71 shop floors of OTC drug stores. The methodology chapter 
also addressed the ethical issues to ensure that the study was not conducted unethically. In this 
regard, ethical clearance was sought from the Humanities and Social Sciences Research Ethics 
Committee in University of KwaZulu-Natal which was approved with reference number 
HSS/1922/017D.  The data collected was analysed using a statistical software known as Social 
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Package of Statistical Software (SPSS) and aided by Analysis of Moment Structures (Amos) 
version 22, for both descriptive statistics and structural equation modelling respectively.   
     
In Chapter Five, the results from the data analysis were presented and explained. First, 
Cronbach alpha statistics were conducted to analysis the internal consistency reliability of the 
test items and the results were satisfactory. Composite reliability was also undertaken to test 
for construct reliability in the CFA and the results indicate that all the latent variables had 
satisfactory internal consistency reliability. Validity measures were validated through EFA and 
CFA and further supported by AVE and the results proved acceptable. Given that quantitative 
research methodology was employed, numeric data was reported and explained. The chapter 
presented results from both descriptive statistics and inferential statistics, specifically, EFA and 
SEM. Structural equation modelling was carried out in two phases as recommended in the 
literature. First, a measurement model was carried out through CFA to confirm the results of 
the EFA and also to provide a further test for construct reliability and validity. This was 
followed by a structural model to analyse the proposed hypotheses in the study. The chapter 
also reviewed and explained the model fit indices and also provided the path diagrams of both 
the measurement and structural models of the SEM.    
  
In Chapter Six, the researcher discussed the results presented in Chapter Five in relation to the 
extant literature and past studies. Guided by the research objectives, this chapter discussed the 
customer perceptions of packaging of medicinal herbal products distributed at the OTC drug 
market, the brand equity of herbal medicines and the contribution of packaging to the value of 
brands of plant medicines in the OTC pharmaceutical market.   
 
Consistent with past studies, the current research supported the hypotheses that overall brand 
equity is positively affected by brand association, brand awareness and brand loyalty in the 
OTC drug market. Added, a total of 89% of customers who took part in the research were 
happy with the appearance of the herbal medicines. Given this result, the research confirmed 
the proposition that packaging positively and significantly influence overall brand equity of 
herbal medicines through the mediating role of brand association, brand loyalty and brand 
awareness. However, the study supported the hypothesis that brand quality is significantly 
influenced by packaging but rejected the proposition that perceived quality through packaging 
contributes to enhance overall brand equity. Overall, the research established that packaging 
has significant but mediated influence on overall brand equity.   
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In the seventh chapter, the researcher provides the overview of the thesis, highlighting the 
extent to which the empirical results have addressed the research questions and hence, the 
objectives. The chapter highlighted the key findings of the research upon which conclusions 
are drawn, while recommendations and directions for future studies are proposed based upon 
the conclusions and limitations of the research.  
  
7.3 Recommendations  
Based upon the results of the research, the researcher proposes the following recommendations.  
 
 The study found that brand awareness positively and significantly influence the value 
of brands of herbal medicines in the OTC pharmaceutical market. Hence, herbal 
medicine companies should allocate resources to create strong awareness so that the 
brands can be instantly recognized and recalled by customers to enhance their value in 
the OTC pharmaceutical market.  
 
 Moreover, the study confirmed that brand associations contributes to enhance the brand 
equity of herbal medicines in the OTC pharmaceutical market in Kumasi Metropolis. 
Therefore, traditional herbal medicine practitioners should create positive image for 
their brands to increase the value of the brands in the OTC market.  Efforts should also 
be made to improve the product features to enrich the perceived value of the brand to 
support brand associations.   
 
 Furthermore, the study points out that brand loyalty is the major source of value for 
brands of herbal medicines in the OTC market. Recognizing the strategic role of loyalty 
in the OTC drug market, herbal medicine manufacturers should invest more resources 
to develop loyalty and if increased, can enhance the strength of their brands in the OTC 
market in Kumasi Metropolis. 
 
 The study also established that perceived quality has no positive and significant 
influence on the value of brands of herbal medicines sold at the OTC market in Kumasi 
Metropolis. Perceived product quality is recognised as key business thrust for many 
companies and can be the motivation for programs designed to enhance brand equity. 
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Moreover, perceived quality has been identified as one of the top-rated assets that 
provides sustainable competitive advantage for firms (Aaker, 1992).  As a result, 
traditional medicine firms should produce high quality products consistently, especially 
compared to competitors’ products to enrich their customers` perceptions of quality of 
their brands.  
 
 In addition, traditional medicine firms should constantly track and measure customers` 
awareness, association and loyalty of their brands in order to sustain and increase the 
value of their brands in the OTC pharmaceutical market in the Metropolis.  
 
 The results of this study also confirm Aaker`s (1996) customer-based brand equity 
model. In this regard, traditional medicine companies can adopt this model in their 
marketing strategy to provide focus and guidance for assessing previous marketing 
activities and design future marketing actions for their brands.   
 
 The study also found that a large majority (89.0) of the customers were of the view that 
the packaging of herbal medicines was of good quality, whilst 2.1% of them were of 
the opinion that the packaging is bad. Although, a marginal percentage of the customers 
were dissatisfied with the overall packaging of herbal medicines, traditional herbal 
medicine companies still need to improve upon the packaging to enhance customer 
perceptions of overall packaging design of plant medicines in the OTC market.   
 
 The study also revealed that packaging significantly contributes to strengthen brand 
awareness, loyalty, association and perceived quality of herbal medicines in the OTC 
drug market in Kumasi. Consequently, traditional herbal medicine firms should 
frequently track customers` perceptions of packaging, especially the design elements of 
the herbal medicines with the view to supporting the awareness, association, loyalty 
and perceived quality of their brands in the OTC market.   
 
 The findings of the research established that packaging has stronger influence on brand 
loyalty than any other brand equity dimensions in the OTC health market in Kumasi 
Metropolis. As a result, traditional herbal medicine companies should go beyond the 
industry`s regulatory requirements of packaging and design customer-driven packages 
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through the combination of colours, photograph and typography to satisfy their 
customers to support brand loyalty.  
 
 The study also revealed that packaging significantly contributes to strengthen overall 
brand equity of herbal medicines through the mediating impact of brand awareness, 
loyalty and association in the OTC drug market in the Metropolis. Consequently, 
traditional herbal medicine companies should not consider packaging as an afterthought 
but rather prioritize packaging decisions in their branding strategy to develop 
customers’ awareness, associations, loyalty and perceptions of quality to enhance brand 
equity in the OTC drug market in the Metropolis.   
 
 The empirical findings of the research demonstrate that packaging has stronger 
influence on brand loyalty than any other brand equity constructs and hence, overall 
brand equity in the OTC health market in Kumasi. Hence, traditional herbal medicine 
companies should go beyond the industry`s regulatory requirements of packaging and 
design customer-driven packages through the combination of colours, photograph and 
typography to satisfy their customers to support brand loyalty.  
  
7.4 Contribution to Body of Knowledge  
A review of marketing literature shows that many authors have investigated the importance of 
brand equity in the FMCGs industry of late (e.g. Pappu et al., 2005; Buil et al., 2013; Asif et 
al., 2016; Yoo et al., 2000; Gil et al., 2007), but few researchers (e.g. Schuiling & Moss, 2004; 
Panchal et al., 2012; Sanyal & Datta, 2011) have concentrated on the significance of brand 
equity in the OTC pharmaceutical market. Moreover, the few studies focused on the importance 
of brand equity in the orthodox health care industry. Currently, there is little or no research that 
has examined brand equity of herbal medicines in the OTC pharmaceutical market. Therefore, 
the current study is unique and hence, the study has bridged the knowledge gap by contributing 
to advance the existing stock of literature on brand theory of plant medicine in the OTC drug 
market.  
 
The study relied on Aaker`s (1991; 1996) CBBE framework and the findings indicate that the 
drivers of value for brands of herbal medicines in the OTC product market are brand loyalty, 
brand association and brand awareness. These results of the thesis are important since they 
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supplement earlier studies and  have contributed  simultaneously to  the current body of 
knowledge of CBBE  in the OTC health market because this is the first time model of this kind 
has been adopted to empirically examine the brand equity of plant medicines in the OTC drug 
market.  
 
Moreover, the results of this study are important because they have provided knowledge and 
understanding to traditional herbal medicine practitioners on how they can develop, track and 
manage the value of their brands in the OTC pharmaceutical market. More importantly, the 
study confirmed that brand loyalty has greater influence on the value of brands of medicinal 
herbal products in the OTC market. Given the relative scarcity of resources, this would help 
traditional herbal medicine firms to concentrate their efforts to develop brand loyalty to build 
strong brands in the OTC pharmaceutical market.     
  
Moreover, the impact of packaging on customer-buying decisions (e.g. Deliya & Parmar, 2012; 
Silayoi & Speece, 2004; 2007; Rundh, 2005; Rettie & Brewer, 2000) and brand 
communications (e.g. Underwood & Klein, 2002; Underwood, 2003; Agariya et al., 2012) in 
the traditional customer packaged goods market is well-documented in the marketing literature. 
However, few authors have identified the influence of packaging on brand equity (e.g. 
Brodersen & Manolova, 2008; Pieterse, 2013) in the customer packaged goods industry. The 
limited empirical studies concentrated on only the influence of packaging on the brand equity 
constructs rather than on the overall brand equity. Essentially, no previous empirical research 
has investigated the influence of packaging on the overall brand equity. As a result, this thesis 
has contributed to enhance the existing body of knowledge on packaging and brand equity as 
it is one of the few studies that have examined the significance of packaging in supporting the 
overall brand equity, more specifically, in the OTC pharmaceutical market. This has enabled 
the importance of packaging to brand equity to be viewed holistically, particularly, in the OTC 
health care market.   
   
The study employed the dimensionality of Aaker`s (1996) CBBE model to ascertain the 
influence of packaging on overall brand equity of plant medicines in the OTC product market. 
The study found that the overall value of brands of herbal medicines is positively influenced 
by packaging through the mediating impact of brand loyalty, brand awareness and brand 
association. The empirical results of the study have also advanced the current frontiers of 
knowledge of traditional herbal medicine firms as the study has brought to light the key 
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importance of packaging in supporting the formation of brand equity in the OTC 
pharmaceutical market.  Consequently, herbal medicine companies can adopt this model and 
strengthen the overall value of their brands by designing attractive and innovative packaging 
through effective combination of colours, photograph, typography, material, printed 
information and size and shape. The study also established that packaging has a stronger 
influence on brand loyalty and ultimately, overall value of the brand.  
 
Moreover, this thesis is one of the few studies that has empirically confirmed that packaging 
has a significant but indirect effect on brand equity, particularly in the OTC pharmaceutical 
market. As result, the study would equip managers of plant medicine companies with 
knowledge and insight about the strategic role of packaging to brand equity in the OTC health 
care industry.    
  
7.5 Limitations of the Research  
Although the present research is based on robust methodology and extant literature, the study 
had some challenges.  
Not all the herbal medicine retail shops operating in the Kumasi Metropolis had registered with 
the Traditional Medicine Practice Council (TMPC). Hence, only those registered herbal retail 
outlets were included in the study. Moreover, some of the licensed herbal shops operating 
outside the central business district and along the main streets in the metropolis were difficult 
to locate immediately. Maps and directions of locations were not displayed either on billboards 
or digitalized. Directions to some of these shops were made possible through the information 
obtained from the residents in those suburbs.  
Also, the study was restricted to Kumasi Metropolis due to cultural diversity, time and financial 
constraints. This implies that, generalisation of the research findings to the entire nation might 
not be possible. Therefore, a tactful approach was adopted to limit the generalization of the 
results to the city under study only.   
  
Furthermore, the research was conducted on only herbal medicines produced locally and a 
sample was selected from the end-users of this product. Drawing from only a single product 
category suggests that the findings of the research could not be generalized across non-durable 
packaged customer goods. Nonetheless, the findings of the research could be applicable to non-
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prescription orthodox drugs that are sold at the OTC market where there is little or no assistance 
by the health care professionals.    
 
Moreover, Made-in-Ghana herbal medicines are sold online as well as in the shops in Ghana. 
However, this study was limited to only in-store retail environment and consequently, the 
online customers` perceptions of packaging and brand equity of herbal medicines were not 
captured in this research. As a result, the findings of the research could not be generalized to 
the entire OTC retail market.    
 
Furthermore, the study was conducted in the Kumasi metropolis, the second largest city in 
Ghana where majority are literate population and have moderate to high income. This indicates 
that the findings of the study did not include the perceptions of customers who are illiterate, 
poor and reside in rural communities in Ghana.   
 
Finally, the study employed only quantitative research design where closed-ended 
questionnaires were used to capture the views of customers on packaging and brand equity to 
achieve the purpose of the study. Consequently, the current research methodology employed 
did not for in-depth investigation of the research problem.    
   
7.6 Direction for Future Research 
 The purpose of the current study was to examine the influence of packaging and overall brand 
equity of plant medicines in the OTC medicine market in Kumasi Metropolis. Consequently, 
the study was confined only to Kumasi. Therefore, a larger sample of respondents from 
different parts of the country could be included in similar research in order to generalize the 
results across the population in Ghana. While increasing the geographical location of the 
present study, different samples of products could be selected to further enhance the 
generalizability of the findings across wider product categories.  
  
In addition, the current research relied on the quantitative research option where closed-ended 
questions were solely used to capture the views of respondents to address the research problem. 
A similar research is proposed by employing a mixed method paradigm to allow in-depth study 
of the research problem to counter the limitations of the current research methodology.   
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Moreover, customer perceptions of and their attitudes towards packaging and branding might 
change or develop over time. The current research employed a cross-sectional survey to capture 
the perceptions and attitudes of customers on the impact of packaging on brand equity and the 
dimensions of brand equity on brand equity at one point in time. There is a need to employ 
longitudinal survey research to assess the changing customer perceptions and behaviour over 
time to enrich the current study.    
 
The present research employed customer perceptions to study the brand equity of herbal 
medicines sold at the OTC market. To understand the financial outcome of the CBBE of OTC 
herbal medicines, it is further proposed that similar research should be carried out to study the 
financial value of brands of herbal medicines in the OTC pharmaceutical market.  
Moreover, the study was limited to in-store environment and for that matter future research 
should consider online retailing of herbal medicines in Ghana. This could further enhance the 
generalizability of the findings to the retailing of herbal medicines in Ghana.  
The current study investigated consumers` perceptions of one of the elements of a brand (i.e., 
packaging) and its influence on brand equity in the OTC drug market. Future research can be 
carried to examine the other brand elements like, brand name, slogan, symbols, jingles and 
logo and their influence on brand equity in the OTC market.  
     
7.7 Conclusion   
The purpose of this thesis was to examine the influence of packaging and brand equity of herbal 
medicines in the OTC pharmaceutical market. As a result, the study also sought to identify the 
customers’ perceptions of packaging of plant medicines in the OTC market. The research 
further examine the key sources of brand equity of medicinal herbal products in the OTC 
product market.     
  
First, the study established that brand associations, brand awareness and brand loyalty are the 
value-creating assets of brands of herbal medicines in the OTC pharmaceutical market. This 
outcome confirmed the dimensionality of Aaker`s (1996) CBBE model. More importantly, the 
study found that, among the CBBE dimensions, brand loyalty has dominant impact on overall 
value of brands in the OTC health market. The research therefore confirms that brand loyalty 
is the most important characteristics of a healthy brand and concurs with both Aaker`s (1996) 
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and Keller`s (2001) CBBE models which suggest that brand loyalty is the ‘heart’ of brand 
equity.  
  
As competition in the pharmaceutical industry as whole increases and differences in product 
performance get closer and closer, traditional herbal medicine firms can be ahead of the 
competition by developing and managing the dimensions of the brand equity in the OTC 
market. In addition, efforts directed towards developing loyalty in the OTC drug market will 
substantially contribute to enhance the value of brands of herbal medicines. While a company`s 
market offerings can be obsolete and/or copied by similar firms, a strong brand is unique and 
timeless (Kotler & Pfoertsch, 2006). Consequently, branding cannot be considered as an 
afterthought by plant medicine companies but rather prioritize it in their strategic marketing 
decisions.   
  
Moreover, the study points out that a large majority of the customers consider packaging of 
herbal medicines as attractive and durable. As a result, the packaging design of herbal 
medicines contributed significantly to enhance brand awareness, brand loyalty, brand 
association and perceived quality of herbal medicines in the OTC market. The study also 
further confirmed that packaging has indirect impact on brand equity through the mediating 
influence of brand awareness, brand associations and brand loyalty of plant medicines in the 
OTC drug market.  
 
The study therefore establishes that a well-designed packaging strengthens brand loyalty, 
perceived quality, brand image and brand awareness, and hence the overall performance of the 
brands in the OTC market. More importantly, designing appealing packaging for herbal 
medicines will have a dominant impact on brand loyalty and ultimately, the brand strength in 
the OTC medicine market. Although, customers depended on packaging to subjectively 
evaluate the quality of plant medicines, the perceived quality of the herbal medicines induced 
by the packaging was very low to contribute to enhance the overall brand strength of plant 
medicines in the OTC market.   
  
Obviously, a distinctive packaging is as an important brand-building tool as it plays a similar 
role as the marketing communications element in building healthy brands in the OTC 
pharmaceutical market. This confirms that apart from packaging performing logistic functions, 
it is also an important marketing tool in the OTC pharmaceutical market. Ultimately, traditional 
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herbal medicine companies can enhance and sustain brand loyalty, brand awareness and brand 
association and hence, the overall value of their brands by producing distinctive product 
packaging.   
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APPENDICES 
 
Appendix 1A: Herbal Drug Capsules Bought By Respondents   
                        Herbal Medicines Capsules  Frequency  Percent  Valid 
Percent  
Cumulative 
Percent  
Valid  Anti-fatigue & Inflammations  1  3.6  3.6  3.6  
Genecure  1  3.6  3.6  7.1  
Gidi Power  1  3.6  3.6  10.7  
Givers  5  17.9  17.9  28.6  
Kingdom  2  7.1  7.1  35.7  
Osompa  1  3.6  3.6  39.3  
Postarite  1  3.6  3.6  42.9  
Sak  1  3.6  3.6  46.4  
Samenk  2  7.1  7.1  53.6  
Sibi Men  1  3.6  3.6  57.1  
Sibi Womens Capsule  1  3.6  3.6  60.7  
Tinatett  6  21.4  21.4  82.1  
Victory Garlic  1  3.6  3.6  85.7  
Yafo  1  3.6  3.6  89.3  
Zamna  1  3.6  3.6  92.9  
Zipman  2  7.1  7.1  100.0  
Total  28  100.0  100.0    
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Appendix 1B: Herbal Medicine Ointment Bought by Participants    
 Herbal Medicine 
Ointment/Creams  
Frequency  Percent  Valid 
Percent  
Cumulative 
Percent  
Valid  Angel  4  28.6  28.6  28.6  
Boafo Ointment  1  7.1  7.1  35.7  
Dompe Dompe  1  7.1  7.1  42.9  
Ebenezer Ointment  2  14.3  14.3  57.1  
Genecure  1  7.1  7.1  64.3  
ILO Jonns  1  7.1  7.1  71.4  
Laud  2  14.3  14.3  85.7  
Mercy Cream  2  14.3  14.3  100.0  
Total  14  100.0  100.0    
  
  
Appendix 1C: Herbal Medicine Mixture Bought by Participants   
Herbal Medicine Mixtures  Frequency  Percent  Valid Percent  Cumulative Percent  
Valid    1  .4  .4  .4  
Adom  10  4.1  4.1  4.5  
Adutwumwaa  24  9.8  9.8  14.3  
Adwoa Herbal  1  .4  .4  14.8  
Agbevi Tonic  2  .8  .8  15.6  
Akos Herbal  1  .4  .4  16.0  
Alpha Garlic  1  .4  .4  16.4  
Angel  2  .8  .8  17.2  
B.R.S. Mixture  2  .8  .8  18.0  
Bethel GPC  1  .4  .4  18.4  
Champion  1  .4  .4  18.9  
Danni  2  .8  .8  19.7  
Divine Garlic  2  .8  .8  20.5  
Dr. Boateng  2  .8  .8  21.3  
Dr. Forkuo Herbal   2  .8  .8  22.1  
Entras and Appilege  1  .4  .4  22.5  
Enye Mahoden  1  .4  .4  23.0  
Givers  5  2.0  2.0  25.0  
Ibrahim Mixture  2  .8  .8  25.8  
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K and G herbal   2  .8  .8  26.6  
Kingdom  2  .8  .8  27.5  
Lawson Herbal  1  .4  .4  27.9  
M.Y. Caesar Tea  2  .8  .8  28.7  
Madam Catherine  2  .8  .8  29.5  
Malamix  2  .8  .8  30.3  
Rooter Mixture  3  1.2  1.2  31.6  
Sahat  1  .4  .4  32.0  
Sak  1  .4  .4  32.4  
Solak  9  3.7  3.7  36.1  
Sparnis  4  1.6  1.6  37.7  
Sparnis Garlic  4  1.6  1.6  39.3  
 Taabea  100  41.0  41.0  80.3  
Time  41  16.8  16.8  97.1  
Top Tonic  1  .4  .4  97.5  
Ulcerplex  1  .4  .4  98.0  
Victory  2  .8  .8  98.8  
Victory Garlic  1  .4  .4  99.2  
Yaakson  1  .4  .4  99.6  
Yafo  1  .4  .4  100.0  
Total  244  100.0  100.0    
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APPENDIX 2:  INFORMED CONSENT  
  
University of KwaZulu-Natal School of Management, IT and Governance  
Durban, South Africa  
  
Researcher: Peter Oppong Kwasi / 024 660 8781  
Supervisor: Prof Maxwell A. Phiri /+27 33 260 5843  
Date…………………………………………………………………..  
Dear Respondent,   
I am Peter Kwasi Oppong, a Doctor of Philosophy (PhD) student in the School of Management, 
Information Technology and Governance of University of KwaZulu-Natal, Durban in South Africa. 
You are invited to participate in a research study entitled: “The Influence of Packaging and Brand  
Equity on Over-the-Counter Herbal Medicines in Kumasi, Ghana” for my PhD degree. The purpose of 
the research is to identify the contribution of packaging to the value of brands of herbal medicines sold 
at over-the-counter drug market in Kumasi Metropolis.   
Through your participation, I will be able to understand the role of packaging design in strengthening 
the value of brands of herbal drugs sold at over-the-counter drug market. The elements of a brand`s 
value include: brand awareness, brand quality, brand loyalty and customers` mental associations with 
the brand. The results of the research are intended to contribute to improve packaging design and the 
value of brands of herbal medicines sold at the over- the-counter domestic drug market.   
Your participation in this survey is completely voluntary, and you may refuse to participate or withdraw 
from the research at any point in time with no negative consequences. There will be no monetary gain 
from participating in the survey. Moreover, your identity as a participant will be kept confidential and 
anonymous throughout the entire survey and by no means will it appear in print. I would appreciate if 
you would participate and permit me to use your responses for the research purpose only. The data 
provided will also be stored securely during the research and archived for a period of five years at the 
University of KwaZulu-Natal and thereafter, the data will be destroyed.  This research has been ethically 
reviewed and approved by the University of KwaZulu-Natal Humanities and Social Sciences Research 
Ethics Committee with the approval number HSS/1922/017D.   
If you have any queries or concerns about completing the questionnaire, or about participating in the 
research, please do not hesitate to contact my Supervisor on the above listed address or the University 
of KwaZulu-Natal Humanities & Social Sciences Research Ethics Committee at the address below:   
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Humanities & Social Sciences Research Ethics Administration   
Research Office, Westville Campus  
Govan Mbeki Building  
Private Bag X 54001   
Durban, 4000  
KwaZulu-Natal, South Africa  
Tel: 27 31 2604557  
Email: HSSREC@ukzn.ac.za     
The survey should take you approximately 15 minutes to complete. I hope you will take the time to 
complete the survey.   
 
Sincerely,  
 ………………………………                                                                                                                                 
Peter Kwasi Oppong   
  
Required ⃰  
Please, indicate below your consent to participate in this survey.  I hereby:   
                       [  ] Agree to the terms and conditions stated above  
                       [  ] Do Not agree to the terms and conditions stated above  
  
  
APPENDIX 3: QUESTIONNAIRE  
  
SECTION A:  BIOGRAPHICAL DATA  
Please, select the check box that applies to you.  
Gender:  Male [   ] 01    Female [   ] 02   
Age:   18 – 25 years [   ] 01   26 – 35 years   [   ] 02   36 – 45 years [   ] 03   
46 – 60 years [    ] 04   More than 60 years [   ] 05     
Education:  Basic education [    ] 01   Secondary education [    ] 02    Diploma education 03 [    ]  
Tertiary education [    ] 04   any other specify……………………………………  
Occupation/ Profession: Teaching [    ] 01 Trading [    ]02   Artisan  [    ]03   Nurse [    ] 04  Clerk  [     
]05   Security  [    ]06    Manager  [    ]07 any other specify…………………  
Income spend per day: Less than $1[    ] 01   $1 to less than $2 [    ] 02   $2 to less than $4 [    ] 03    
Greater than or equal to $4 [    ] 05   any other specify…………………………  
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SECTION B: BRAND EQUITY DIMENSIONS AND BRAND EQUITY  
Please, tick and fill in the questions that apply to you.   
Do you frequently buy herbal drugs?  Yes 01 [    ]    No 02 [    ]  
Name the brand (s) of herbal drug that you buy frequently……….....................................  
 
SECTION C: ATTRACTIVENESS OF ELEMENTS OF PACKAGING DESIGN  
Please, tick (√) in the box provided below that matches your view on the quality of each element of 
packaging design of herbal drugs that you buy.  
 
Packaging 
Elements  
Extremely   
Good   
Very  
Good  
  
Good  
  
Average   
  
 Bad  
Very  
 Bad  
Extremely  
  Bad  
       1     2      3      4     5     6        7  
Colour                
Photography                
Size/Shape                
Printed  
Information  
              
Packaging   
Material  
              
Typography                
Overall  
Packaging  
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 SECTION D: PACKAGING AND BRAND EQUITY  
Please, indicate the degree at which you agree or disagree with the following statements by ticking 
the boxes provided using the following scale;   1= Strongly Disagree (SD)   
2 =Disagree (D)     3 = Neutral (N)    4 =Agree (A)     5 = Strongly Agree   (SA)  
  
I: Packaging    
                               Statements   1  2  3  4  5  
1  The packaging offer better protection for this brand             
2  The packaging preserves the contents of this brand             
3  The packaging provides enough information about this brand            
4  The packaging of this brand makes this brand environmentally-
friendly   
          
5  The packaging of this brand makes this brand convenient to use            
6  This brand`s packaging makes this brand portable            
  
II:  Brand Awareness   
  Statements   1   2   3   4  5  
1   I am familiar with the packaging of this brand              
2  I can easily recognize the packaging of this brand among other 
competing brands   
          
3  Some characteristics of this brand`s packaging come to my mind 
quickly  
          
4  When I think about this brand, the first thing that comes to my 
mind is its packaging  
          
5  I am aware of the packaging of this brand             
 
V:  Perceived Quality     
  Statements  1   2   3  4   5  
1  The packaging of this brand makes this brand function well               
2  The packaging of this brand makes this brand very reliable             
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3  The packaging of this brand shows that the quality of the brand is 
very high         
          
4  I can always trust this brand`s packaging for quality if I want a 
brand of high quality     
          
5  This brand`s packaging makes the product safe for use             
  
III:  Brand Association  
  Statements  1   2  3  4  5  
1  This brand`s packaging makes this brand offer good value for money             
2  This brand`s packaging makes me like the image of this brand            
3  The packaging of this brand makes the image of this brand unique 
compared to its competing brands    
          
4  The packaging of this brand makes me like and trust the company 
that made this brand  
          
5  The packaging of this brand makes me respect and admire people who 
buy this brand  
          
  
      VI:  Brand Loyalty  
  Statements  1  2  3  4  5  
1  The packaging of this brand would make this brand my first choice 
when buying herbal drug  
          
2  The packaging of this brand would make me recommend this brand to 
my friends   
          
3  Considering this brand`s packaging, I am willing to buy this brand even 
if its price is a little higher than that of competing brands   
          
4  The packaging of this brand makes me loyal to this brand             
5  
  
I will keep on buying this brand as long as I am satisfied with the 
packaging of this brand  
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VII:  Overall Brand Equity   
  Statements  1  2  3  4  5  
1  This brand`s packaging gives me reason to buy this brand instead of 
any other brand, even if they are the same in quality or price   
          
2  The packaging of this brand would make me prefer to buy this brand, 
even if another brand has the same features as this brand  
          
3  The packaging of this brand makes this brand more than a product to 
me  
          
4  This brand`s packaging makes it seems smarter to purchase this brand, 
if another brand is not different from this brand in any way   
          
5  The packaging of this brand makes me prefer this brand, if there is 
another brand as good as this brand   
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